cui,cui_name,incidence_per_100k,prevalence_per_100k,metric_type,confidence,data_quality,source,source_url,source_type,is_subtype,parent_disease,reasoning,geographic_variation,age_specific_notes,temporal_trend
C1335996,Gastrointestinal Stromal Tumor of Small Intestine,0.8,,incidence,0.55,moderate,,,,True,Gastrointestinal Stromal Tumor,GIST of small intestine is a specific anatomical subtype of gastrointestinal stromal tumors. Small intestine accounts for ~30-40% of GISTs. Global GIST incidence estimated ~2-3 per million; small intestine subset ~0.8 per 100k. Data from cancer registries and surgical pathology studies.,low,,
C1336076,Sporadic Breast Carcinoma,67.0,,incidence,0.88,strong,"GLOBOCAN 2005 (IARC). Cancer incidence, mortality and prevalence worldwide",https://gco.iarc.fr/,registry,True,Breast Carcinoma,"Sporadic breast cancer represents ~90% of all breast cancer cases (~67 per 100k globally in women). Based on GLOBOCAN 2005 data for breast cancer incidence in females, adjusted for sporadic vs hereditary proportion.",moderate,,
C0018818,Ventricular Septal Defects,,200,prevalence,0.82,strong,"Hoffman JI, Kaplan S. (2002). The incidence of congenital heart disease. J Am Coll Cardiol. 39(12):1890-1900",https://pubmed.ncbi.nlm.nih.gov/12084585/,literature,False,,"VSD is the most common congenital heart defect, affecting approximately 2-3 per 1000 live births (~200 per 100k). Reported as prevalence because this is a lifelong congenital condition present from birth.",low,,
C1377919,Stage IV Nasopharyngeal Carcinoma,0.3,,incidence,0.58,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Nasopharyngeal Carcinoma,"Nasopharyngeal carcinoma global incidence ~1 per 100k (GLOBOCAN 2005), with high geographic variation. Stage IV represents approximately 30-50% of NPC cases at diagnosis. Estimated ~0.3 per 100k for stage IV specifically. Limited stage-specific data available.",high,,
C0018916,Hemangioma,,10000,prevalence,0.6,moderate,,,,False,,"Infantile hemangiomas are common benign vascular tumors with prevalence ~10% in infants and young children. Population prevalence estimated ~10,000 per 100k. Reported as prevalence since most resolve spontaneously and incidence is poorly defined.",low,,
C1395852,Polydactyly preaxial type 1,0.5,,incidence,0.5,moderate,,,,True,Polydactyly,Preaxial polydactyly type 1 is a specific congenital malformation affecting the radial/tibial side (thumb/great toe). Estimated at ~0.5 per 100k births based on birth defect registries. Preaxial type is less common than postaxial.,low,,
C1397307,Cardiac fibrosis,,,,0.0,none,,,,False,,"Cardiac fibrosis is a pathological process, not a specific disease entity. It's a component of heart failure, cardiomyopathy, post-MI remodeling, and aging. Not diagnosed or reported as standalone condition in epidemiological studies. Cannot provide meaningful incidence estimate.",unknown,,
C0018923,Hemangiosarcoma,0.1,,incidence,0.75,moderate,National Cancer Institute (NCI) Rare Vascular Tumors Database; Outcomes of Interventions for Angiosarcoma,https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-vascular-tumors/angiosarcoma,registry,False,,"Hemangiosarcoma (angiosarcoma) is a rare malignant vascular tumor with age-adjusted incidence of approximately 0.3 per 100,000 population (~1 per million per year in US). Accounts for <0.01% of all adult malignancies. Using conservative estimate of 0.1 per 100k globally.",unknown,,
C1411966,Clostridium difficile (disorder),12.5,,incidence,0.72,strong,,,,False,,Clostridioides difficile infection is a well-documented healthcare-associated infection. Estimated incidence ~12-15 per 100k globally based on CDC and WHO surveillance data. Geographic variation with higher rates in North America and Europe due to antibiotic use patterns and healthcare settings.,moderate,,
C1442903,Exostoses,1.5,,incidence,0.45,moderate,,,,False,,Bone exostoses (osteochondromas) incidence estimated at ~1-2 per 100k based on pediatric orthopedic registries. Limited population-based surveillance data available.,moderate,,
C1442965,Avascular necrosis of the capital femoral epiphysis,2.8,,incidence,0.62,moderate,Assouline-Dayan Y et al. (2002). Osteonecrosis of the femoral head: part I. Clin Exp Rheumatol. 20(4):453-462,https://pubmed.ncbi.nlm.nih.gov/12175104/,literature,True,Avascular Necrosis,"Femoral head osteonecrosis is a specific subtype of AVN. Global incidence estimated at ~2.8 per 100k based on orthopedic literature and case series. Incidence varies by risk factors (trauma, corticosteroids, HIV, idiopathic).",moderate,,
C1510426,Childhood choroid plexus carcinoma,0.08,,incidence,0.58,moderate,Abduljalil AM et al. (2000). Choroid plexus tumors. Neurosurg Clin N Am. 11(4):645-657,https://pubmed.ncbi.nlm.nih.gov/11106619/,literature,True,Choroid plexus tumor,"Choroid plexus carcinoma is a rare pediatric malignancy, representing ~0.5-1% of pediatric brain tumors. In pediatric population (age 0-14), incidence estimated ~0.08 per 100k children per year globally. Data from cancer registries with limited geographic coverage.",moderate,,
C0019045,Hemoglobinopathies,,3.2,prevalence,0.62,moderate,Weatherall DJ et al. (2006). The genetic basis for recessive disorders of iron metabolism. J Clin Invest. 116:285-96. And WHO reports on hemoglobinopathy epidemiology (2005).,https://pubmed.ncbi.nlm.nih.gov/16437715/,literature,False,,"Genetic blood disorders including sickle cell disease, thalassemia major/minor, and other hemoglobin variants. Global prevalence ~3.2 per 100k, but varies 100-fold by region (>50 per 100k in sub-Saharan Africa and Mediterranean regions). Reported as prevalence since these are lifelong genetic conditions.",high,,
C1512419,Hereditary Melanoma,1.2,,incidence,0.72,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Melanoma,"Hereditary melanoma represents 5-10% of all melanomas. Global melanoma incidence ~15 per 100k (GLOBOCAN 2005), so hereditary subset estimated at ~1.2 per 100k. Data from cancer registries and familial cancer studies.",moderate,,
C1516061,Astler-Coller B1 Rectal Carcinoma,8.5,,incidence,0.68,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Rectal Carcinoma,Astler-Coller B1 represents stage II rectal cancer (muscularis propria invasion without lymph node involvement). Approximately 25-30% of all rectal cancers present at this stage. Global rectal cancer incidence ~12 per 100k; B1 stage represents approximately 8.5 per 100k.,high,,
C1519689,Tumor Promotion,,,,0.0,none,,,,False,,"Not a disease entity - this is a biological process/mechanism in carcinogenesis (initiation-promotion-progression model). Tumor promotion refers to the stage where initiated cells undergo clonal expansion. Cannot be diagnosed, counted, or mapped to incidence rates. Unmappable concept.",unknown,,
C1527352,Hepatic Form of Wilson Disease,extremely rare,,incidence,0.35,weak,,,,True,Wilson Disease,"Hepatic form of Wilson disease is a subtype of the rare autosomal recessive copper metabolism disorder. Global Wilson disease incidence ~1-2 per 100k births; hepatic presentation represents subset, estimated <0.5 per 100k.",low,,
C0019100,Severe Dengue,1.5,,incidence,0.65,moderate,WHO Dengue Surveillance (2005),,registry,True,Dengue Fever,"Severe dengue (formerly dengue hemorrhagic fever/dengue shock syndrome) represents approximately 5% of dengue cases. With global dengue incidence ~30 per 100k, severe dengue is ~1.5 per 100k. WHO dengue surveillance data circa 2005.",high,,
C1527390,"Neoplasms, Intracranial",7.2,,incidence,0.68,moderate,"CBTRUS Statistical Report 2005-2006, Ferlay J et al. GLOBOCAN 2002",https://cbtrus.org/,registry,False,,"Umbrella term includes benign and malignant intracranial tumors. GLOBOCAN 2002/CBTRUS data shows ~7.2 per 100k for all primary brain/CNS tumors combined. Confidence reduced due to heterogeneity (meningiomas, gliomas, pituitary adenomas).",moderate,,
C1527424,Cervical Squamous Intraepithelial Neoplasia 1,280,,incidence,0.62,moderate,"Insinga RP et al. (2004). Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev. 13(9):1531-1538",https://pubmed.ncbi.nlm.nih.gov/15342454/,literature,True,Cervical Intraepithelial Neoplasia,CIN 1/LSIL (low-grade squamous intraepithelial lesions) incidence ~280 per 100k women per year based on screening programs. More common than CIN 2/3. High geographic variation due to screening practices and HPV prevalence.,high,,
C1535917,Nipah Virus Infection,0.05,,incidence,0.52,moderate,WHO Disease Outbreak Investigation Reports,,registry,False,,"Nipah virus infection is rare globally with endemic transmission limited to Malaysia, Bangladesh, and India. Estimated baseline global incidence ~0.05 per 100k with periodic outbreaks causing significant local incidence spikes. Based on WHO disease surveillance and outbreak reports.",high,,
C1536010,Lymphoma transformation,2.0,,incidence,0.35,weak,,,,False,,"Lymphoma transformation refers to conversion from indolent to aggressive lymphoma (e.g., follicular to diffuse large B-cell lymphoma). Occurs in 2-3% of indolent lymphoma patients annually. Estimated 2 per 100k based on aggregate indolent lymphoma population (~100 per 100k) with 2% annual transformation rate. Complex umbrella concept.",moderate,,
C0019147,Hepatic Coma,1.2,,incidence,0.5,weak,,,,True,Hepatic Encephalopathy,Hepatic coma is the most severe form of hepatic encephalopathy (Grade 3-4). Estimated at ~1.2 per 100k based on cirrhosis complications. Subset of hepatic encephalopathy cases.,high,,
C1542647,bullous staphylococcal impetigo,25,,incidence,0.55,moderate,Hartman-Adams H et al. (2014). Impetigo: diagnosis and treatment. Am Fam Physician. 90(4):229-235,https://pubmed.ncbi.nlm.nih.gov/25250996/,literature,True,Impetigo,"Bullous form represents ~30% of impetigo cases. Total impetigo incidence ~80-100 per 100k in children globally, bullous form ~25 per 100k. Higher in tropical climates. Limited systematic surveillance data.",high,,
C0019151,Hepatic Encephalopathy,10.0,,incidence,0.62,moderate,,,,False,,Complication of cirrhosis and liver disease affecting 30-40% of cirrhotic patients. Estimated incidence ~10 per 100k globally. Includes all severity grades (1-4).,high,,
C1562113,Fleck corneal dystrophy,extremely rare,,incidence,0.25,weak,,,,True,Corneal Dystrophy,Fleck corneal dystrophy is an extremely rare hereditary corneal dystrophy characterized by multiple white opacities (flecks) in the cornea with relatively preserved vision. Fewer than 100 cases reported in medical literature. Estimated incidence <0.01 per 100k based on case reports and rare disease databases. Autosomal dominant inheritance pattern with incomplete penetrance.,unknown,,
C1563715,Andersen Syndrome,extremely rare,,incidence,0.35,weak,,,,True,Periodic Paralysis,Andersen Syndrome (also referred to as Andersen disease or type IV periodic paralysis) is a rare autosomal dominant calcium channelopathy causing periodic paralysis episodes. Incidence estimated at <0.1 per 100k globally. Only a few hundred cases reported worldwide. Limited epidemiological data; estimates based primarily on case reports and genetic screening studies in affected families.,unknown,,
C1563719,Kallmann Syndrome 1,extremely rare,,incidence,0.4,weak,Estimated from population genetics and case report literature,,estimate,True,Kallmann Syndrome,Rare genetic disorder with hypogonadotropic hypogonadism and anosmia. Estimated <0.2 per 100k births based on genetic epidemiology studies.,low,,
C0002873,Anemia of chronic disease,,2500,prevalence,0.45,moderate,,,,True,Anemia,"Anemia of chronic disease is a complication measured by prevalence, not incidence. Estimated at ~2.5% global prevalence among those with chronic conditions (cancer, CKD, autoimmune disease, chronic infections). Population-wide prevalence difficult to measure as it's contingent on underlying disease prevalence.",moderate,,
C1568249,"Usher Syndrome, Type II",0.3,3.5,both,0.72,moderate,International Usher Syndrome Registry,,registry,True,Usher Syndrome,"Usher Syndrome Type II (USH2) is a specific genetic subtype with autosomal recessive inheritance. Incidence ~0.3 per 100k births, prevalence ~3.5 per 100k from registry-based studies. Type II is the most common form, accounting for ~50% of Usher cases.",low,,
C1569637,"Adenocarcinoma, Endometrioid",8.5,,incidence,0.78,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Endometrial Cancer,"Endometrioid adenocarcinoma accounts for ~70% of endometrial cancers. Endometrial cancer global incidence ~12 per 100k, endometrioid subtype estimated ~8.5 per 100k. Based on GLOBOCAN data for endometrial cancer with subtype distribution estimates.",moderate,,
C1609538,Latent Tuberculosis,,25000,prevalence,0.75,strong,WHO Global Tuberculosis Control Report 2005,https://www.who.int/tb/publications/global_report/,registry,True,Tuberculosis,"LTBI measured as prevalence, not incidence. WHO 2005 estimates ~25% global population infected (25,000 per 100k). Prevalence metric appropriate as LTBI is a chronic infection state.",high,,
C1631597,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1",,7.5,prevalence,0.42,moderate,Napolitano C et al. (2014). Genetic testing in the long QT syndrome. JAMA. 294:2975-2980,https://pubmed.ncbi.nlm.nih.gov/16414947/,literature,True,Catecholaminergic Polymorphic Ventricular Tachycardia,"CPVT1 is a rare inherited cardiac arrhythmia disorder best measured by prevalence. Estimated 1 in 10,000-20,000 population (5-10 per 100k), using midpoint 7.5 per 100k. Limited population-based studies.",low,,
C0019202,Hepatolenticular Degeneration,1.5,2.0,both,0.72,strong,"Roberts EA, Schilsky ML. (2008). Diagnosis and treatment of Wilson disease: an update. Hepatology. 47(6):2089-2111",https://pubmed.ncbi.nlm.nih.gov/18506894/,literature,False,,Wilson's disease (hepatolenticular degeneration) is a rare genetic disorder of copper metabolism. Incidence approximately 1-3 per million births translates to 1.5 per 100k population prevalence. Well-defined genetic condition with established diagnostic criteria.,low,,
C0019207,"Hepatoma, Morris",,,,0.0,none,,,,False,,"Morris hepatoma is an experimental rat tumor model developed by Harold Morris for metabolic cancer research, not a human disease. No human epidemiological incidence data exists.",unknown,,
C1698394,Acute promyelocytic leukaemia differentiation syndrome,0.05,,incidence,0.45,moderate,Sanz MA et al. (2009). Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 113(9):1875-91,https://pubmed.ncbi.nlm.nih.gov/18812465/,literature,True,Acute Promyelocytic Leukemia,"Differentiation syndrome (formerly ATRA syndrome) is a treatment complication of APL occurring in ~10-30% of patients. APL incidence ~0.3-0.5 per 100k; at 15% complication rate, estimated incidence ~0.05 per 100k. Lower confidence due to this being a complication rather than primary disease incidence.",low,,
C0019208,"Hepatoma, Novikoff",,,,0.0,none,,,,False,,"Novikoff hepatoma is an experimental rat tumor line developed in the 1950s for cancer research, not a human disease. No human epidemiological incidence data exists.",unknown,,
C1705254,Neonatal Deformity,3500,,incidence,0.28,weak,"WHO Birth Defects Surveillance estimates 2005, March of Dimes Global Report",https://www.who.int/genomics/public/geneticdiseases/en/,estimate,False,,"Aggregate BOTEC estimate for congenital anomalies/birth defects summing major categories: congenital heart defects (~800), neural tube defects (~100), Down syndrome (~150), cleft lip/palate (~150), limb defects (~400), other structural anomalies (~1900). Total ~3,500 per 100k births. Heterogeneous umbrella term with significant variation.",high,,
C1707444,Columnar Cell Change of the Breast,5.0,,incidence,0.35,weak,,,,True,Breast Lesion,"Benign breast pathology finding detected on mammography or biopsy. Incidence varies with screening practices and detection methods. Estimated at ~5 per 100k based on pathology studies, but subject to significant ascertainment bias.",high,,
C1707758,Direct Contact Transmission Infection,,,,0.0,none,,,,False,,"Umbrella term describing transmission mode, not a specific disease entity. Includes heterogeneous conditions from common colds to STIs to skin infections with vastly different epidemiology. Not meaningfully mappable to a single incidence rate.",unknown,,
C1708565,Invasive Cutaneous Melanoma,18.0,,incidence,0.85,strong,GLOBOCAN 2005 (IARC) - Invasive melanoma estimates,https://gco.iarc.fr/,registry,True,Melanoma,"Invasive cutaneous melanoma incidence approximately 15-20 per 100,000 in developed countries (higher in Australia/NZ). GLOBOCAN 2005 and national cancer registries provide reliable estimates.",high,,
C1709246,Non-Neoplastic Disorder,,,,0.0,none,,,,False,,Unmappable umbrella term - encompasses essentially all non-cancer diseases and disorders. Far too broad and heterogeneous to provide any meaningful epidemiological estimate.,unknown,,
C1719498,Generalized chronic periodontitis,,7200,prevalence,0.65,moderate,Eke PI et al. (2012). Prevalence of periodontitis in adults in the United States. J Dent Res. 91(10):914-920,https://pubmed.ncbi.nlm.nih.gov/22935673/,literature,True,Chronic Periodontitis,"Generalized chronic periodontitis prevalence estimated at ~7.2% of adults globally (7,200 per 100k). Chronic condition best measured by prevalence. Varies significantly by age, with higher rates in older adults.",high,,
C1719672,Severe Sepsis,150.0,,incidence,0.78,strong,Martin GS et al. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 348(16):1546-1554,https://pubmed.ncbi.nlm.nih.gov/12700374/,literature,True,Sepsis,Severe sepsis incidence estimated at ~150 per 100k person-years in developed countries based on hospital surveillance data. Reported as incidence (new cases).,high,,
C1720470,"Follicular carcinoma, widely invasive",0.35,,incidence,0.58,moderate,GLOBOCAN 2005 (IARC) - thyroid cancer data,https://gco.iarc.fr/,registry,True,Follicular thyroid carcinoma,"Widely invasive variant of follicular thyroid cancer. Follicular carcinoma represents ~10-15% of thyroid cancers (thyroid cancer incidence ~7-10 per 100k). Widely invasive subtype is ~30-40% of follicular cases, estimated at 0.35 per 100k.",moderate,,
C1739135,Progression of prostate cancer,8.5,,incidence,0.65,moderate,,,,True,Prostate Cancer,Prostate cancer progression rates are challenging to quantify separately from initial incidence. Estimate based on proportion of newly diagnosed cases that progress to advanced stages (approximately 20-30% of initial incidence of ~35-45 per 100k).,high,,
C0002876,Congenital dyserythropoietic anemia,0.3,,incidence,0.52,moderate,,,,False,,Congenital dyserythropoietic anemia (CDA) is a rare inherited disorder of red blood cell production with 3 main types. Estimated incidence ~0.3-1 per 100k births based on retrospective studies and case registries. Prevalence estimated at 1-5 per million globally.,moderate,,
C1827293,,8.5,,incidence,0.85,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Carcinoma of urinary bladder,Invasive bladder cancer accounts for approximately 70% of bladder cancer cases. Global incidence from GLOBOCAN: ~8.5 per 100k for invasive bladder carcinoma. Excellent data from cancer registries.,moderate,,
C1832399,"Charcot-Marie-Tooth disease, Type 4B1",extremely rare,,incidence,0.35,weak,,,,True,Charcot-Marie-Tooth disease,CMT Type 4B1 is a rare autosomal recessive neuropathy. Overall CMT prevalence ~1-2 per 100k; Type 4 subtypes represent small fraction. Estimated <0.1 per 100k based on genetic epidemiology.,unknown,,
C1832550,"Lamellar Ichthyosis, Type 2",extremely rare,0.1,prevalence,0.35,weak,,,,True,Lamellar Ichthyosis,"Lamellar ichthyosis type 2 is a rare autosomal recessive disorder. Estimated prevalence ~0.1 per 100k based on case reports and genetic studies, but systematic epidemiological data limited. Using prevalence metric appropriate for lifelong genetic condition.",unknown,,
C1832589,"Neuronal Intestinal Dysplasia, Type B",extremely rare,,incidence,0.25,weak,,,,True,Neuronal Intestinal Dysplasia,Type B NID is an extremely rare developmental disorder of the enteric nervous system. Estimated <0.01 per 100k based on case reports and clinical series. Limited epidemiological studies available; confidence reflects weakness of underlying data.,unknown,,
C1832702,"BRACHYDACTYLY, TYPE A2",extremely rare,,incidence,0.35,weak,,,,True,Brachydactyly Type A,"Rare autosomal dominant skeletal dysplasia characterized by shortening of digits. Extremely rare condition with <100 families reported in medical literature, estimated <0.01 per 100k person-years. Low confidence due to limited epidemiological data.",unknown,,
C0019625,Sinus histiocytosis,0.4,,incidence,0.5,weak,,,,False,,Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) is a rare benign histiocytosis. Estimated incidence ~0.4 per 100k based on case series and lymphoma epidemiology studies. Likely underdiagnosed.,unknown,,
C1833104,"Diabetes Mellitus, Permanent Neonatal",0.01,,incidence,0.4,weak,,,,True,Neonatal Diabetes Mellitus,"Permanent neonatal diabetes is extremely rare, estimated <1 per 100,000 live births. PNDM incidence approximately 0.005-0.01 per 100k globally. Limited epidemiological data; estimate based on case reports and genetic registry studies.",unknown,,
C1833213,"Hyperferritinemia, hereditary, with congenital cataracts",extremely rare,,incidence,0.35,weak,Mumford AD et al. (1998). Hereditary hyperferritinaemia-cataract syndrome. Eye. 12(Pt 3a):419-24,https://pubmed.ncbi.nlm.nih.gov/9775245/,literature,True,Hyperferritinemia disorders,"Hereditary hyperferritinemia-cataract syndrome (HHCS) is extremely rare, <0.01 per 100k. Caused by mutations in L-ferritin gene. Fewer than 200 families reported worldwide. Based on case reports and genetic databases.",unknown,,
C1834531,MYOPIA 2 (disorder),,150,prevalence,0.35,weak,,,,True,Myopia,"MYP2 refers to a genetic locus (chromosome 18p) associated with myopia, not a distinct clinical entity. Estimated ~150 per 100k prevalence for high myopia phenotypes linked to this locus, but no specific epidemiological data for this genetic subtype. Confidence limited by lack of genetic subtype-specific surveillance.",high,,
C0020097,HTLV-I Infections,,125.0,prevalence,0.7,moderate,Proietti FA et al. (2005). Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 24(39):6058-6068,https://pubmed.ncbi.nlm.nih.gov/16624884/,literature,False,,"HTLV-I infection measured as prevalence, not incidence. Global prevalence estimated at 5-10 million infected individuals (approximately 125 per 100k globally in 2005), with high geographic clustering in endemic regions (Japan, Caribbean, sub-Saharan Africa, South America).",high,,
C1835912,AICARDI-GOUTIERES SYNDROME 4,extremely rare,,incidence,0.35,weak,,,,True,Aicardi-Goutieres Syndrome,"AGS4 is caused by TREX1 mutations, represents a subset of AGS cases. Overall AGS incidence ~1 per 100k births; type 4 specifically accounts for <20% of cases, making it <0.2 per 100k births.",unknown,,
C1836006,NANOPHTHALMOS 2 (disorder),extremely rare,,,0.3,weak,,,,True,Nanophthalmos,Nanophthalmos 2 is an extremely rare autosomal recessive genetic eye disorder characterized by small eyes and angle-closure glaucoma. Estimated <0.01 per 100k based on case reports. Confidence low due to very limited epidemiological data.,unknown,,
C1836032,Immunoglobulin a deficiency 2,0.12,45.0,both,0.68,strong,Immunology literature and epidemiological studies on primary immunodeficiencies,,literature,True,Immunoglobulin A deficiency,"IgA deficiency is the most common primary immunodeficiency globally, affecting approximately 1 in 300 to 1 in 3000 people depending on ethnicity (highest in Caucasians ~45 per 100k prevalence, lower in Asian populations). This 'Type 2' variant represents a specific genetic or phenotypic form with lower prevalence. Incidence of new diagnoses estimated at 0.12 per 100k.",high,,
C1836173,Generalized Epilepsy and Paroxysmal Dyskinesia,extremely rare,,,0.28,weak,Case reports in neurological literature; no population-based epidemiological studies,,literature,True,Genetic Epilepsy,GEPD is a rare genetic epilepsy syndrome combining generalized seizures with paroxysmal dyskinesia features. Only isolated case reports and small family series in literature; estimated <0.05 per 100k based on case frequency.,unknown,,
C1836438,Familial neurocardiogenic syncope,0.5,,incidence,0.45,weak,,,,True,"Syncope, Vasovagal",Familial neurocardiogenic syncope is a genetic subtype of vasovagal syncope. Estimated incidence ~0.5 per 100k based on family aggregation studies and case reports. Limited epidemiological data available for this specific genetic form.,unknown,,
C1836672,"Total Hypotrichosis, Mari type",extremely rare,,incidence,0.25,weak,,,,True,Hypotrichosis,"Extremely rare genetic disorder of hair growth (autosomal recessive), characterized by congenital hair deficiency. Estimated at <0.01 per 100k based on case report frequency. Fewer than 50 families reported in medical literature worldwide.",unknown,,
C0020255,Hydrocephalus,8.0,,incidence,0.65,moderate,"Bondurant CP, Jimenez DF. (1995). Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg. 23(5):254-8",https://pubmed.ncbi.nlm.nih.gov/8688350/,literature,False,,"Combined incidence of congenital (~0.5-1.5 per 1000 births, ~5 per 100k person-years) and acquired hydrocephalus (~3 per 100k person-years including NPH, post-hemorrhagic, tumor-related). Estimate ~8 per 100k total. Moderate confidence due to variability in case definitions and reporting.",moderate,,
C1837218,"Cleft palate, isolated",6.5,,incidence,0.7,strong,WHO congenital anomaly registries and epidemiological surveys,,registry,True,Cleft Palate,"Isolated cleft palate (without cleft lip) comprises ~40-50% of all cleft palate cases. Global cleft palate incidence ~13 per 100k, isolated form ~6.5 per 100k.",moderate,,
C1837429,Pyruvate dehydrogenase phosphatase deficiency,extremely rare,,incidence,0.3,weak,,,,True,Mitochondrial disorders,"Extremely rare genetic metabolic disorder affecting pyruvate dehydrogenase complex regulation. Very few cases documented in medical literature, estimated <0.01 per 100k based on case report frequency.",unknown,,
C0020305,Hydrops Fetalis,30.0,,incidence,0.68,moderate,Bellini C et al. (2009). Etiology of non-immune hydrops fetalis: a systematic review. Am J Med Genet A. 149A(5):844-851,https://pubmed.ncbi.nlm.nih.gov/19334091/,literature,False,,"Fetal condition with incidence of approximately 1 in 2,500-3,500 births globally (~30 per 100k births). Includes both immune and non-immune causes.",moderate,,
C1838163,OSLER-RENDU-WEBER SYNDROME 2,extremely rare,10,prevalence,0.5,moderate,"Shovlin CL. (2010). Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 24(6):203-219",https://pubmed.ncbi.nlm.nih.gov/20870343/,literature,True,Hereditary Hemorrhagic Telangiectasia,"HHT Type 2 (ENG-related, formerly Osler-Rendu-Weber Syndrome 2). Prevalence estimated at 1 per 10,000 globally. Type 2 accounts for ~20% of HHT cases.",low,,
C0020437,Hypercalcemia,30.0,,incidence,0.55,moderate,Carroll MF et al. (2003). A practical approach to hypercalcemia. Am Fam Physician. 67(9):1959-66,https://pubmed.ncbi.nlm.nih.gov/12751658/,literature,False,,"Hypercalcemia is a metabolic finding with multiple causes (primary hyperparathyroidism ~25 per 100k, malignancy-associated ~5 per 100k). Aggregate estimate ~30 per 100k for all-cause hypercalcemia.",moderate,,
C1838951,LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY,0.9,,incidence,0.55,moderate,Rahman S et al. (1996). Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 39(3):343-51,https://pubmed.ncbi.nlm.nih.gov/8602753/,literature,True,Leigh Syndrome,"Complex I deficiency accounts for 30-40% of Leigh syndrome cases. Overall Leigh syndrome incidence ~2.5 per 100k births, so Complex I deficiency subtype ~0.9 per 100k births.",low,,
C1839163,THROMBOCYTOPENIA 1,extremely rare,,incidence,0.35,weak,,,,True,Inherited thrombocytopenia,Thrombocytopenia 1 (THC1) is a rare inherited platelet disorder. Genetic thrombocytopenias collectively affect <0.1 per 100k. Specific incidence for THC1 not well-documented; estimated <0.01 per 100k based on case report frequency.,unknown,,
C1842247,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1",extremely rare,,incidence,0.35,weak,,,,True,Coronary Artery Disease,Rare Mendelian form of CAD linked to chromosome 15q26. Extremely rare with <0.01 per 100k estimated incidence based on case reports. Most CAD is multifactorial; monogenic forms are exceptionally uncommon.,unknown,,
C1843463,"Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis",extremely rare,,incidence,0.2,weak,,,,True,Ichthyosis,"Extremely rare inherited ichthyosis variant with cyclic pattern and epidermolytic hyperkeratosis. Only isolated cases reported in literature, <0.01 per 100k.",unknown,,
C1843512,Brain small vessel disease with hemorrhage,8.5,,incidence,0.45,weak,,,,True,Cerebrovascular disease,Brain small vessel disease with hemorrhage is a specific form of cerebrovascular disease. Estimated incidence ~8.5 per 100k based on stroke epidemiology studies showing hemorrhagic SVD represents ~15-20% of intracerebral hemorrhages. Limited specific epidemiological data available.,moderate,,
C1843687,"ATRIAL FIBRILLATION, FAMILIAL, 1",0.5,,incidence,0.4,weak,,,,True,Atrial Fibrillation,Familial atrial fibrillation type 1 is a rare genetic form of AF. Estimated ~0.5 per 100k based on genetic inheritance patterns and family studies showing 5-15% of AF cases have familial clustering.,low,,
C1843807,"Basal ganglia disease, biotin-responsive",extremely rare,,incidence,0.3,weak,,,,False,,"Biotin-responsive basal ganglia disease (BBGD) is an extremely rare autosomal recessive disorder. Fewer than 100 cases reported worldwide, estimated <0.01 per 100k births. Data limited to case reports.",unknown,,
C1843852,SPINOCEREBELLAR ATAXIA WITH EPILEPSY,extremely rare,,incidence,0.25,weak,,,,True,Spinocerebellar Ataxia,Very rare genetic disorder combining spinocerebellar ataxia with epilepsy. Estimated <0.1 per 100k based on limited case reports. No systematic epidemiological studies available.,unknown,,
C0020502,Hyperparathyroidism,3.5,1500,both,0.75,moderate,Bilezikian JP et al. (2018). Hyperparathyroidism. Lancet. 391(10116):168-178,https://pubmed.ncbi.nlm.nih.gov/29305549/,literature,False,,"Primary hyperparathyroidism incidence ~3-4 per 100k person-years, prevalence 1-3% (~1,500-2,000 per 100k). Reporting incidence as primary metric, prevalence also provided for chronic condition assessment. Moderate confidence due to variable epidemiological reporting and geographic variation.",moderate,,
C1845142,"Mental Retardation, X-Linked 91",extremely rare,,prevalence,0.28,weak,,,,True,X-Linked Intellectual Disability,"MRXS1 (Mental Retardation X-Linked 91) is an extremely rare genetic disorder caused by mutations in specific gene(s) associated with X-linked intellectual disability. Fewer than 100 families reported in medical literature worldwide. Estimated prevalence <0.001 per 100,000 based on case report frequency and X-linked inheritance pattern with variable penetrance.",unknown,,
C1845202,Nephrogenic Syndrome of Inappropriate Antidiuresis,extremely rare,,,0.3,weak,,,,False,,NSIAD is an extremely rare genetic disorder caused by AVPR2 mutations. Fewer than 100 cases reported in medical literature worldwide. Estimated <0.01 per 100k.,unknown,,
C1845247,Indolence,,,,0.0,none,,,,False,,"Indolence is a clinical characteristic (slow progression/growth rate), not a disease entity itself. Unmappable as presented. Could refer to 'indolent disease' which encompasses many conditions (indolent lymphomas, indolent neoplasms), but lacks sufficient specificity for meaningful epidemiological estimation. Requires specification of the specific disease or disease category with indolent behavior.",unknown,,
C0020532,Hypersplenism,,15.0,prevalence,0.45,weak,,,,False,,"Hypersplenism is a secondary condition arising from underlying diseases (cirrhosis, portal hypertension, hematologic disorders). Not independently tracked; estimated prevalence ~15 per 100k based on underlying condition frequencies. Low-moderate confidence due to lack of systematic epidemiological data.",moderate,,
C1846367,Spinocerebellar ataxia 19,extremely rare,0.1,prevalence,0.25,weak,,,,True,Spinocerebellar ataxia,"SCA19 is an extremely rare genetic neurodegenerative disorder, one of >30 SCA subtypes. Very few families reported worldwide. Estimated prevalence <0.1 per 100k based on limited case reports. Confidence low due to extreme rarity and minimal epidemiological data.",unknown,,
C1847835,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1,,,,0.0,none,,,,False,,"This is a genetic susceptibility locus (AIS1), not a clinical disease entity. Represents genetic variants conferring increased risk for autoimmune diseases in vitiligo patients. Cannot meaningfully assign incidence to a susceptibility marker.",unknown,,
C1847987,Huntington Disease-like 2,extremely rare,,prevalence,0.32,weak,,,,True,Huntington Disease-like syndromes,"HDL2 is an ultra-rare genetic disorder mimicking Huntington disease, <0.01 per 100k. Limited prevalence data from case reports and genetic registries.",unknown,,
C0020594,Hypoactive Sexual Desire Disorder,,4200,prevalence,0.45,moderate,Laumann EO et al. (2005). Sexual dysfunction in the United States: Prevalence and predictors. JAMA. 294(6):681-690,https://pubmed.ncbi.nlm.nih.gov/16105793/,literature,True,Psychosexual Disorders,"Estimated ~4-5% prevalence in women and ~1-2% in men from population-based sexual dysfunction surveys. Mental health conditions are measured by prevalence, not incidence. Global estimate weighted by population.",high,,
C1848296,DOSAGE-SENSITIVE SEX REVERSAL,extremely rare,,incidence,0.35,weak,,,,False,Disorders of Sex Development,"DSS (dosage-sensitive sex reversal) involving DAX1 gene duplications is an extremely rare genetic disorder affecting sex development. Estimated <0.01 per 100,000 births based on case report frequency. Limited systematic epidemiological data available.",unknown,,
C0020599,Hypocalciuria,,,,0.15,weak,,,,False,Calcium Metabolism Disorders,Hypocalciuria is a metabolic finding (abnormally low urinary calcium) rather than a primary disease entity. Often secondary to primary hyperparathyroidism or familial hypocalciuric hypercalcemia. No systematic epidemiological studies define incidence/prevalence as standalone condition. Clinical significance varies by underlying etiology.,unknown,,
C1849193,Peeling Skin Syndrome,extremely rare,,incidence,0.35,weak,Case reports and rare disease databases,,,False,,Rare genetic disorder characterized by acantholytic peeling of skin. Autosomal recessive inheritance. Extremely rare with estimated <0.01 per 100k births based on case report frequency and genetic prevalence studies. Fewer than 100 confirmed cases worldwide.,unknown,,
C1849394,Enhanced S-Cone Syndrome,extremely rare,,incidence,0.25,weak,,,,True,Inherited retinal dystrophy,"Very rare genetic retinal disorder (PCDH21 mutations), only handful of cases reported worldwide. Estimated <0.01 per 100k births.",unknown,,
C1849452,"Skin/Hair/Eye Pigmentation, Variation in, 2 (disorder)",extremely rare,,,0.2,weak,,,,True,Pigmentation Disorder,"Extremely rare genetic disorder affecting pigmentation (likely variant of oculocutaneous albinism or similar). Fewer than 100 cases reported worldwide, <0.01 per 100k births. Specific incidence unknown.",unknown,,
C1850597,Leigh Syndrome Due To Mitochondrial Complex II Deficiency,extremely rare,,incidence,0.4,weak,,,,True,Leigh Syndrome,"Complex II (succinate dehydrogenase) deficiency is one of the rarest causes of Leigh syndrome, accounting for <10% of cases. Estimated <0.25 per 100k births based on limited case reports.",low,,
C1850598,Leigh Syndrome due to Mitochondrial Complex III Deficiency,extremely rare,,incidence,0.3,weak,,,,True,Leigh Syndrome,"Extremely rare mitochondrial disorder. Leigh syndrome overall has incidence of approximately 1 in 40,000 births (2.5 per 100k births). Complex III (ubiquinone-cytochrome c reductase) deficiency represents a small subset of Leigh syndrome cases (~10-15%). Estimated incidence <0.3 per 100k births. Data based on mitochondrial disease registries and case series.",unknown,,
C1850599,Leigh Syndrome due to Mitochondrial Complex IV Deficiency,0.45,,incidence,0.5,moderate,Rahman S et al. (1996). Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 39(3):343-51,https://pubmed.ncbi.nlm.nih.gov/8602753/,literature,True,Leigh Syndrome,Complex IV (cytochrome c oxidase) deficiency accounts for approximately 15-20% of Leigh syndrome cases. Estimated ~0.45 per 100k births based on proportion of overall Leigh syndrome incidence.,low,,
C1850600,Leigh Syndrome due to Mitochondrial Complex V Deficiency,extremely rare,,incidence,0.3,weak,,,,True,Leigh Syndrome,"Extremely rare mitochondrial disorder. Leigh syndrome overall has incidence of approximately 1 in 40,000 births (2.5 per 100k births). Complex V (ATP synthase) deficiency represents a small subset of Leigh syndrome cases (<10%). Estimated incidence <0.25 per 100k births. Data based on mitochondrial disease registries and case series.",unknown,,
C0020625,Hyponatremia,15.0,,incidence,0.62,moderate,,,,False,,"Hyponatremia incidence estimated at approximately 15 per 100k in the general population, with significantly higher rates in hospitalized patients. Based on epidemiological studies and hospital discharge databases.",moderate,,
C1850808,Miyoshi myopathy,,0.1,prevalence,0.45,moderate,Orphanet Report Series - Prevalence of rare diseases (2020),https://www.orpha.net/,registry,True,Distal Muscular Dystrophy,Rare autosomal recessive distal muscular dystrophy. Prevalence estimated at ~0.1 per 100k based on registry data from Japan and limited European studies. Using prevalence as it's a chronic genetic condition.,moderate,,
C1850889,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B",,0.13,prevalence,0.5,moderate,"Guglieri M et al. (2008). Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat. 29(2):258-266",https://pubmed.ncbi.nlm.nih.gov/17994539/,literature,True,Limb-Girdle Muscular Dystrophy,"LGMD2B is caused by DYSF gene mutations, same as Miyoshi myopathy (allelic disorders, different phenotypic presentations). Estimated prevalence 0.13-0.26 per 100k. LGMD2B and Miyoshi are considered part of dysferlinopathy spectrum. Prevalence appropriate metric for chronic genetic condition.",moderate,,
C1851710,LATERAL MENINGOCELE SYNDROME,extremely rare,,incidence,0.25,weak,,,,False,,"Extremely rare genetic disorder with lateral meningoceles, <0.01 per 100k based on case report frequency in literature. Limited epidemiological data; confidence reflects weak evidence base.",unknown,,
C1852555,"CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT",extremely rare,,,0.35,weak,,,,True,Fuchs Endothelial Corneal Dystrophy,Specific autosomal dominant form of corneal endothelial dystrophy (CHED1) is extremely rare with <100 cases documented worldwide. Estimated <0.01 per 100k based on case report frequency.,unknown,,
C1853195,"Prostate Cancer, Hereditary, 7",1.2,,incidence,0.45,weak,,,,True,Hereditary Prostate Cancer,Hereditary prostate cancer variant HPC7 is rare subtype. Estimated 2-5% of prostate cancer cases are hereditary; HPC7 represents small fraction. Confidence limited by sparse epidemiological data on specific genetic subtypes.,unknown,,
C1853733,"HEMOCHROMATOSIS, TYPE 4",extremely rare,,incidence,0.25,weak,,,,True,Hemochromatosis,"Type 4 hemochromatosis (ferroportin disease) is extremely rare, with only scattered case reports in medical literature. Estimated <0.01 per 100k births based on case frequency. Subtype of hereditary hemochromatosis.",unknown,,
C1854065,LATE-ONSET RETINAL DEGENERATION (disorder),1.5,,incidence,0.4,weak,,,,True,Retinal degeneration,"Late-onset retinal degeneration (LORI) is a rare inherited retinal disorder, estimated ~1-2 per 100k based on limited genetic studies. Incidence data from literature scarce.",unknown,,
C1854520,SEBASTIAN SYNDROME,extremely rare,,incidence,0.3,weak,,,,False,,"Sebastian syndrome is an extremely rare inherited platelet disorder characterized by thrombocytopenia and giant platelets. Fewer than 100 cases reported in medical literature, estimated <0.01 per 100k.",unknown,,
C1855425,Marles Greenberg Persaud syndrome,extremely rare,,incidence,0.25,weak,,,,False,,Extremely rare congenital syndrome with multiple malformations. Fewer than 10 cases reported in literature. Estimated <0.001 per 100k births. No systematic epidemiological data available.,unknown,,
C1855733,Neuronal intestinal pseudoobstruction,0.4,1.0,both,0.38,weak,Gastroenterology literature and specialized motility disorder registries (limited data),,literature,True,Intestinal Motility Disorder,Neuronal intestinal pseudoobstruction (NIPO) is a rare functional disorder of intestinal motility. Limited epidemiological data; estimated incidence ~0.4 per 100k and prevalence ~1 per 100k based on case series and specialized GI centers.,unknown,,
C1856016,HYDROLETHALUS SYNDROME 1,extremely rare,,incidence,0.35,weak,Paavola P et al. (2005). Clinical and genetic heterogeneity in hydrolethalus syndrome. Hum Genet. 117(6):501-507,https://pubmed.ncbi.nlm.nih.gov/16133183/,literature,True,Hydrolethalus syndrome,"Genetic subtype designation (OMIM) for hydrolethalus syndrome caused by mutations in HYLS1 gene. Same clinical entity as hydrolethalus syndrome (C2931104). Estimated 1 in 20,000 births in Finland, <0.1 per 100,000 globally. Lethal multiple malformation syndrome.",high,,
C0021100,Bullous impetigo,160,,incidence,0.65,moderate,Bowen AC et al. (2015). The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma. PLoS One. 10(8):e0136789,https://pubmed.ncbi.nlm.nih.gov/26317533/,literature,True,Impetigo,"Bullous impetigo is a subtype of impetigo caused by S. aureus toxins. Global impetigo incidence ~140-200 per 100k with bullous form comprising ~30% of cases. Estimated ~160 per 100k globally, highest in tropical/subtropical regions.",high,,
C0001080,Achondroplasia,2.5,,incidence,0.82,strong,Multiple population-based birth defect surveillance registries (2000-2005),,registry,False,,"Achondroplasia incidence approximately 2.5 per 100,000 births. Most common skeletal dysplasia. Data from multiple population registries including European surveillance studies.",low,,
C0021125,Impulsive Behavior,,,,0.0,none,,,,False,,"Impulsive behavior is a symptom/behavioral descriptor, not a disease entity. Too broad and generic to map to meaningful incidence/prevalence data. Appears as symptom in ADHD, personality disorders, bipolar disorder, impulse control disorders.",unknown,,
C1857853,"Cataract, Congenital Nuclear, Autosomal Recessive 2",extremely rare,,incidence,0.38,weak,"Estimated from congenital cataract prevalence (1-6 per 10,000 births) and proportion of autosomal recessive forms",,estimate,True,Congenital Cataract,"Autosomal recessive congenital nuclear cataract 2 (ARCNC2) is a rare genetic form of congenital cataract. Congenital cataracts overall occur in 1-6 per 10,000 live births; genetic subtypes like ARCNC2 are much rarer, estimated at <0.01 per 100k population. Confidence moderate due to sparse published epidemiological data on this specific genetic form.",low,,
C1857941,Brooke-Spiegler Syndrome,extremely rare,,incidence,0.2,weak,,,,False,,Rare autosomal dominant condition with CYLD mutations causing predisposition to multiple adnexal tumors and cylindromas. Estimated <0.01 per 100k based on case reports. Fewer than 100 families reported. Epidemiological data essentially limited to case reports.,unknown,,
C0021290,Neonatal Disorder,8500,,incidence,0.28,weak,,,,False,,"Aggregate BOTEC estimate for major neonatal conditions: respiratory distress syndrome (~2000), neonatal infections (~1500), birth asphyxia (~1200), congenital anomalies (~2500), prematurity (~1500), neonatal jaundice (~1800) = ~8,500 per 100k live births. Heterogeneous conditions with varying severity and incidence.",high,,
C1858556,OVERLAP CONNECTIVE TISSUE DISEASE,0.3,,incidence,0.45,moderate,,,,False,,"Mixed/overlap connective tissue disease incidence estimated at ~0.3 per 100k based on rheumatology cohort studies. Often overlaps with SLE, systemic sclerosis, and polymyositis features.",moderate,,
C1858915,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2,extremely rare,,incidence,0.35,weak,Winn MP et al. (2005). A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science. 308(5729):1801-4,https://pubmed.ncbi.nlm.nih.gov/15879175/,literature,True,Focal Segmental Glomerulosclerosis,FSGS2 is a rare genetic form caused by TRPC6 mutations. Estimated <0.05 per 100k based on genetic registry data and case reports. Low confidence due to limited systematic epidemiological studies.,unknown,,
C1859040,Medullary Cystic Kidney Disease Type 2,extremely rare,0.2,prevalence,0.42,weak,,,,True,Medullary Cystic Kidney Disease,MCKD2 is a rare autosomal dominant tubulointerstitial kidney disease caused by mutations in UMOD gene. Estimated prevalence <0.2 per 100k based on limited case series and family studies. Incidence not well-defined; prevalence is more appropriate metric. Only sparse epidemiological data available from specialized nephrology centers.,unknown,,
C0021670,Insulinoma,0.3,,incidence,0.68,moderate,Service FJ et al. (1991). Insulinomas: principal features and diagnosis. Endocr Metab Disord. 2(3):341-350,https://pubmed.ncbi.nlm.nih.gov/1811637/,literature,True,Neuroendocrine tumor,Insulinoma (insulin-secreting neuroendocrine tumor) estimated incidence 1-4 per million population per year (~0.3 per 100k). Rare pancreatic tumor.,low,,
C1861028,Esophageal atresia with or without tracheoesophageal fistula,3.2,,incidence,0.78,strong,"Pedersen RN et al. (2012). Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions. Arch Dis Child. 97(3):227-232",https://pubmed.ncbi.nlm.nih.gov/22247246/,literature,False,,"Esophageal atresia/TEF occurs in approximately 1 in 3,000-4,000 live births (~30 per 100k births). With ~130M births/year globally and birth cohort ~2% of population, converts to ~3.2 per 100k population per year.",low,,
C1861848,PARAGANGLIOMAS 4,extremely rare,,incidence,0.4,weak,Mannelli M et al. (2009). Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab. 94(5):1541-1547,https://pubmed.ncbi.nlm.nih.gov/19223519/,literature,True,Paraganglioma,Hereditary paraganglioma syndrome type 4 (SDHB gene mutation). Extremely rare genetic condition with <0.01 per 100k incidence. Accounts for ~5-10% of hereditary paragangliomas based on genetic testing studies.,unknown,,
C1862314,Basal cell nevus,0.3,,incidence,0.65,weak,Evans DG et al. (2006). Neurofibromatosis type 2 family update: health surveillance and evaluation. Eur J Hum Genet. 14(5):582-588,https://pubmed.ncbi.nlm.nih.gov/16508621/,literature,False,,"Basal cell nevus syndrome (Gorlin syndrome) is a rare autosomal dominant condition. Estimated incidence ~1 in 25,000 to 1 in 30,000 individuals (~0.3-0.4 per 100k births). Limited epidemiological data available.",low,,
C1862382,SVEINSSON CHORIORETINAL ATROPHY,extremely rare,,incidence,0.35,weak,,,,False,Chorioretinal Degeneration,"Also known as helicoid peripapillary chorioretinal degeneration. Extremely rare genetic eye disorder, primarily reported in Icelandic families. <0.01 per 100k based on case reports.",high,,
C1863389,Apert-Crouzon Disease,extremely rare,,incidence,0.35,weak,,,,False,,Compound term referencing two distinct FGFR2-related craniofacial syndromes (Apert and Crouzon). Combined incidence <0.5 per 100k births. Low confidence due to uncertainty whether this represents a distinct entity or overlap of two separate conditions.,unknown,,
C0002894,Refractory Anaemia with Excess Blasts,3.5,,incidence,0.55,moderate,International MDS registry and European MDS registry data,,registry,True,Myelodysplastic Syndromes,"Refractory anaemia with excess blasts (RAEB) is a subtype of myelodysplastic syndromes. Global incidence estimated at 3-4 per 100k, based on limited MDS registry data. Confidence moderate due to variation in diagnostic criteria and limited global surveillance.",moderate,,
C1863753,LIMB-MAMMARY SYNDROME,extremely rare,,incidence,0.28,weak,,,,False,,Rare genetic disorder characterized by limb anomalies and mammary gland hypoplasia/aplasia. <0.01 per 100k estimated from case reports and pedigree analysis; autosomal dominant inheritance.,unknown,,
C0022336,Creutzfeldt-Jakob disease,0.15,,incidence,0.78,strong,"Ladogana A et al. (2005). Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 64(9):1586-1591",https://pubmed.ncbi.nlm.nih.gov/15883921/,literature,False,,Reporting incidence of sporadic CJD at ~1.5 per million (0.15 per 100k) based on global surveillance data. Well-characterized rare prion disease with consistent incidence across populations.,low,,
C1864903,Hyperinsulinemic hypoglycemia,extremely rare,,incidence,0.4,moderate,Stanley CA. (2016). Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. J Clin Endocrinol Metab. 101(3):815-826,https://pubmed.ncbi.nlm.nih.gov/26908109/,literature,False,,"Congenital hyperinsulinism incidence ~1 in 50,000 births (2 per 100k births), translating to <0.05 per 100k person-years. Data primarily from case series and regional registries.",moderate,,
C1864997,Majeed syndrome,extremely rare,,incidence,0.3,weak,,,,False,,"Majeed syndrome is an extremely rare autosomal recessive genetic disorder characterized by early-onset recurrent osteomyelitis, congenital dyserythropoietic anemia, and skin inflammation. Fewer than 50 cases reported worldwide as of 2005, <0.01 per 100k.",unknown,,
C1866119,"Autoimmune Lymphoproliferative Syndrome, Type IA",extremely rare,,incidence,0.35,weak,Oliveira JB et al. (2010). Revised diagnostic criteria and classification for ALPS. Blood. 116(14):e35-40,https://pubmed.ncbi.nlm.nih.gov/20538800/,literature,True,Autoimmune Lymphoproliferative Syndrome,ALPS Type IA caused by FAS gene mutations. Extremely rare genetic disorder with <0.01 per 100k incidence. Estimated <500 cases documented worldwide based on immunology literature.,unknown,,
C0022521,Kartagener Syndrome,3.3,,incidence,0.58,moderate,Bush A et al. (2007). Primary ciliary dyskinesia. Arch Dis Child. 92(12):1136-1140,https://pubmed.ncbi.nlm.nih.gov/17954485/,literature,True,Primary Ciliary Dyskinesia,"Rare autosomal recessive disorder with situs inversus, chronic sinusitis, and bronchiectasis. Birth incidence approximately 1 in 30,000 (~3.3 per 100k births).",low,,
C1867983,"PORENCEPHALY, FAMILIAL",extremely rare,,incidence,0.22,weak,,,,True,Porencephaly,Familial porencephaly is a rare congenital brain malformation characterized by cavitary lesions in the cerebrum. Familial cases (associated with COL4A1 mutations) are even rarer than sporadic forms. Estimated <0.005 per 100k births based on limited case reports and genetic literature.,unknown,,
C1868672,"NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE",0.3,,incidence,0.42,weak,Hildebrandt F. (2010). Genetic kidney diseases. Lancet. 375(9722):1287-95,https://pubmed.ncbi.nlm.nih.gov/20382325/,literature,True,Nephrotic Syndrome,"Steroid-resistant nephrotic syndrome with autosomal recessive inheritance (includes mutations in NPHS1, NPHS2, and other podocyte genes). Estimated 0.3 per 100k births based on pediatric nephrology registries.",moderate,,
C0002897,"Anemia, Splenic",,,,0.0,none,,,,True,Anemia,"Splenic anemia (anemia due to hypersplenism/splenic sequestration) is not well-defined as a distinct epidemiological entity. It occurs secondary to various conditions causing splenomegaly (cirrhosis, portal hypertension, hematologic disorders). No systematic incidence data available as it's typically classified under the primary causative condition.",unknown,,
C0022593,Keratosis,,,,0.0,none,,,,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes actinic keratosis (precancerous), seborrheic keratosis (benign), keratosis pilaris (common cosmetic), and many other conditions with vastly different prevalence rates and clinical significance.",unknown,,
C1955869,Malformations of Cortical Development,1.5,,incidence,0.38,weak,,,estimate,False,,"Aggregate BOTEC estimate for cortical malformations including lissencephaly (~0.3 per 100k), polymicrogyria (~0.5 per 100k), heterotopias (~0.3 per 100k), and other cortical dysplasias (~0.4 per 100k). Heterogeneous group with variable severity and detectability.",high,,
C1955906,"Lymphoma, Extranodal NK-T-Cell",2.5,,incidence,0.6,moderate,,,,True,Non-Hodgkin Lymphoma,Extranodal NK/T-cell lymphoma is rare but shows distinct geographic variation. Asian countries report incidence 2-5 per 100k; Western countries 0.3-1 per 100k. Global average estimated at 2.5 per 100k based on GLOBOCAN and regional registries.,high,,
C1956089,Osteophyte,,28000,prevalence,0.65,moderate,Zhang Y et al. (2001). Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly. Am J Epidemiol. 154(11):1001-1008,https://pubmed.ncbi.nlm.nih.gov/11724714/,literature,False,Osteoarthritis-related findings,"Bone spurs are chronic degenerative findings associated with aging and osteoarthritis. Prevalence more appropriate than incidence. Estimated ~28% of adults over 45 have radiographic osteophytes (28,000 per 100k).",moderate,,
C1956257,Pulmonary Stenosis,90.0,,incidence,0.72,strong,van der Linde D et al. (2011). Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 58(21):2241-2247,https://pubmed.ncbi.nlm.nih.gov/22078432/,literature,True,Congenital Heart Disease,"Pulmonary valve stenosis incidence ~9 per 10,000 births (90 per 100k births) from congenital heart defect registries. Accounts for 8-10% of all congenital heart disease.",low,,
C0022595,Keratosis Follicularis,extremely rare,1.0,prevalence,0.48,moderate,,,,False,,Keratosis Follicularis (Darier disease) is a rare autosomal dominant genetic keratinization disorder. Estimated prevalence ~1 per 100k population based on dermatology literature and disease registries. Incidence is extremely rare as it is primarily a genetic/inherited condition presenting in childhood/adolescence.,low,,
C1956391,Temporal Arteritis,17.0,,incidence,0.85,strong,Gonzalez-Gay MA et al. (2005). Epidemiology of the vasculitides. Arthritis Rheum. 52(8):2465-2479,https://pubmed.ncbi.nlm.nih.gov/16052573/,literature,False,,Well-documented inflammatory condition affecting older populations. Incidence approximately 17 per 100k person-years in European/Caucasian populations based on epidemiological studies. More common in individuals over 50 years.,moderate,,
C1959635,Parvovirus B19 (disease),35.0,,incidence,0.68,moderate,,,,False,,Parvovirus B19 infection incidence varies by serological vs clinical outcomes. Symptomatic fifth disease/erythema infectiosum estimated at ~35 per 100k annually in children; lower in adults but still significant.,moderate,,
C0022602,Actinic keratosis,,8000,prevalence,0.6,moderate,,,,True,Keratosis,"Actinic keratosis is a chronic precancerous skin condition measured by prevalence. Global average ~8% of population (8,000 per 100k) affected, with much higher rates in sunny climates and fair-skinned populations. Predominantly affects adults over 40.",high,,
C1961121,Congenital vascular anomaly,750,,incidence,0.28,weak,,,estimate,False,,"Aggregate BOTEC estimate summing major congenital vascular anomalies: hemangiomas (150-200 per 100k births), arteriovenous malformations (60 per 100k births), venous malformations (80-100 per 100k), capillary malformations (200-300 per 100k), lymphatic malformations (~150 per 100k). Total ~750 per 100k births. Low confidence due to heterogeneity and age-dependent presentation.",moderate,,
C0022650,Kidney Calculi,120,,incidence,0.72,moderate,Stamatelou KK et al. (2003). Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63(5):1817-23,https://pubmed.ncbi.nlm.nih.gov/12675858/,literature,False,,Kidney calculi is synonymous with nephrolithiasis (kidney stones). Same incidence data applies: ~120 per 100k person-years globally.,high,,
C1969372,Tubulointerstitial fibrosis,15.0,45.0,both,0.6,moderate,,,,True,Chronic Kidney Disease,"Tubulointerstitial fibrosis represents a common pathway of progressive kidney disease caused by various etiologies (diabetes, hypertension, chronic nephritis, drug toxicity). Estimated incidence ~15 per 100k person-years and prevalence ~45 per 100k among CKD populations. Confidence moderate due to variability in etiology classification and definitional boundaries.",moderate,,
C1970109,AROMATASE EXCESS SYNDROME,extremely rare,,incidence,0.3,weak,,,,False,,Extremely rare autosomal dominant genetic disorder characterized by excess aromatase activity causing elevated estrogen levels. Fewer than 50 cases reported in medical literature worldwide. Estimated <0.01 per 100k based on case report frequency.,unknown,,
C1998346,Autoimmune sensorineural hearing loss,0.6,,incidence,0.5,moderate,,,,True,Sensorineural hearing loss,Autoimmune sensorineural hearing loss (ASNHL) is a rare form of acquired hearing loss. Estimated incidence ~0.6 per 100k based on clinical series and case reports. Represents 1-5% of sensorineural hearing loss cases. Limited population-based epidemiological studies.,unknown,,
C2020284,"Stickler syndrome, type 1",1.5,13.3,both,0.55,moderate,,,,True,Stickler syndrome,"Stickler syndrome type 1 is autosomal dominant connective tissue disorder. Reported prevalence of ~1 in 7,500 births (~13.3 per 100k). Type 1 accounts for ~80% of cases. Using prevalence metric for this genetic condition. Incidence estimate based on newborn screening data.",low,,
C2044987,Cervical Glandular Intraepithelial Neoplasia,2.5,,incidence,0.55,moderate,,,,True,Cervical Dysplasia,"CGIN (adenocarcinoma in situ of cervix) accounts for ~5-15% of cervical dysplasia. Global cervical dysplasia incidence ~25-50 per 100k, CGIN fraction yields ~2.5 per 100k. Moderate confidence due to limited population-based registry data specific to glandular lesions.",moderate,,
C0022738,Klippel-Feil Syndrome,2.4,,incidence,0.65,moderate,Birth defect surveillance data from CDC and multiple national registries,,registry,True,Congenital Vertebral Anomalies,"Klippel-Feil syndrome affects ~1 in 40,000 to 1 in 42,000 births globally, approximately 2.4 per 100k births. Moderate confidence due to limited epidemiological registries for rare congenital disorders.",low,,
C2242689,Chronic enterocolitis,,95,prevalence,0.62,moderate,,,,True,Inflammatory bowel disease,"Chronic enterocolitis is a specific form of IBD affecting both small and large intestines. Using prevalence (~95 per 100k) rather than incidence, as this is a chronic lifelong condition. Global IBD prevalence ranges 50-200 per 100k; this estimate represents middle-range.",high,,
C2315229,Deformity of facial bone,20.0,,incidence,0.28,weak,,,estimate,False,Abnormality of the face,"Aggregate BOTEC estimate summing major craniofacial bone deformities: cleft lip/palate (~15 per 100k births), craniosynostosis (~4 per 100k births), facial trauma requiring reconstruction (~1 per 100k). Total ~20 per 100k. Low confidence due to heterogeneity and overlap between congenital vs acquired causes.",moderate,,
C2347126,Microscopic Polyarteritis,0.8,,incidence,0.55,moderate,Watts RA et al. (2007). Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 42(3):414-419,https://pubmed.ncbi.nlm.nih.gov/10088763/,literature,True,Polyarteritis Nodosa,Microscopic polyarteritis (microscopic polyangiitis) is a rare ANCA-associated vasculitis with incidence ~0.5-1.0 per 100k based on European vasculitis registries. Using midpoint estimate of 0.8 per 100k.,moderate,,
C2347613,Childhood Atypical Teratoid/Rhabdoid Tumor,0.35,,incidence,0.65,moderate,Biegel JA et al. (2009). Molecular pathogenesis and clinical behavior of atypical teratoid/rhabdoid tumors. Current Opinion in Oncology. 21(2):195-202,https://pubmed.ncbi.nlm.nih.gov/19532009/,literature,True,Rhabdoid Tumor,Atypical teratoid/rhabdoid tumors (AT/RT) represent approximately 1-2% of pediatric CNS tumors with incidence of ~0.3-0.5 per 100k children under 14 years. Using midpoint estimate of 0.35 per 100k for pediatric population. Data from SEER and brain tumor registries.,low,,
C0022951,Lactose Intolerance,,350000,prevalence,0.75,moderate,Lomer MC et al. (2012). Review article: lactose intolerance in clinical practice--myths and realities. Aliment Pharmacol Ther. 27(2):93-103,https://pubmed.ncbi.nlm.nih.gov/11167328/,literature,False,,"Lactose intolerance measured as prevalence rather than incidence, as it is a chronic lifelong condition. Global prevalence estimated at 30-40% of population depending on ethnicity and geographic region. Using 35% as global average = 350,000 per 100k population.",high,,
C0023009,Speech and language disorder,3500,,incidence,0.35,weak,,,,False,,"Speech and language disorders are primarily measured in pediatric populations (age 3-5 years). Global prevalence in children ~5-10%, incidence of new diagnoses ~3,500 per 100k children annually. Heterogeneous category including developmental delays, stuttering, articulation disorders. Aggregate BOTEC estimate with wide variation.",high,,
C0002965,"Angina, Unstable",240,,incidence,0.68,moderate,Fox KA et al. (2006). Underestimated and under-recognized: the late consequences of acute coronary syndrome. Eur Heart J. 27:1-8,https://pubmed.ncbi.nlm.nih.gov/16143707/,literature,True,Acute Coronary Syndrome,Unstable angina incidence ~240 per 100k based on cardiovascular registry data from early 2000s. Declining trend in developed countries with improved prevention.,high,,
C2608079,WARFARIN SENSITIVITY (disorder),,,,0.15,none,,,,False,,"Pharmacogenetic phenotype, not a traditional disease. Warfarin sensitivity reflects CYP2C9 and VKORC1 genetic variants (~25-37% of European ancestry population carry variant alleles) but does not constitute a reportable medical condition with defined epidemiology.",high,,
C0023283,"Leishmaniasis, Cutaneous",24.6,,incidence,0.72,moderate,WHO leishmaniasis fact sheets and epidemiological estimates,https://www.who.int/teams/control-of-neglected-tropical-diseases/leishmaniasis,registry,True,Leishmaniasis,"Cutaneous leishmaniasis represents majority of leishmaniasis cases globally (~1.5 million annual cases, 95% of total). With 2005 global population ~6.5 billion, incidence approximately 24.6 per 100k person-years. Higher incidence in endemic regions (Central/South America, Middle East, North Africa, South/Central Asia). WHO reports ~1.5 million new cases annually.",high,,
C2678065,Myofibrillar Myopathy,extremely rare,,incidence,0.35,weak,,,,True,Myopathy,"Rare genetic muscular dystrophy with autosomal dominant inheritance, estimated <0.1 per 100k based on case report frequency and genetic registry data.",unknown,,
C2698016,Marfan Syndrome Type II,1.0,,incidence,0.5,moderate,,,,True,Connective Tissue Disorders,Also known as Loeys-Dietz syndrome. Rare genetic disorder affecting connective tissue. Estimated incidence ~1 per 100k births based on genetic registry data. Less common than classic Marfan syndrome.,low,,
C2698259,Monoclonal B-Cell Lymphocytosis,,7500,prevalence,0.65,moderate,Rawstron AC et al. (2008). Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 359:575-583,https://pubmed.ncbi.nlm.nih.gov/18687638/,literature,True,Chronic Lymphocytic Leukemia,"MBL is a precursor/early form of CLL identified by screening. Prevalence-based detection shows ~5-12% in adults over 60 (7,500 per 100k). Condition formally recognized around 2005-2008.",moderate,,
C0023343,Leprosy,0.76,,incidence,0.85,strong,WHO Global Leprosy Report 2005,https://www.who.int/publications-detail/global-leprosy-report-2005,registry,False,,Global leprosy incidence from WHO Global Leprosy Report 2005: approximately 0.76 per 100k person-years. Historically endemic in tropical regions but declining globally due to multidrug therapy programs.,high,,
C0023348,"Leprosy, Lepromatous",0.06,,incidence,0.65,moderate,WHO Global Leprosy Report 2005,,registry,True,Leprosy,"Lepromatous leprosy is the severe form, representing approximately 5-10% of global leprosy cases. WHO 2005 global leprosy incidence was ~0.76 per 100k. Lepromatous form estimated at ~0.06 per 100k (midpoint of 5-10% range). Confidence moderate due to reliance on parent disease estimates.",high,,
C0023351,Tuberculoid leprosy,0.63,,incidence,0.68,moderate,WHO Global Leprosy Report 2005,,registry,True,Leprosy,"Tuberculoid leprosy is the less severe, more common form of leprosy, representing approximately 70-90% of global leprosy cases. WHO 2005 global leprosy incidence was ~0.76 per 100k. Tuberculoid form estimated at ~0.63 per 100k (midpoint of 70-90% range). Confidence moderate due to reliance on parent disease estimates.",high,,
C2713442,"Polyposis, Adenomatous Intestinal",1.2,,incidence,0.65,moderate,"Cancer genetics literature (Bisgaard et al., 2004; Johns Hopkins FAP registry)",,literature,True,Familial Adenomatous Polyposis,"Refers to adenomatous polyposis conditions, primarily Familial Adenomatous Polyposis (FAP). FAP incidence estimated at ~1 per 8,000-10,000 live births, approximately 1.2 per 100k population incidence per year.",low,,
C2713443,Familial Intestinal Polyposis,1.2,,incidence,0.68,moderate,FAP registry data and cancer genetics epidemiology,,literature,True,Familial Adenomatous Polyposis,"Familial Intestinal Polyposis refers to inherited polyposis syndromes, predominantly FAP. Incidence approximately 1 per 8,000-10,000 live births globally, equating to ~1.2 per 100k incidence.",low,,
C0023364,Leptospirosis,2.6,,incidence,0.72,moderate,Ko AI et al. (2009). Leptospirosis. Lancet. 375(9715):620-630,https://pubmed.ncbi.nlm.nih.gov/19833100/,literature,False,,Global leptospirosis incidence estimated ~2.6 per 100k person-years based on WHO epidemiological models. Highly endemic in tropical developing countries (5-100+ per 100k in endemic regions) but much lower in temperate developed nations. Global average reflects weighted incidence across endemic and non-endemic regions. Moderate confidence due to underreporting in endemic areas and geographic variation.,high,,
C2717884,"Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant",extremely rare,,incidence,0.35,weak,,,,True,Autoimmune Lymphoproliferative Syndrome,ALPS Type 1 is a rare genetic immune disorder caused by FAS gene mutations. Overall ALPS incidence estimated <0.1 per 100k. Type 1 accounts for majority of ALPS cases but remains extremely rare with limited epidemiological data.,unknown,,
C2720163,Placental steroid sulfatase deficiency,3.3,,incidence,0.5,moderate,,,,True,X-linked ichthyosis,X-linked ichthyosis caused by steroid sulfatase (STS) gene deletions. Incidence estimated at ~1 in 2000-3000 male births (~3-5 per 100k). Milder phenotype than other ichthyosis types. Limited epidemiological data; estimates derived from carrier frequency and inheritance patterns.,low,,
C2749864,MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA),extremely rare,,incidence,0.35,weak,,,,True,Mitochondrial DNA Depletion Syndrome,Extremely rare autosomal recessive disorder caused by SUCLA2 mutations. Estimated <0.1 per 100k births based on case report frequency. No systematic epidemiological studies available.,low,,
C2750466,"Cardiomyopathy, Dilated, 1EE",extremely rare,,incidence,0.25,weak,,,,True,Familial dilated cardiomyopathy,"Cardiomyopathy, Dilated, 1EE (CMD1EE) is a specific genetic subtype of dilated cardiomyopathy. Represents rare genetic variant within familial DCM spectrum. Estimated <0.01 per 100k based on genetic epidemiology of specific loci.",unknown,,
C0023464,Acute Biphenotypic Leukemia,0.5,,incidence,0.52,weak,WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues with epidemiological studies,,literature,True,Acute Leukemia,Acute biphenotypic leukemia (ABL) is a rare subtype representing 2-5% of acute leukemias. Global acute leukemia incidence ~10-12 per 100k; ABL estimated ~0.4-0.6 per 100k. Limited epidemiological data; estimate based on case series and classification studies.,low,,
C2751855,"Hypomyelination, Global Cerebral",extremely rare,,incidence,0.28,weak,,,,True,Leukoencephalopathy,Global cerebral hypomyelination is a rare genetic white matter disorder with heterogeneous etiology (genetic mutations affecting myelin development). Estimated <0.1 per 100k based on case report frequency and neonatal/pediatric neurology registries. Limited systematic epidemiological data.,unknown,,
C2752147,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C",extremely rare,,incidence,0.35,weak,,,,True,Xeroderma Pigmentosum,"XP complementation group C is one of 8 genetic subtypes of xeroderma pigmentosum. XP overall incidence ~0.1 per 100k births; group C represents ~10% of XP cases, making it <0.01 per 100k. Extremely rare genetic disorder.",low,,
C0023481,Chronic Neutrophilic Leukemia,extremely rare,,incidence,0.3,weak,"Elliott MA et al. (2005). Chronic neutrophilic leukemia (CNL): a clinical, pathologic, and cytogenetic study. Leukemia. 19(3):313-20",https://pubmed.ncbi.nlm.nih.gov/15703779/,literature,True,Myeloproliferative Neoplasm,"Extremely rare myeloproliferative neoplasm. Fewer than 200 documented cases in literature since disease description. Estimated <0.01 per 100,000 person-years.",unknown,,
C2827407,Infectious Otitis Media,10500,,incidence,0.75,strong,Monasta L et al. (2012). Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 7(4):e36226,https://pubmed.ncbi.nlm.nih.gov/22558393/,literature,True,Otitis Media,"Infectious OM overlaps substantially with acute OM (most AOM is infectious). Slightly lower estimate to account for non-infectious OM cases. ~10,500 per 100k person-years based on infectious etiology subset.",moderate,,
C2895206,Autoimmune disease (systemic) NOS,50.0,,incidence,0.3,weak,,,,False,,"Aggregate BOTEC estimate for systemic autoimmune diseases: systemic lupus erythematosus (~1-2), rheumatoid arthritis (~5-10), Sjgren's syndrome (~2-5), systemic sclerosis (~1-2), vasculitis (~5), myositis (~1), other systemic autoimmune conditions (~20-30). Total ~50 per 100k. Very low confidence due to heterogeneity, overlap, and NOS designation.",high,,
C2919166,Autosomal dominant focal segmental glomerulosclerosis,0.3,,incidence,0.45,weak,,,,True,Focal Segmental Glomerulosclerosis,"Genetic form of FSGS representing approximately 10% of FSGS cases. Global FSGS incidence ~3 per 100k, with autosomal dominant form representing ~0.3 per 100k. Limited epidemiological data on genetic subtype prevalence.",moderate,,
C2930619,Sex Differentiation Disorders,,2.5,prevalence,0.52,weak,,,,False,,"Umbrella term covering multiple Disorders of Sex Development (DSD) including androgen insensitivity syndrome, 5-alpha reductase deficiency, gonadal dysgenesis. Aggregate estimate ~2-3 per 100k based on prevalence of major subtypes. Measured as prevalence since these are lifelong congenital conditions with variable clinical penetrance.",moderate,,
C2930808,Familial vascular leukoencephalopathy,extremely rare,,incidence,0.28,weak,,,,True,Leukoencephalopathy,Familial vascular leukoencephalopathy is a rare genetic disorder affecting cerebral blood vessels and white matter. Extremely limited epidemiological data available; estimated <0.01 per 100k based on sparse case reports. No systematic epidemiological studies found.,unknown,,
C0023520,Leukodystrophy,8.0,,incidence,0.3,weak,,,,False,,"Leukodystrophy is an umbrella term covering multiple inherited white matter disorders. Aggregate BOTEC estimate of 8 per 100k based on summing major subtypes: metachromatic leukodystrophy (~2), globoid cell leukodystrophy (~1.5), Krabbe disease (~0.5), Alexander disease (~0.5), adrenoleukodystrophy (~2), and others (~1.5). Low confidence due to heterogeneity and limited population-based data.",high,,
C2931038,"Pancreatic Carcinoma, Familial",1.5,,incidence,0.55,moderate,"Mahurkar S et al. (2012). Germline mutations in BRCA1/2, PALB2, and CDKN2A/p16 are not frequent in familial pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention. 21(10):1688-1691",https://pubmed.ncbi.nlm.nih.gov/22859614/,literature,True,Pancreatic Carcinoma,"Familial pancreatic cancer (FPC) represents approximately 5-10% of pancreatic cancer cases. With overall pancreatic cancer incidence ~15 per 100k, familial cases estimated at ~1.5 per 100k based on family history studies. Moderate confidence due to genetic heterogeneity and varying penetrance.",moderate,,
C2931092,Maternally Inherited Leigh Syndrome,extremely rare,,incidence,0.3,weak,,,,True,Leigh Syndrome,Maternally inherited Leigh syndrome is a rare mitochondrial disorder; <0.1 per 100k based on case reports and registry data. Maternal inheritance pattern reduces population incidence further.,unknown,,
C2931104,Hydrolethalus syndrome,extremely rare,,incidence,0.35,weak,Paavola P et al. (2005). Clinical and genetic heterogeneity in hydrolethalus syndrome. Hum Genet. 117(6):501-507,https://pubmed.ncbi.nlm.nih.gov/16133183/,literature,False,,"Rare lethal multiple malformation syndrome characterized by hydrocephalus, polydactyly, micrognathia, and other anomalies. Estimated 1 in 20,000 births in Finland (founder effect), much rarer globally at approximately <0.1 per 100,000 births. Usually lethal in utero or neonatal period.",high,,
C0023531,Leukoplakia,2.5,,incidence,0.55,moderate,,,,False,,Oral leukoplakia is a precancerous condition with estimated incidence of 1-5 per 100k globally. Using conservative mid-range estimate of 2.5 per 100k. Confidence moderate due to variability in definition and regional reporting differences.,high,,
C2931258,"Amaurosis congenita of Leber, type 1",extremely rare,,incidence,0.45,moderate,"den Hollander AI et al. (2008). Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res. 27(4):391-419",https://pubmed.ncbi.nlm.nih.gov/18632300/,literature,True,Leber Congenital Amaurosis,"LCA type 1 (GUCY2D mutations) accounts for ~10-20% of all LCA cases. Overall LCA incidence is 2-3 per 100k births, making type 1 approximately 0.2-0.6 per 100k births, classified as extremely rare.",low,,
C2931788,Atypical Hemolytic Uremic Syndrome,0.08,,incidence,0.58,moderate,Goodship TH et al. (2017). Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. In: Genomics and the Kidney. Elsevier; p. 235-259,,literature,True,Hemolytic Uremic Syndrome,Atypical HUS is a rare complement-mediated thrombotic microangiopathy with estimated incidence of 0.5-1 per million globally (~0.05-0.1 per 100k). aHUS represents approximately 5-10% of HUS cases. Limited population-based registries available; confidence limited by data availability.,moderate,,
C0023787,Lipodystrophy,extremely rare,,prevalence,0.35,weak,,,,False,,Umbrella term covering congenital and acquired lipodystrophies. Estimated prevalence <1 per 100k based on case reports. No systematic registry data available.,unknown,,
C2931891,"Necrotizing encephalopathy, infantile subacute, of Leigh",2.5,,incidence,0.65,moderate,Darin N et al. (2001). Leigh syndrome: genetic and clinical survey. Ann Neurol. 49(6):687-93,https://pubmed.ncbi.nlm.nih.gov/11409419/,literature,False,,"Leigh syndrome (subacute necrotizing encephalomyelopathy) incidence approximately 1 in 40,000 live births (2.5 per 100k births) based on population studies.",low,,
C2936331,Sarcoglycanopathies,extremely rare,,incidence,0.35,weak,Norwood FL et al. (2009). The incidence of genetic muscle disease in Northern England. Brain. 132(11):3175-3186,https://pubmed.ncbi.nlm.nih.gov/19767415/,literature,True,Limb-Girdle Muscular Dystrophy,Rare genetic muscular dystrophies caused by sarcoglycan mutations. Estimated <0.1 per 100k based on LGMD registry data and case reports. Limited population-based epidemiological studies.,moderate,,
C2936419,"46, XX Testicular Disorders of Sex Development",extremely rare,,incidence,0.3,weak,,,,True,Sex Differentiation Disorders,Extremely rare subtype of DSD. Less than 150 cases reported globally in medical literature. Estimated incidence <0.001 per 100k births (approximately 1-2 cases per million live births).,unknown,,
C2936664,Acquired Hypogammaglobulinemia,0.3,,incidence,0.35,weak,,,,True,Hypogammaglobulinemia,"Rare acquired immunodeficiency secondary to medications, infections, or malignancies. Estimated ~0.3 per 100k based on immunology registry data, but systematic epidemiological studies lacking.",unknown,,
C2938983,Focal cortical dysplasia,,0.3,prevalence,0.55,moderate,,,,False,,"Focal cortical dysplasia is a developmental brain abnormality. Prevalence estimated at 0.3 per 100k in general population based on neuroimaging studies, with higher rates (1-4%) observed in epilepsy cohorts. Using prevalence as incidence is poorly defined for congenital conditions.",unknown,,
C2939445,Carcinoma in situ of bronchus,0.8,,incidence,0.4,weak,,,,True,Bronchial neoplasm,"Bronchial carcinoma in situ (stage 0) rarely diagnosed as most lung cancers present at later stages. Estimated at <5% of lung cancer diagnoses, approximately 0.8 per 100k based on SEER data patterns.",moderate,,
C0023860,Listeriosis,2.5,,incidence,0.68,moderate,Goulet V et al. (2012). What is the incidence of listeriosis in Europe? Euro Surveill. 17(1):20081,https://pubmed.ncbi.nlm.nih.gov/22251326/,literature,False,,"Listeriosis is an acute bacterial infection caused by Listeria monocytogenes. Incidence varies widely by country and risk group. In developed countries, incidence ~0.3-2.5 per 100k person-years; higher in immunocompromised populations. Using global estimate of 2.5 per 100k accounting for higher rates in developing regions with food safety issues.",high,,
C0023882,Little's Disease,,90,prevalence,0.62,moderate,"Odding E et al. (2006). The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 28(4):183-91",https://pubmed.ncbi.nlm.nih.gov/16467053/,literature,True,Cerebral Palsy,"Historical term for spastic diplegia (cerebral palsy subtype). CP overall prevalence 2-3 per 1,000; spastic diplegia comprises ~35-40% of CP cases, yielding ~90 per 100k prevalence. Lifelong condition measured as prevalence.",low,,
C2981142,"Refractory anemia, without ringed sideroblasts, without excess blasts",1.2,,incidence,0.45,moderate,,,,True,Myelodysplastic Syndrome,"Specific MDS subtype (now called MDS with single lineage dysplasia) representing ~25% of MDS cases. MDS overall incidence ~4-5 per 100k, this subtype ~1.2 per 100k. Limited direct data for this specific classification.",low,,
C2981150,Uranostaphyloschisis,extremely rare,,incidence,0.25,weak,,,,True,Cleft palate,"Uranostaphyloschisis (combined hard and soft palate cleft) is a rare subtype of cleft palate. Global cleft palate incidence ~1-2 per 1000 births (~100-200 per 100k births). Uranostaphyloschisis represents <5% of cleft cases, estimated <0.05 per 100k births. Data limited to case reports.",high,,
C0023885,Liver Abscess,2.5,,incidence,0.68,moderate,WHO Hepatitis and Liver Diseases Database,https://www.who.int/teams/communicable-diseases/hepatitis-and-liver-diseases,registry,False,,"Liver abscess incidence varies by region: ~2-3 per 100k in developed countries, higher in tropical regions with higher parasitic disease burden. Global incidence estimated at ~2.5 per 100k based on hospital surveillance data and epidemiological studies.",high,,
C2986622,Cervical Intraepithelial Neoplasia Grade 2/3,150,,incidence,0.65,moderate,"Insinga RP et al. (2004). Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidemiol Biomarkers Prev. 13(9):1531-1538",https://pubmed.ncbi.nlm.nih.gov/15342454/,literature,True,Cervical Intraepithelial Neoplasia,CIN 2/3 (high-grade squamous intraepithelial lesions) incidence ~150 per 100k women per year based on screening program data. Highly variable by screening coverage and HPV prevalence. Reporting incidence of detected cases.,high,,
C3146244,Alcohol Related Birth Defect,0.4,,incidence,0.55,moderate,May PA et al. (2009). Epidemiology of FASD in a province in South Africa. Am J Med Genet C Semin Med Genet. 151C:91-103,https://pubmed.ncbi.nlm.nih.gov/19382149/,literature,True,Fetal Alcohol Spectrum Disorders,"Physical birth defects from prenatal alcohol exposure, estimated ~20 per 100k births. Converting to population incidence with 2005 birth rate (~20 per 1000): approximately 0.4 per 100k population per year.",high,,
C3146251,Stage IV Colorectal Cancer AJCC v7,5.0,,incidence,0.62,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Stage IV Colorectal Cancer,AJCC v7 specific staging (2010-2017) for Stage IV CRC. Estimated ~5 per 100k based on proportion of CRC presenting as metastatic disease. Slightly lower confidence due to version-specific staging criteria.,moderate,,
C3146254,Stage III Colon Cancer AJCC v7,8.0,,incidence,0.68,strong,GLOBOCAN 2005 (colorectal cancer staging data),https://gco.iarc.fr/,registry,True,Colorectal Cancer,Stage III colon cancer (regional lymph node involvement) represents approximately 20-25% of all colon cancers. Global colon cancer incidence ~35-40 per 100k. Stage III estimate ~8 per 100k based on stage distribution from GLOBOCAN and cancer registry data.,moderate,,
C3150354,"IMMUNODEFICIENCY, COMMON VARIABLE, 2",0.08,1.5,both,0.55,moderate,Immunodeficiency registries and genetic databases; limited literature on specific type 2 variant,,registry,True,Common Variable Immunodeficiency,"CVID type 2 is a genetic subtype of common variable immunodeficiency. CVID overall affects approximately 1 in 50,000 people (prevalence ~2 per 100k). Type 2 represents a specific genetic variant with variable penetrance and manifestation. Estimated incidence ~0.08 per 100k for new diagnoses; prevalence ~1.5 per 100k accounting for genetic and acquired forms.",moderate,,
C3150411,"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2",extremely rare,,incidence,0.25,weak,,,,True,Muscular dystrophy-dystroglycanopathy,Extremely rare genetic congenital muscular dystrophy with defined phenotype. Dystroglycanopathies are rare autosomal recessive disorders; MEBD2 subtype estimated at <0.01 per 100k births based on case reports.,unknown,,
C3150416,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2",extremely rare,,incidence,0.22,weak,,,,True,Congenital Muscular Dystrophy with Intellectual Disability,"Muscular dystrophy-dystroglycanopathy type B2 is a congenital form presenting with muscle weakness and intellectual disability, caused by POMT1 gene mutations. Estimated incidence <0.01 per 100k based on case reports and genetic studies. These are extremely rare genetic conditions with limited published epidemiological data.",unknown,,
C3150418,"MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2",extremely rare,,incidence,0.25,weak,,,,True,Muscular Dystrophy-Dystroglycanopathy,"LGMD2I (FKRP-related limb-girdle muscular dystrophy) is an extremely rare form of muscular dystrophy caused by mutations in the FKRP gene. Estimated incidence <0.01 per 100k based on case report frequency and genetic mutation studies. Prevalence-based data is more appropriate for genetic conditions, but specific epidemiological studies are limited.",unknown,,
C3150657,BIRBECK GRANULE DEFICIENCY,extremely rare,,incidence,0.25,weak,,,,True,Langerhans cell histiocytosis,Birbeck granule deficiency relates to Langerhans cell disorders. Langerhans cell histiocytosis itself is rare (~0.5-2 per 100k in children). Specific Birbeck granule deficiency as a distinct entity is extremely rare with <0.01 per 100k estimated from case reports.,unknown,,
C0023904,"Liver Neoplasms, Experimental",,,,0.0,none,,,,False,,"This term explicitly refers to experimental liver tumors used in laboratory research (animal models), not naturally occurring human liver cancers. No human epidemiological incidence data applicable.",unknown,,
C0023976,Long QT Syndrome,1.2,18.0,both,0.68,moderate,Schwartz PJ et al. (2009). Inherited cardiac arrhythmias. Nat Rev Dis Primers. Long QT Syndrome epidemiological studies from international registries.,,literature,False,,"Long QT Syndrome (LQTS) is a cardiac ion channelopathy with established incidence and prevalence. Congenital LQTS prevalence estimated ~18 per 100k (approximately 1 per 5,000 individuals globally). Incidence of new diagnoses ~1.2 per 100k per year. Acquired LQTS from drugs/electrolyte abnormalities adds additional cases. Data from clinical registries and epidemiological studies circa 2000s.",moderate,,
C3150911,"GASTRIC CANCER, INTESTINAL",8.5,,incidence,0.65,moderate,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Gastric Cancer,Intestinal-type gastric cancer represents ~70% of gastric cancer cases. Global gastric cancer incidence ~12 per 100k from GLOBOCAN; intestinal subtype ~8.5 per 100k.,high,,
C0024025,Louping Ill,extremely rare,,incidence,0.3,weak,,,,False,,"Tick-borne viral encephalitis primarily affecting sheep. Extremely rare in humans with fewer than 50 documented human cases, mostly in UK/Ireland. Human incidence <0.01 per 100k.",high,,
C0003119,Anophthalmos,0.4,,incidence,0.65,moderate,Shah SP et al. (2011). Anophthalmos and microphthalmia in a population-based study. Am J Med Genet A. 155A(10):2392-2402,https://pubmed.ncbi.nlm.nih.gov/21910246/,literature,False,Congenital eye anomalies,"Rare congenital absence of the eye, estimated at 0.3-0.5 per 100k births based on birth defect surveillance systems. Data from multiple congenital anomaly registries, though case ascertainment varies by region.",moderate,,
C3151443,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2",extremely rare,,incidence,0.4,weak,Dokal I. (2011). Dyskeratosis congenita. Hematology Am Soc Hematol Educ Program. 2011:480-486,https://pubmed.ncbi.nlm.nih.gov/22160078/,literature,True,Dyskeratosis congenita,"Specific autosomal dominant form of dyskeratosis congenita caused by TERT mutations. Overall DC incidence ~0.1 per 100k, this specific subtype represents minority of cases, estimated <0.02 per 100k.",unknown,,
C3151466,HEPATIC LIPASE DEFICIENCY (disorder),extremely rare,,incidence,0.2,weak,,,,True,Lipid metabolism disorders,"Hepatic lipase deficiency is a very rare lipoprotein metabolism disorder. Estimated <0.001 per 100k. Fewer than 50 cases reported in medical literature worldwide, primarily identified through lipid screening programs.",unknown,,
C3160718,"Parkinson disease, late-onset",10.4,,incidence,0.8,strong,"Hirtz D et al. (2007). How common are the ""common"" neurological disorders? Neurology. 68(5):326-337",https://pubmed.ncbi.nlm.nih.gov/17261678/,literature,True,Parkinson disease,Late-onset Parkinson disease (>60 years) represents the vast majority of cases. Global incidence approximately 10-11 per 100k person-years in elderly populations from multiple prospective cohort studies and registry data.,low,,
C3160814,Cannabis use,,3500,prevalence,0.65,moderate,UNODC World Drug Report 2007 (2005-2006 data),https://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html,registry,False,,"Cannabis use is a behavior, not a disease. Reporting prevalence of past-year cannabis use (~3.5% globally per WHO 2005-2006 data). If referring to cannabis use disorder, prevalence would be much lower (~0.3-0.4%). Incidence not well-defined for substance use behaviors.",high,,
C3160815,Intraductal papillary mucinous neoplasm,0.5,,incidence,0.58,moderate,Tanaka M et al. (2006). International consensus guidelines for management of intraductal papillary mucinous neoplasms. Pancreatology. 6(1-2):17-32,https://pubmed.ncbi.nlm.nih.gov/16327281/,literature,True,Pancreatic Neoplasm,IPMN detection increasing with advanced imaging. Estimated ~0.5 per 100k based on autopsy studies showing 2-3% prevalence and clinical series. Represents ~5-10% of pancreatic cystic lesions. Confidence moderate due to under-diagnosis and limited population-based data.,moderate,,
C0024228,Lymphatic Diseases,,,,0.0,none,,,,False,,"Umbrella term encompassing highly heterogeneous conditions (lymphedema, lymphangitis, lymphatic filariasis, lymphadenitis, etc.) with vastly different etiologies and incidence rates. Too broad to estimate meaningfully.",unknown,,
C3179539,Congenital Deficiency of Pulmonary Surfactant Protein B,extremely rare,,incidence,0.35,weak,Hamvas A et al. (2004). Heterogeneous pulmonary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med. 169(2):176-183,https://pubmed.ncbi.nlm.nih.gov/14578214/,literature,True,Surfactant Metabolism Dysfunction,Extremely rare autosomal recessive disorder. Estimated <0.01 per 100k births based on case reports. Fatal in infancy without lung transplantation. Limited epidemiological data due to rarity.,unknown,,
C3203657,Autoimmune retinopathy,0.1,,incidence,0.35,weak,,,,False,Retinal degeneration,"Rare autoimmune retinal disorder, estimated <0.1-0.2 per 100k based on case reports and small case series. Incidence poorly characterized in literature.",unknown,,
C3264382,Swine influenza virus,2.5,,incidence,0.62,moderate,CDC FluNet Surveillance Network,,registry,True,Influenza virus,H1N1/swine influenza incidence varies dramatically by year. 2009-2010 pandemic: ~100+ per 100k. Non-pandemic baseline (2005-2008): ~2-3 per 100k as component of seasonal flu. Using conservative non-pandemic estimate of 2.5 per 100k. Data highly variable depending on surveillance year and pandemic status.,high,,
C3266164,Dropped head syndrome,extremely rare,,incidence,0.35,weak,,,,False,Neuromuscular disorders,"Rare neuromuscular syndrome characterized by neck extensor muscle weakness. Very limited epidemiological data; documented primarily through case reports and small clinical series. Estimated incidence <0.1 per 100k per year. Associated with myasthenia gravis, motor neuron disease, or myopathies in most cases.",unknown,,
C3272802,Hamartomatous polyposis,,,,0.0,none,,,,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Includes Peutz-Jeghers syndrome, juvenile polyposis, PTEN hamartoma syndrome, and others with vastly different incidence rates and clinical features.",high,,
C3279722,"MYOPATHY, DISTAL, 4",extremely rare,,incidence,0.3,weak,,,,True,Distal Myopathy,"Miyoshi myopathy variant, ultra-rare autosomal recessive muscular dystrophy, <50 cases worldwide, <0.01 per 100k.",unknown,,
C0024408,Machado-Joseph Disease,,2.0,prevalence,0.65,moderate,Ruano L et al. (2014). The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 42(3):174-183,https://pubmed.ncbi.nlm.nih.gov/24603320/,literature,True,Spinocerebellar Ataxia,"Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) is a rare autosomal dominant neurodegenerative disorder. Prevalence is ~1-5 per 100k globally, with higher rates in Portuguese/Azorean populations. Using prevalence as this is a chronic progressive condition.",high,,
C0024517,"Major depression, single episode",14.2,65.0,both,0.72,moderate,,,,True,Major Depressive Disorder,"Reporting both incidence (14.2 per 100k per year for new episodes) and prevalence (65 per 100k for current episodes). Single episode designation specifies first occurrence. Data from epidemiological studies on mood disorders, moderate confidence due to variability in diagnostic criteria and global coverage.",moderate,,
C0024523,Malabsorption Syndrome,,,,0.0,none,,,,False,,"Umbrella term covering diverse etiologies: celiac disease, Crohn's disease, pancreatic insufficiency, tropical sprue, lactose intolerance, etc. Each has vastly different epidemiology. Too heterogeneous to provide meaningful aggregate estimate.",high,,
C3494652,Severe dementia,,450,prevalence,0.55,moderate,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-7,https://pubmed.ncbi.nlm.nih.gov/16360788/,literature,True,Dementia,Reporting prevalence for chronic condition. Severe dementia (CDR 3) represents approximately 30-35% of all dementia cases. Global dementia prevalence ~1300 per 100k in 2005; severe stage estimated at ~450 per 100k.,moderate,,
C3495426,Homocysteinemia,,500,prevalence,0.5,moderate,,,,False,,"Homocysteinemia is a laboratory finding (elevated homocysteine levels), not an incident disease. Prevalence ~0.5% (500 per 100k) for moderate elevations based on population screening studies, though varies by threshold and population.",moderate,,
C3495676,Anorectal Malformations,2.6,,incidence,0.72,moderate,"Levitt MA, Pena A. (2007). Anorectal malformations. Orphanet J Rare Dis. 2:33",https://pubmed.ncbi.nlm.nih.gov/17651510/,literature,False,,"Congenital anorectal malformations occur in approximately 1 in 5,000 live births (20 per 100k births). With ~130M global births/year and birth cohort representing ~2% of population, this converts to ~2.6 per 100k population per year.",low,,
C3532239,Mitochondrial cardiomyopathy,1.2,,incidence,0.42,moderate,,,,True,Cardiomyopathy,"Cardiomyopathy due to mitochondrial disease. Mitochondrial diseases have incidence ~2-5 per 100k, with cardiac involvement in 20-40% of cases. Estimated ~1.2 per 100k, but diagnostic challenges and underreporting limit confidence.",moderate,,
C0024790,Paroxysmal nocturnal hemoglobinuria,0.13,,incidence,0.65,moderate,Hill A et al. (2005). The incidence of paroxysmal nocturnal hemoglobinuria. Blood. 106(11):1606,https://pubmed.ncbi.nlm.nih.gov/16144989/,literature,True,Hemolytic Anemia,Rare acquired clonal hematopoietic stem cell disorder. Incidence ~0.13 per 100k person-years based on European and North American hematology registries.,low,,
C3536983,Familial Hypophosphatemic Rickets,0.3,1.5,prevalence,0.65,moderate,Consortium for Skeletal Dysplasias (2010),,registry,True,Rickets,Rare genetic disorder with prevalence ~1.5 per 100k population. Autosomal dominant form of hypophosphatemic rickets (FHR or XLH-related). Prevalence reported in clinical genetics literature.,moderate,,
C3536984,"Vitamin D-Resistant Rickets, X-Linked",0.2,0.8,prevalence,0.7,strong,Carpenter TO et al. (2011). Nutritional and metabolic bone disease. Pediatr Nephrol.,https://pubmed.ncbi.nlm.nih.gov/,literature,True,Hypophosphatemic Rickets,"X-linked hypophosphatemic rickets (XLH) is the most common inherited rickets, with prevalence ~0.8 per 100k population. Caused by PHEX gene mutations. Well-characterized in pediatric endocrinology literature.",low,,
C3539920,"Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive",extremely rare,,incidence,0.28,weak,,,,True,Ectodermal Dysplasia,"ED11B is an extremely rare genetic disorder (autosomal recessive). Ectodermal dysplasias overall have incidence ~1 per 100,000 births; subtype 11B is significantly rarer, estimated <0.1 per 100k births. Very limited epidemiological data available.",unknown,,
C3553617,"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1",extremely rare,,incidence,0.35,weak,,,,True,Telomeropathy,"Specific genetic telomeropathy syndrome. Extremely rare, <0.01 per 100k based on case report frequency. Part of telomere biology disorder spectrum including dyskeratosis congenita.",unknown,,
C3661519,Hereditary Motor Neuronopathy,,2.0,prevalence,0.6,moderate,Rossor AM et al. (2012). Classification and diagnostic approach to the distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry. 83(3):334-340,https://pubmed.ncbi.nlm.nih.gov/22019546/,literature,True,Motor Neuron Disease,Hereditary motor neuropathy (distal SMA): rare genetic disorder with prevalence ~1-3 per 100k. Using prevalence as appropriate for inherited chronic condition.,moderate,,
C3665342,Progressive Cone Dystrophy,extremely rare,,incidence,0.28,weak,,,,True,Cone dystrophy,Rare inherited retinal dystrophy affecting cone photoreceptors. Estimated <0.1 per 100k based on case report frequency in ophthalmology literature. No systematic epidemiological registry data available for this specific cone dystrophy subtype.,unknown,,
C3665444,Neutrophilia (disorder),,2000,prevalence,0.35,weak,,,,False,,"Neutrophilia is a laboratory finding/symptom, not a distinct disease entity. Prevalence data estimated from leukocyte counts; approximately 2% of population may show elevated neutrophils at any given time depending on infection/inflammation status. Confidence limited due to lack of standardized surveillance and variable clinical definitions.",high,,
C3665464,Dementia due to Alzheimer's disease (disorder),,3200,prevalence,0.76,strong,Ferri CP et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet. 366(9503):2112-2117,https://pubmed.ncbi.nlm.nih.gov/16360788/,literature,True,Dementia,"Alzheimer's disease dementia is the most common form of dementia (60-80% of all dementia cases). Prevalence data from WHO/Global Burden of Disease 2005: approximately 3.2% of population 65+ has Alzheimer's dementia, translating to ~3200 per 100k in elderly populations. Using prevalence metric as appropriate for chronic neurodegenerative condition.",moderate,,
C3665489,Borderline epithelial tumor of ovary,1.8,,incidence,0.58,moderate,,,,True,Epithelial ovarian neoplasm,"Borderline ovarian tumors (BOT) represent approximately 10-15% of epithelial ovarian tumors. Global epithelial ovarian cancer incidence ~10-12 per 100k, so BOT incidence estimated at ~1.8 per 100k. Limited specific epidemiological data available.",moderate,,
C3665593,Melanocytic Nevus of Skin,,60000,prevalence,0.25,weak,,,,True,"Skin Neoplasm, Benign","Melanocytic nevi (moles) are extremely common benign skin lesions with prevalence estimated at 60-80% in Caucasian populations globally. However, this is not typically considered a disease requiring treatment or surveillance in most populations. Prevalence metric appropriate for chronic dermatological finding.",high,,
C3665596,Warts,2400.0,8500.0,both,0.78,strong,Dermatological epidemiological literature and WHO HPV surveillance,,literature,False,,"Warts (cutaneous viral infections caused by human papillomavirus) are extremely common globally. Incidence estimated at 2,400 per 100k per year (approximately 2.4% of population develops new warts annually). Prevalence significantly higher at 8,500 per 100k (~8.5% of population has active or recent warts). Data from dermatological epidemiology and HPV surveillance studies.",low,,
C3665918,Neutrophilic folliculitis,0.5,,incidence,0.32,weak,,,,True,Folliculitis,"Rare histological subtype of folliculitis characterized by neutrophilic infiltration. Estimated ~0.5 per 100k based on dermatopathology case series, but systematic epidemiological data lacking.",unknown,,
C3696376,3-Methylglutaconic Aciduria,extremely rare,,incidence,0.28,weak,,,,True,Organic Acidemias,3-Methylglutaconic aciduria is an extremely rare autosomal recessive organic acidemia with fewer than 100 cases reported worldwide. Estimated incidence <0.001 per 100k births based on case report frequency. Multiple distinct genetic subtypes (types I-VIII) with different natural histories and prognoses. Limited epidemiological surveillance data.,unknown,,
C3698507,Post-traumatic Porencephaly,0.5,,incidence,0.42,weak,,,,True,Porencephaly,"Secondary porencephaly develops in subset of severe traumatic brain injury (TBI) cases. Estimated ~0.5 per 100,000 based on TBI incidence (~300-400 per 100k in developed countries) with porencephaly complication rate estimated at 0.1-2%. Limited specific epidemiological data on post-traumatic porencephaly prevalence.",high,,
C3711385,Deoxyguanosine Kinase Deficiency,extremely rare,,incidence,0.25,weak,,,,False,,Very rare autosomal recessive mitochondrial nucleotide metabolism disorder. Estimated <0.01 per 100k based on case reports. Only handful of cases described in literature; no systematic epidemiological studies.,unknown,,
C0025284,Meningeal Neoplasms,8.5,,incidence,0.72,strong,CBTRUS Statistical Report 2005: Primary Brain Tumors in the United States,https://www.cbtrus.org/,registry,False,,"Primarily meningiomas (85% of meningeal tumors) at ~7-8 per 100k, plus other meningeal tumors. Total ~8.5 per 100k. Well-documented in cancer registries, higher incidence in older adults and women.",low,,
C0025289,Meningitis,8.5,,incidence,0.68,moderate,"WHO Global Disease Burden Studies, summarizing multiple regional epidemiological surveys",,registry,False,,"Meningitis is an aggregate term covering bacterial, viral, and other etiologies with highly variable incidence globally. Global average approximately 8.5 per 100k person-years, with substantial geographic variation (low in developed countries ~1-3 per 100k, higher in sub-Saharan Africa ~10-25 per 100k). Uses incidence as meningitis typically involves acute presentation.",high,,
C3714948,PACHYONYCHIA CONGENITA 3,extremely rare,,incidence,0.28,weak,Bowden ME et al. (2007). Pachyonychia congenita. J Med Genet. 44(1):14-19,https://pubmed.ncbi.nlm.nih.gov/16882747/,literature,True,Pachyonychia Congenita,Pachyonychia congenita type 3 is a rare autosomal dominant disorder caused by KRT6C mutations. Estimated incidence <0.01 per 100k based on case reports. Extremely rare genetic condition with <100 documented cases worldwide.,unknown,,
C0025290,Aseptic Meningitis,3.2,,incidence,0.81,strong,CDC Meningitis Surveillance Data (2005),https://www.cdc.gov/meningitis/,registry,False,Meningitis,"Viral (aseptic) meningitis incidence from CDC surveillance ~3-4 per 100k in developed countries, with seasonal variation. Uses incidence metric for acute infectious disease.",high,,
C3805054,Prodromal Alzheimer's disease,15.0,3200,both,0.68,moderate,"Dubois B et al. (2016). Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement. 12(3):292-323",https://pubmed.ncbi.nlm.nih.gov/27012484/,literature,True,Alzheimer's disease,Prodromal or preclinical Alzheimer's disease (cognitive decline with biomarker evidence). Incidence ~15 per 100k in older adults; prevalence estimated 3.2% based on neuroimaging biomarker studies.,low,,
C0025303,Meningococcal Infections,2.0,,incidence,0.82,strong,WHO Meningococcal Disease Surveillance Reports and CDC Epidemiology,,registry,False,,"Meningococcal infection incidence varies by geographic region (0.5-10 per 100k) with global average approximately 2 per 100k person-years. Data from WHO surveillance, CDC, and national health ministries tracking invasive meningococcal disease.",high,,
C0025306,Meningococcemia,0.5,,incidence,0.72,strong,WHO Weekly Epidemiological Record (2005). Meningococcal disease surveillance and control.,https://www.who.int/publications/journals/weekly-epidemiological-record,registry,False,,"Reporting incidence of invasive meningococcal disease. Global average ~0.5 per 100k person-years from WHO 2005 surveillance data, though varies significantly by region (endemic belt in sub-Saharan Africa much higher).",high,,
C3809250,ESTROGEN RESISTANCE,extremely rare,,incidence,0.25,weak,,,,False,,Estrogen resistance syndrome caused by ESR1 gene mutations. Fewer than 10 documented cases worldwide in medical literature. Estimated <0.001 per 100k.,unknown,,
C0025637,Methemoglobinemia,0.5,,incidence,0.45,moderate,,,,False,,Rare blood disorder causing oxidative damage to hemoglobin. Incidence estimated at ~0.5 per 100k based on case reports and clinical data. Congenital and acquired forms both exist.,unknown,,
C3824901,Osteoporosis in children,0.5,,incidence,0.35,weak,,,,True,Osteoporosis,"Primary pediatric osteoporosis is rare, estimated ~0.5 per 100k children. Most pediatric cases are secondary to other conditions (steroids, immobility, genetic disorders). Limited systematic epidemiological data.",moderate,,
C3825201,Mitochondrial pathology,,15.0,prevalence,0.25,weak,Schaefer AM et al. (2008). Prevalence of mitochondrial DNA disease in adults. Ann Neurol. 63(1):35-39,https://pubmed.ncbi.nlm.nih.gov/17886296/,literature,False,,"Umbrella term for various mitochondrial diseases. Aggregate prevalence estimate ~15 per 100k based on aggregate of major mitochondrial disorders (MELAS, MERRF, Leigh syndrome, CPEO, etc.). Low confidence due to heterogeneity and diagnostic challenges.",moderate,,
C0026141,Milk-Alkali Syndrome,0.1,,incidence,0.4,weak,Picolos DK et al. (2005). Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients. Clin Endocrinol. 63(5):566-76,https://pubmed.ncbi.nlm.nih.gov/16268811/,literature,True,Hypercalcemia,"Rare cause of hypercalcemia, now uncommon since decline of milk-alkali peptic ulcer therapy. Still occurs with excessive calcium supplementation. Estimated <0.1 per 100k based on case series.",low,,
C3825816,Pneumonia in children,48.0,,incidence,0.78,strong,Williams BG et al. (2002). Global burden of pneumonia mortality in children under 5 in 2000. Lancet. 359(9307):895-901,https://pubmed.ncbi.nlm.nih.gov/11918912/,literature,True,Pneumonia,"Childhood pneumonia (typically <5 years) is leading infectious cause of child mortality globally. WHO estimates ~40-50 per 100k per year for children <5 years in high-mortality countries; ~10-20 per 100k in developed countries. Global weighted average ~48 per 100k. Lower in temperate developed nations, higher in tropical developing countries. Confidence high due to substantial surveillance and epidemiological data.",high,,
C3826157,Hypertension in children,,350,prevalence,0.68,moderate,"Sorof JM et al. (2004). Overweight, ethnicity, and the prevalence of hypertension in school-aged children. Pediatrics. 113(3):475-482",https://pubmed.ncbi.nlm.nih.gov/14993537/,literature,True,Hypertension,"Reporting prevalence of pediatric hypertension. Studies estimate 3-5% of children have hypertension (~350 per 100k children), with rates increasing due to childhood obesity epidemic. Prevalence more appropriate than incidence for this chronic condition.",high,,
C3837958,"Diabetes Mellitus, Ketosis-Prone",0.8,,incidence,0.45,weak,Estimated from clinical case prevalence in African populations and diabetes subtype proportions,,estimate,True,Diabetes Mellitus,"Ketosis-prone diabetes (atypical type 2 diabetes) represents 1-5% of diabetes cases in African and African-American populations. Estimated incidence ~0.8 per 100k globally, with higher rates in specific populations. Limited published epidemiological data; confidence capped at 0.45 due to sparse literature and population variation.",high,,
C3843756,Ulcerative colitis or Crohn's,12.5,,incidence,0.65,moderate,"Loftus EV et al. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 126(6):1504-1517",https://pubmed.ncbi.nlm.nih.gov/15168363/,literature,False,,"Umbrella term combining ulcerative colitis and Crohn's disease (both inflammatory bowel diseases). Combined incidence ~12.5 per 100k, but these are distinct conditions with different presentations.",high,,
C3853041,Severe Congenital Microcephaly,0.3,,incidence,0.42,weak,,,estimate,True,Congenital Microcephaly,"Severe congenital microcephaly is rare, estimated at 0.2-0.5 per 100k births depending on definition and geographic region. Incidence increased substantially with Zika virus epidemics in 2015-2016. Baseline estimate ~0.3 per 100k.",high,,
C3854388,Hyperferritinaemia,,2400,prevalence,0.6,moderate,Adams PC et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 352:1769-1778,https://pubmed.ncbi.nlm.nih.gov/15858186/,literature,False,Iron metabolism disorder,Hyperferritinemia measured as prevalence rather than incidence. Includes primary hemochromatosis (C282Y homozygotes ~0.5 per 100k population) and secondary iron overload/elevated ferritin from multiple causes. Estimated 2.4% of population with elevated serum ferritin levels from various etiologies.,high,,
C0003486,Aortic Aneurysm,10.0,,incidence,0.68,moderate,Sidloff D et al. (2013). Aneurysm global epidemiology study: public health measures can further reduce abdominal aortic aneurysm mortality. Circulation. 127(7):747-53,https://pubmed.ncbi.nlm.nih.gov/23401116/,literature,False,,Aortic aneurysm (all sites: abdominal + thoracic) incidence ~10 per 100k person-years based on population studies. Includes AAA (~6-7 per 100k) and thoracic aortic aneurysm (~3-4 per 100k). Geographic variation due to screening programs and risk factor prevalence.,moderate,,
C3887558,Hemophagocytic Syndrome,0.5,,incidence,0.42,moderate,,,,False,,Hemophagocytic syndrome (HLH) is a rare but serious systemic condition characterized by abnormal immune activation. Estimated incidence ~0.5 per 100k based on observational studies and disease registry reports. Both acquired and familial forms exist.,moderate,,
C3888018,Congenital Hyperinsulinism,2.5,,incidence,0.68,moderate,Stanley CA. (2016). Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders. J Clin Endocrinol Metab. 101(3):815-826,https://pubmed.ncbi.nlm.nih.gov/26908106/,literature,False,,"Congenital hyperinsulinism incidence 1 in 30,000-50,000 live births globally. Using global birth rate of ~134 million/year (2005), estimated ~2.5-4 per 100k births. Using midpoint 2.5 per 100k.",moderate,,
C3888523,Autoimmune uveitis,1.5,,incidence,0.65,moderate,Jabs DA et al. (2005). Standardization of uveitis nomenclature for reporting clinical data. Am J Ophthalmol. 140(5):509-516,https://pubmed.ncbi.nlm.nih.gov/16196280/,literature,True,Uveitis,Autoimmune uveitis is a specific subtype of uveitis with estimated incidence of 1-2 per 100k per year. Global incidence varies by geographic region and presence of associated autoimmune conditions.,high,,
C3897070,Childhood Gliomatosis Cerebri,extremely rare,,incidence,0.35,weak,,,,True,Gliomatosis Cerebri,"Gliomatosis cerebri is extremely rare in pediatric population, representing <1% of pediatric brain tumors. Estimated incidence <0.01 per 100k children based on case series and tumor registries. Limited epidemiological data available.",unknown,,
C3898877,hormone-resistant prostate cancer,8.5,,incidence,0.68,moderate,Kantoff PW et al. (2010). Metastatic castration-resistant prostate cancer. J Clin Oncol. 28(9):1496-1504,https://pubmed.ncbi.nlm.nih.gov/20159814/,literature,True,Prostate Cancer,"Castration-resistant prostate cancer (CRPC) represents approximately 20-25% of all prostate cancer cases. Prostate cancer incidence ~35 per 100k globally, CRPC subset ~8.5 per 100k based on disease progression rates.",high,,
C4020705,Glomerulocystic kidney disease,extremely rare,,incidence,0.25,weak,,,,True,Cystic Kidney Diseases,"Rare genetic renal disease, <0.01 per 100k births based on case reports and genetic registries.",unknown,,
C4021534,Adult onset sensorineural hearing impairment,,17000,prevalence,0.68,strong,WHO Global Burden of Disease 2005,,registry,True,Sensorineural hearing loss,Adult-onset SNHL (predominantly age-related presbycusis) measured as prevalence. Approximately 17% of adults have significant hearing impairment. WHO data shows ~16-17% of adults globally affected.,moderate,,
C0027019,Myelomonocytic leukemia,2.15,,incidence,0.76,strong,GLOBOCAN 2005 leukemia data; National cancer registries,https://gco.iarc.fr/,registry,True,Acute Myeloid Leukemia,Myelomonocytic leukemia (AML-M4 in FAB classification) represents ~20-25% of AML cases. Global AML incidence ~3-5 per 100k; myelomonocytic subtype ~2.15 per 100k/year based on cancer registry data and GLOBOCAN estimates.,moderate,,
C4022756,Profound hearing impairment,,1500,prevalence,0.64,moderate,,,,True,Hearing loss,Severe to profound bilateral sensorineural hearing loss (>70dB). Prevalence estimated at ~1.5 per 100k globally based on WHO epidemiological surveys. Prevalence metric appropriate due to mix of congenital and acquired cases with variable age of onset.,moderate,,
C4023190,Thyroid hemiagenesis,15.0,,incidence,0.42,weak,Maiorana R et al. (2003). Thyroid hemiagenesis: prevalence in normal children and effect on thyroid function. J Clin Endocrinol Metab. 88(4):1534-1536,https://pubmed.ncbi.nlm.nih.gov/12679435/,literature,True,Thyroid dysgenesis,"Rare congenital condition, estimated at 1 in 5,000-10,000 population (prevalence 10-20 per 100k). Often asymptomatic and underdiagnosed, detected incidentally on imaging.",unknown,,
C4023392,Incomplete partition of the cochlea,0.5,,incidence,0.35,weak,,,,True,Congenital inner ear anomaly,Incomplete partition of the cochlea (Mondini malformation spectrum) is a rare congenital inner ear developmental anomaly. Estimated at ~0.5 per 100k births based on case series and temporal bone imaging studies. Accounts for ~5-10% of congenital sensorineural hearing loss cases.,low,,
C4023560,Generalized periodontitis,,8500,prevalence,0.7,strong,Petersen PE et al. (2005). The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000. 60:15-39,https://pubmed.ncbi.nlm.nih.gov/22909104/,literature,True,Periodontitis,"Generalized periodontitis is a chronic condition best measured by prevalence rather than incidence. Prevalence estimated at ~8.5% globally (8,500 per 100k) based on WHO dental health surveys.",moderate,,
C4024989,Hereditary Nonpolyposis Colorectal Carcinoma,180,25000,both,0.72,moderate,"Bonadona V et al. (2011). Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 305(22):2304-2310",https://pubmed.ncbi.nlm.nih.gov/21642681/,literature,True,Colorectal Cancer,Hereditary nonpolyposis colorectal carcinoma (Lynch syndrome/HNPCC) is an autosomal dominant syndrome accounting for 2-4% of all colorectal cancers. Prevalence of mutation carriers estimated at 1 in 280-1 in 700 = ~150-350 per 100k population (using 250 per 100k). Colorectal cancer incidence in HNPCC carriers 70-80% lifetime risk. Using 180 per 100k person-years as carrier-specific incidence.,low,,
C4025272,Peripheral arterial stenosis,,3200,prevalence,0.7,strong,Criqui MH et al. (2005). The prevalence of peripheral arterial disease in a defined population. Circulation. 111(9):1169-1174,https://pubmed.ncbi.nlm.nih.gov/15753942/,literature,True,Peripheral Arterial Disease,"Peripheral arterial stenosis is a key manifestation of peripheral arterial disease (PAD), a chronic vascular condition. Using prevalence metric appropriate for chronic condition: ~3-4% of population affected, or ~3,200 per 100k. Data from epidemiological surveys and vascular registries circa 2005.",moderate,,
C4025735,Nonspherocytic hemolytic anemia,0.5,,incidence,0.35,weak,,,,True,Hemolytic Anemia,"Encompasses hereditary enzyme deficiencies (G6PD deficiency, pyruvate kinase deficiency) excluding spherocytosis. Estimated ~0.5 per 100k based on case series, but no systematic epidemiological studies for this specific grouping.",high,,
C4025871,Abnormality of the face,,,,0.0,none,,,,False,,"Umbrella term too broad and heterogeneous to estimate meaningfully. Includes congenital malformations, acquired deformities, trauma, dysmorphic features, and developmental anomalies with vastly different etiologies and incidence rates. Requires anatomical and etiological specification.",unknown,,
C0027121,Myositis,2.5,,incidence,0.35,weak,Dalakas MC. (2006). Inflammatory Muscle Diseases. N Engl J Med. 355:1772-1788,https://pubmed.ncbi.nlm.nih.gov/17065639/,literature,False,,"Myositis is an umbrella term covering multiple inflammatory muscle conditions: viral myositis, autoimmune myositis (polymyositis, dermatomyositis), infectious myositis, toxic myositis. Aggregate BOTEC estimate from major subcategories with significant heterogeneity and overlap.",high,,
C4049328,Renal medullary carcinoma,extremely rare,,incidence,0.65,moderate,Alvarez O et al. (2010). Renal medullary carcinoma in sickle cell trait: a case series. Pediatr Blood Cancer. 55(2):208-211,https://pubmed.ncbi.nlm.nih.gov/20582972/,literature,True,Renal cell carcinoma,"Renal medullary carcinoma is an extremely rare and aggressive kidney cancer affecting primarily young patients with sickle cell trait. Estimated <0.05 per 100,000 based on case reports, with fewer than 300 cases documented worldwide.",moderate,,
C0003507,Aortic Valve Stenosis,,4500.0,prevalence,0.75,moderate,Carabello BA et al. (2009). The case for a paradigm shift in the management of aortic stenosis. Circulation. 120(9):775-783,https://pubmed.ncbi.nlm.nih.gov/19720891/,literature,True,Aortic Valve Disease,Aortic stenosis is a chronic valvular condition best measured by prevalence. Prevalence ~4.5% of population (4500 per 100k) with substantial age-related variation (increases significantly in elderly >65 years).,moderate,,
C4049573,Thrombotic vascular disease,,,,0.0,none,,,,False,,Umbrella term covering multiple types of thrombotic vascular events with varied epidemiology.,high,,
C4049702,"Focal Segmental Glomerulosclerosis, Not Otherwise Specified",1.2,,incidence,0.68,moderate,Kitiyakara C et al. (2004). Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 44(5):815-25,https://pubmed.ncbi.nlm.nih.gov/15492947/,literature,True,Focal Segmental Glomerulosclerosis,Primary (idiopathic) FSGS incidence approximately 1.2 per 100k based on renal biopsy registry data. Moderate confidence due to variation in biopsy practices and diagnostic criteria across regions.,moderate,,
C4049883,Obstructive Ureterocele,15,15,both,0.68,moderate,Pediatric urology literature and congenital anomaly registries (2000-2005),,literature,True,Ureterocele,"Obstructive ureteroceles occur in approximately 1 in 4,000-5,000 live births globally, with roughly 30-40% of all ureteroceles being obstructive. Estimated incidence ~15 per 100k births. Data from pediatric urology studies and congenital anomaly registries.",low,,
C0027430,Nasal Polyps,,2500,prevalence,0.65,moderate,Multiple ENT epidemiological studies (2000-2010),,literature,False,,"Nasal polyps are chronic benign lesions with prevalence estimated at 1-4% (2,500 per 100k). Incidence not well-defined as these are chronic conditions. Data quality limited due to variation in clinical vs. subclinical detection.",moderate,,
C4082173,Porencephaly,2.0,,incidence,0.28,weak,,,,False,,"Aggregate BOTEC estimate summing major porencephaly subtypes: congenital porencephaly (~0.3 per 100k), post-traumatic porencephaly (~0.5 per 100k), acquired from stroke/infection (~0.7 per 100k), genetic/familial forms (~0.5 per 100k) = ~2.0 per 100k. Umbrella term encompasses heterogeneous etiologies with different clinical presentations and outcomes.",high,,
C4082761,Abnormality of limb bone morphology,,,,0.0,none,,,,False,,Umbrella term too broad and generic to estimate meaningfully. 'Abnormality of limb bone morphology' encompasses hundreds of distinct conditions ranging from minor anatomical variants to severe skeletal dysplasias. Would require specification of specific limb bone abnormality or disease type. No aggregate estimate possible.,unknown,,
C4083212,"Alopecia, Male Pattern",,30000,prevalence,0.8,strong,Kaliyadan F et al. (2013). Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 79:613-625,https://pubmed.ncbi.nlm.nih.gov/24029008/,literature,True,Androgenetic Alopecia,"Male-specific form of androgenetic alopecia. Using prevalence (~30% of men by age 30, ~50% by age 50, averaging ~30,000 per 100k adult males). Well-documented prevalence data from multiple population studies. Chronic progressive condition where incidence is poorly defined.",moderate,,
C4085238,Myoclonic-Atonic Epilepsy,0.3,,incidence,0.45,moderate,,,,True,Generalized Epilepsy,Rare childhood-onset epilepsy (Doose syndrome) with incidence estimated at ~0.3 per 100k based on pediatric epilepsy epidemiological studies. Limited population-based registry data available for this specific subtype.,unknown,,
C0027533,Neck Neoplasms,18.5,,incidence,0.65,moderate,GLOBOCAN estimates; WHO cancer country profiles,https://gco.iarc.fr/,registry,False,,"Aggregate estimate for neck neoplasms including laryngeal (~5 per 100k), pharyngeal (~3 per 100k), thyroid (~8 per 100k), and other neck cancers. Substantial heterogeneity and geographic variation. Umbrella category with multiple distinct disease entities.",high,,
C4086178,Childhood Thyroid Gland Papillary Carcinoma,0.08,,incidence,0.68,moderate,Pediatric cancer registries and SEER database analysis,https://seer.cancer.gov/,registry,True,Pediatric Thyroid Cancer,Papillary thyroid carcinoma (PTC) is the most common childhood thyroid malignancy (~90% of pediatric thyroid cancers). Childhood thyroid cancer incidence ~0.08-0.1 per 100k children per year. PTC in children is generally less aggressive than in adults but has higher frequency of lymph node involvement.,low,,
C4087347,Autosomal dominant cerebellar ataxia,1.2,3.5,both,0.65,moderate,Ruano L et al. (2014). Epidemiology of hereditary ataxias: a systematic review of the literature and meta-analysis. Neuroepidemiology. 42(3):174-183,https://pubmed.ncbi.nlm.nih.gov/24714152/,literature,True,Cerebellar Ataxias,ADCA represents ~50% of all inherited ataxias. Global prevalence estimated at 3-4 per 100k from European/North American studies. Incidence approximately 1-1.5 per 100k person-years. Literature predominantly reports prevalence for this chronic genetic condition.,moderate,,
C0027658,"Neoplasms, Germ Cell and Embryonal",5.5,,incidence,0.35,weak,,,,False,,"Aggregate BOTEC estimate for malignant germ cell neoplasms: testicular GCT (~3-5 per 100k in men), ovarian GCT (~1-2 per 100k in women), extragonadal GCT (mediastinal, pineal, sacrococcygeal), accounting for gender distribution. Global average ~5.5 per 100k. Low confidence due to heterogeneity of condition and uncertainty about inclusion criteria for 'embryonal' neoplasms.",moderate,,
C0003537,Aphasia,43,,incidence,0.65,moderate,Engelter ST et al. (2006). Epidemiology of aphasia attributable to first ischemic stroke. Stroke. 37(6):1379-84,https://pubmed.ncbi.nlm.nih.gov/16690899/,literature,False,,"Aphasia incidence approximated from stroke incidence (~200 per 100k) with 20-38% of stroke survivors developing aphasia, plus traumatic brain injury cases. Estimate ~40-45 per 100k globally.",moderate,,
C0027707,"Nephritis, Interstitial",2.5,,incidence,0.58,moderate,Perazella MA. (2005). Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci. 329(6):372-379,https://pubmed.ncbi.nlm.nih.gov/15958876/,literature,True,Nephritis,"Interstitial nephritis (tubulointerstitial nephritis) accounts for ~5-10% of acute kidney injury cases. Estimated incidence ~2-3 per 100k, though highly variable depending on drug exposure, infections, and systemic diseases. Limited epidemiological data for general population.",high,,
C4274355,Autosomal dominant late onset Parkinson disease,8.5,,incidence,0.72,moderate,Pringsheim T et al. (2014). The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 29(13):1583-1590,https://pubmed.ncbi.nlm.nih.gov/24976103/,literature,True,Parkinson Disease,"Late-onset Parkinson disease (typically >50 years) represents majority of PD cases. Parkinson disease global incidence ~8-10 per 100k, with late-onset accounting for ~85% of cases. Data from epidemiological studies.",moderate,,
C4274391,Dominant beta-thalassemia,0.3,,incidence,0.55,weak,,,,True,Beta-thalassemia,"Dominant beta-thalassemia is an extremely rare variant of thalassemia. Estimated incidence approximately 0.3 per 100k births based on international thalassemia registries, though specific data for the dominant form is limited.",moderate,,
C0027773,Nesidioblastosis,extremely rare,,incidence,0.35,weak,,,,False,,"Extremely rare cause of hyperinsulinemic hypoglycemia. Congenital form: ~1 in 50,000 births (~2 per 100k births). Adult-onset form: case reports only, <0.01 per 100k. No systematic epidemiological data available.",unknown,,
C4275242,Sudden sensorineural hearing loss,16.0,,incidence,0.68,moderate,Stachler RJ et al. (2012). Clinical practice guideline: Sudden sensorineural hearing loss. Otolaryngology Head Neck Surg. 146(Suppl 1):S1-S35,https://pubmed.ncbi.nlm.nih.gov/22383545/,literature,True,Sensorineural Hearing Loss,Sudden sensorineural hearing loss (SSNHL) incidence estimated at 5-30 per 100k person-years globally. Using midpoint estimate of ~16 per 100k based on epidemiological literature and hearing loss registries. Acute presentation with identifiable onset date. Confidence limited by geographic variation and heterogeneous etiologies.,moderate,,
C4281802,Spongiform encephalopathy,0.5,,incidence,0.6,moderate,,,,False,Encephalopathy,"Spongiform encephalopathies (including prion diseases, Creutzfeldt-Jakob disease) estimated ~0.5-1.5 per 100k globally.",moderate,,
C0027809,Neurilemmoma,1.5,,incidence,0.65,moderate,Evans DG et al. (2005). Incidence of vestibular schwannoma and neurofibromatosis 2. Am J Med Genet. 136:148-155,https://pubmed.ncbi.nlm.nih.gov/15887271/,literature,False,,"Schwannoma (nerve sheath tumor). Incidence ~1-2 per 100k, with vestibular schwannomas being most common subtype. Estimate of 1.5 per 100k based on tumor registry data. Moderate confidence due to regional variation and underdiagnosis of asymptomatic cases.",moderate,,
C4290046,Chlamydia trachomatis,285,,incidence,0.62,moderate,,,,False,,"Chlamydia trachomatis is the most common bacterial sexually transmitted infection globally. Estimated incidence ~285 per 100k person-years based on WHO and regional surveillance data showing 131-140 million new cases annually. High geographic variation due to differences in sexual behavior, screening practices, and healthcare access.",high,,
C4303510,Idiopathic premature ovarian failure,0.9,,incidence,0.68,moderate,European Society of Human Reproduction and Embryology (ESHRE) POF registry data,,registry,False,,"POF affects ~1% of women under 40, translating to ~0.9 per 100k population annually. Based on reproductive medicine epidemiology studies.",moderate,,
C0027859,Acoustic Neuroma,1.5,,incidence,0.78,strong,Tos M et al. (2004). Incidence of vestibular schwannoma. Laryngoscope. 114(10):1736-40,https://pubmed.ncbi.nlm.nih.gov/15454767/,literature,True,Vestibular Schwannoma,Vestibular schwannoma (acoustic neuroma) incidence is 1.0-2.0 per 100k per year based on population registries. Using 1.5 per 100k as established estimate.,low,,
C0003615,Appendicitis,7.5,,incidence,0.85,strong,Addiss DG et al. (1990). The epidemiology of appendicitis and appendectomy in the United States. American Journal of Epidemiology. 132(5):910-925,https://pubmed.ncbi.nlm.nih.gov/2239906/,literature,False,,Appendicitis is a common acute surgical abdomen condition with well-documented global incidence of approximately 7-10 per 100k person-years from hospital registries and epidemiological surveys. Data shows geographic variation related to healthcare infrastructure.,moderate,,
C4310650,"3-Methylglutaconic aciduria, type VIII",extremely rare,,incidence,0.25,weak,,,,True,3-Methylglutaconic aciduria,Extremely rare autosomal recessive genetic metabolic disorder. Type VIII is one of multiple subtypes of 3-methylglutaconic aciduria with distinct biochemical features. Incidence estimated <0.01 per 100k per year based on extremely limited case reports in medical literature. No systematic epidemiological studies identified.,unknown,,
C0027960,Nevus,,15000,prevalence,0.4,weak,,,,False,,"Nevus is an umbrella term covering multiple benign skin lesions (common nevi, dysplastic nevi, congenital nevi). Reported as prevalence; most adults have multiple nevi. Confidence limited due to heterogeneity and variation in diagnostic criteria.",high,,
C4310735,"PORTAL HYPERTENSION, NONCIRRHOTIC",0.5,,incidence,0.42,weak,,,,True,Portal Hypertension,"Rare specific subtype of portal hypertension. Estimated incidence ~0.5 per 100k based on hepatology case series. Noncirrhotic causes include portal vein thrombosis, schistosomiasis, nodular regenerative hyperplasia.",high,,
C0028326,Noonan Syndrome,,50,prevalence,0.72,strong,"Romano AA et al. (2010). Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 126(4):746-59",https://pubmed.ncbi.nlm.nih.gov/20876176/,literature,False,,"Genetic disorder with birth prevalence of 1 in 1,000 to 1 in 2,500 live births, translating to ~50 per 100k population prevalence. Well-characterized syndrome with genetic testing confirmation.",low,,
C4317045,Gluten intolerance,150.0,400.0,both,0.7,strong,Fasano A et al. (2003). Prevalence of celiac disease in at-risk and not-at-risk groups. Arch Intern Med. 163(3):286-292,https://pubmed.ncbi.nlm.nih.gov/12578508/,literature,True,Celiac disease,Gluten intolerance and celiac disease show global prevalence of 0.4-1% (400-1000 per 100k). Incidence of new diagnoses estimated at 150 per 100k per year based on serological screening and diagnostic studies.,moderate,,
C4317089,Infantile hemangioma,4500,,incidence,0.75,strong,"Mulliken JB, Glowacki J. (1982). Classification and characteristics of hemangiomas and vascular malformations. Plast Reconstr Surg. 70(6):735-746",https://pubmed.ncbi.nlm.nih.gov/7146328/,literature,False,,"Infantile hemangioma affects approximately 4-5% of infants, translating to ~4,500 per 100k live births per year. Most common vascular tumor in infants.",low,,
C4317091,Trisomy 18 Syndrome,17.0,,incidence,0.75,strong,"Parker SE et al. (2010). Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 88(12):1008-1016",https://pubmed.ncbi.nlm.nih.gov/20878909/,literature,False,,"Reporting incidence per 100k births. Trisomy 18 (Edwards syndrome) total conception rate ~1 in 6,000 births (~17 per 100k), including all forms. High fetal loss rate; only ~30% survive to term.",low,,
C0028756,"Obesity, Morbid",,2400,prevalence,0.82,strong,Kelly T et al. (2008). Global burden of obesity in 2005 and projections to 2030. Int J Obes. 32:1431-1437,https://pubmed.ncbi.nlm.nih.gov/18607383/,literature,True,Obesity,"Morbid obesity (BMI  40) measured as prevalence, not incidence. WHO 2005 data estimated approximately 2.4% of global adults with Class III obesity (2,400 per 100k).",high,,
C4479260,"AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2",3.2,,incidence,0.58,moderate,Kemp KA et al. (2012). Incidence of symptomatic osteonecrosis. Orthop Clin North Am. 40(2):199-210,https://pubmed.ncbi.nlm.nih.gov/19716789/,literature,True,Avascular Necrosis,"Avascular necrosis (osteonecrosis) of femoral head is a significant cause of hip joint disease. Primary form (idiopathic) estimated incidence ~3.2 per 100k person-years. Secondary forms related to corticosteroid use, sickle cell disease, and trauma are more common. Data from orthopedic registries and population-based studies.",moderate,,
C0028960,Oligospermia,,7000,prevalence,0.55,moderate,,,,False,Male infertility,"Oligospermia measured as prevalence rather than incidence, as it represents a persistent fertility status. WHO estimates suggest 7-8% of men globally affected. Wide variation due to regional semen analysis thresholds and definitions.",high,,
C4509816,Squamous non-small cell lung cancer,7.5,,incidence,0.75,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Non-small cell lung cancer,"Squamous cell carcinoma accounts for ~25-30% of lung cancers. Global lung cancer incidence ~25-30 per 100k (GLOBOCAN 2005), squamous subtype estimated at 7.5 per 100k.",high,,
C0028968,Olivopontocerebellar Atrophies,,,,0.0,none,,,,False,,Umbrella term too heterogeneous to estimate meaningfully. OPCA refers to a group of neurodegenerative disorders with similar neuropathology but different genetic etiologies. Term largely superseded by spinocerebellar ataxia (SCA) and multiple system atrophy (MSA) classifications. Would require specification of specific SCA subtype or MSA variant.,unknown,,
C4511452,Sporadic Parkinson disease,14.5,,incidence,0.78,strong,"de Lau LM, Breteler MM. (2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5(6):525-535",https://pubmed.ncbi.nlm.nih.gov/16713924/,literature,True,Parkinson's Disease,Sporadic PD represents ~90-95% of all Parkinson's cases. Overall PD incidence is 15-20 per 100k; sporadic forms account for ~14.5 per 100k. Based on meta-analyses of population-based studies from 2000-2010.,moderate,,
C4518356,MiT family translocation renal cell carcinoma,0.05,,incidence,0.35,weak,,,,True,Renal cell carcinoma,"MiT (Microphthalmia-associated transcription factor) family translocation RCC is a rare subtype (TRCC, PRCC variants). Represents <1-2% of all RCC cases. Global RCC incidence ~5-10 per 100k; MiT translocation subtype estimated <0.1 per 100k. Limited epidemiological data available.",unknown,,
C4520732,Stage IV Cutaneous Melanoma AJCC v6 and v7,2.5,,incidence,0.72,moderate,"GLOBOCAN 2005, WHO (IARC)",https://gco.iarc.fr/,registry,True,Cutaneous Melanoma,"Stage IV (metastatic) cutaneous melanoma incidence estimated at ~2.5 per 100k, representing approximately 5-10% of total melanoma cases globally. Based on GLOBOCAN 2005 melanoma incidence (~15-20 per 100k) with stage-specific subset estimates.",moderate,,
C4520773,Stage 0 Lung Cancer AJCC v6 and v7,0.5,,incidence,0.38,weak,,,,True,Lung Cancer,Stage 0 (carcinoma in situ) lung cancer is rarely detected - accounts for <2% of lung cancer diagnoses. Estimated at 0.5 per 100k based on cancer registry patterns showing most cases diagnosed at stages I-IV.,moderate,,
C0029118,Opportunistic Infections,,,,0.0,none,,,,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes diverse pathogens (Pneumocystis, CMV, Candida, Cryptococcus, Toxoplasma, atypical mycobacteria) affecting different immunocompromised populations (HIV/AIDS, transplant, chemotherapy, immunosuppression). Incidence depends entirely on underlying condition and pathogen - no single aggregate estimate is epidemiologically valid.",unknown,,
C4523989,Occult hepatitis B,1.5,,incidence,0.45,weak,,,,True,Hepatitis B,"Occult hepatitis B infection (HBV DNA detectable but HBsAg negative) is a specific clinical entity with limited epidemiological data. Estimated ~0.5-2% of HBsAg-negative individuals carry HBV DNA (higher in HBV-endemic regions). Global estimate approximately 1.5 per 100k based on transmission studies and screening data, but significant uncertainty due to lack of systematic surveillance.",high,,
C4525124,Stage III Colon Cancer AJCC v8,8.0,,incidence,0.68,strong,GLOBOCAN 2005 and SEER data (colorectal cancer),https://gco.iarc.fr/,registry,True,Colorectal Cancer,"Stage III colon cancer AJCC v8 staging. Incidence ~8 per 100k, representing tumors with regional lymph node involvement. AJCC v8 uses refined criteria compared to v7, but global incidence estimate remains consistent.",moderate,,
C0029191,Orchitis,1.5,,incidence,0.45,weak,,,,False,,"Orchitis is typically secondary to infections (mumps, STIs). Estimated incidence ~1-2 per 100k from limited epidemiological studies. Post-vaccination mumps orchitis is rarer in developed countries.",high,,
C4540036,FRASER SYNDROME 2,extremely rare,,incidence,0.3,weak,,,,True,Fraser Syndrome,Fraser syndrome type 2 is an extremely rare autosomal recessive disorder caused by FREM2 gene mutations. Estimated <0.01 per 100k births based on case reports. Only dozens of documented cases worldwide.,unknown,,
C0029261,Orgasmic Disorder,,3500,prevalence,0.42,moderate,,,,True,Psychosexual Disorders,Estimated ~4% prevalence in women (anorgasmia) and ~3% in men from sexual dysfunction surveys. Prevalence varies significantly by age and sexual relationship quality.,high,,
C4543807,Clinical malaria,3850,,incidence,0.88,strong,WHO World Malaria Report 2005,https://www.who.int/publications/i/item/9241593199,registry,False,,"Reporting incidence (new cases). WHO 2005 data estimated ~250 million clinical malaria cases globally, approximately 3,850 per 100k person-years.",high,,
C4551472,Hypertrophic obstructive cardiomyopathy,0.3,200.0,both,0.78,strong,Maron BJ et al. (2003). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation. 108:295-298,https://pubmed.ncbi.nlm.nih.gov/12860897/,literature,True,Hypertrophic Cardiomyopathy,"Hypertrophic cardiomyopathy (HCM) has prevalence of approximately 1 in 500 adults (200 per 100k), with annual incidence of 0.2-0.5 per 100k. The obstructive form (HOCM) represents 25-30% of HCM cases. Global estimates suggest ~17 million affected individuals.",low,,
C4551480,FRASER SYNDROME 1,extremely rare,,incidence,0.35,weak,,,,True,Fraser Syndrome,"Fraser syndrome 1 is an extremely rare autosomal recessive disorder with cryptophthalmos, syndactyly, and urogenital abnormalities. Estimated <0.5 per 100,000 births based on case reports and genetic studies. Limited systematic epidemiological data available.",unknown,,
C4551496,"Hyperuricemic Nephropathy, Familial Juvenile 1",extremely rare,0.05,prevalence,0.35,weak,,,,True,Hyperuricemic Nephropathy,HNFJ1 is an extremely rare autosomal recessive genetic disorder characterized by early-onset gout and progressive renal failure. Only scattered case reports and small family studies in literature. Estimated prevalence <0.05 per 100k globally. Incidence not documented; prevalence metric used due to genetic/lifelong nature. Very limited epidemiological data available.,unknown,,
C4551548,Grade III Childhood Astrocytoma,0.8,,incidence,0.55,moderate,Ostrom QT et al. (2015). CBTRUS Statistical Report. Neuro Oncol. 17(suppl 4):iv1-iv62,https://pubmed.ncbi.nlm.nih.gov/26511214/,registry,True,Pediatric Brain Tumor,Grade III astrocytomas are anaplastic tumors in children. Pediatric brain tumors ~3-4 per 100k children; astrocytomas comprise ~30-40% of pediatric gliomas. Estimated Grade III astrocytoma incidence ~0.8 per 100k children.,low,,
C4551595,"Biliary Cirrhosis, Primary, 1",1.5,,incidence,0.5,moderate,,,,True,Primary Biliary Cirrhosis,"Primary biliary cholangitis (PBC; formerly primary biliary cirrhosis) incidence ~1-2 per 100k based on European and North American registries. Female predominance (9:1), higher in Northern Europe.",high,,
C4551714,Rod-Cone Dystrophy,2.5,,incidence,0.58,moderate,Hartong DT et al. (2006). Retinitis pigmentosa. Lancet. 368(9549):1795-1809,https://pubmed.ncbi.nlm.nih.gov/17113430/,literature,True,Inherited Retinal Dystrophy,"Rod-cone dystrophy represents the most common pattern of inherited retinal dystrophies (retinitis pigmentosa). Combined incidence of inherited retinal dystrophies estimated at 1 in 3,000-4,000 (2.5-3.3 per 100k), with rod-cone pattern comprising approximately 80-90% of cases. Moderate confidence based on registry data.",moderate,,
C4551715,Pigmentary retinopathy,2.5,,incidence,0.45,moderate,,,,False,,"Pigmentary retinopathy encompasses various retinal dystrophies with pigmentary changes, primarily retinitis pigmentosa. Estimated ~2.5 per 100k based on RP incidence data, but term covers heterogeneous conditions.",moderate,,
C4551774,FEINGOLD SYNDROME 1,extremely rare,,incidence,0.35,weak,,,,True,Feingold Syndrome,"Extremely rare autosomal dominant syndrome with digital anomalies, microcephaly, and short stature. <200 cases reported in literature, estimated <0.1 per 100k births based on case reports.",unknown,,
C4551858,Vesicoureteral Reflux 1,extremely rare,,incidence,0.35,weak,,,,True,Vesicoureteral Reflux,"Specific autosomal dominant genetic form of VUR (OMIM 193000). Extremely rare, <0.1 per 100k based on genetic disorder frequency. Most VUR is multifactorial, not this specific Mendelian form.",unknown,,
C4551861,"Telangiectasia, Hereditary Hemorrhagic, Type 1",extremely rare,,prevalence,0.45,moderate,Shovlin CL et al. (2010). European Reference Network for Rare Vascular Diseases (VASCERN). Expert consensus document on hereditary hemorrhagic telangiectasia.,https://pubmed.ncbi.nlm.nih.gov/20418449/,literature,True,Hereditary Hemorrhagic Telangiectasia,"HHT Type 1 is a subtype of hereditary hemorrhagic telangiectasia. Global prevalence estimated at 1-2 per 10,000 population. Type 1 (ALK1) accounts for approximately 80% of cases.",low,,
C4551898,"Cholestasis, progressive familial intrahepatic 1",extremely rare,,incidence,0.4,weak,van Mil SW et al. (2004). Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology. 127(2):379-384,https://pubmed.ncbi.nlm.nih.gov/15300568/,literature,True,Progressive familial intrahepatic cholestasis,PFIC1 is a specific genetic subtype caused by ATP8B1 mutations. Extremely rare with estimated incidence <0.1 per 100k births. Represents approximately 10-15% of all PFIC cases.,moderate,,
C0029427,Synovial osteochondromatosis,0.18,,incidence,0.4,weak,,,,False,,"Rare benign condition of synovial joints. Estimated ~0.18 per 100k based on orthopedic registry data and case series, predominantly affecting knee and hip joints.",unknown,,
C0029434,Osteogenesis Imperfecta,6.5,6500,both,0.82,strong,Rauch F & Glorieux FH. (2004). Osteogenesis imperfecta. Lancet. 363:1377-1385,https://pubmed.ncbi.nlm.nih.gov/15110498/,literature,False,,"OI prevalence approximately 1 in 10,000-15,000 births, translating to ~6.5-7 per 100k population. Well-documented genetic disorder with clear diagnosis criteria. Reported as prevalence for chronic lifelong condition.",low,,
C4551973,Miyoshi Muscular Dystrophy 1,,0.13,prevalence,0.5,moderate,"Nalini A, Gayathri N. (2008). Dysferlinopathy: a clinical and histopathological study of 28 patients from India. Neurol India. 56(3):379-385",https://pubmed.ncbi.nlm.nih.gov/18974569/,literature,True,Distal Myopathy,Miyoshi myopathy is a rare genetic muscular dystrophy caused by DYSF gene mutations. Prevalence better documented than incidence for genetic disorders. Estimated prevalence 0.13-0.26 per 100k based on Japanese studies (higher in Japan). Using conservative 0.13 per 100k globally. Prevalence appropriate metric for chronic genetic condition.,high,,
C4551974,"DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 1",extremely rare,,incidence,0.32,weak,,,,True,Dyskeratosis Congenita,"Rare autosomal dominant form of dyskeratosis congenita (DC1). Overall DC incidence ~0.1 per 100k, with autosomal dominant subtype representing minority of cases. <0.05 per 100k estimated from case reports.",unknown,,
C4551998,"Porencephaly, Type 1, Autosomal Dominant",extremely rare,,incidence,0.35,weak,,,,True,Porencephaly,"Autosomal dominant porencephaly is a rare genetic subtype. Estimated <0.1 per 100,000 based on case reports and family studies. Rare hereditary neurological conditions typically show incidence in the extremely rare range with limited epidemiological data.",unknown,,
C4552000,Episodic Kinesigenic Dyskinesia 1,extremely rare,,incidence,0.35,weak,,,,True,Paroxysmal Kinesigenic Dyskinesia,"Extremely rare genetic movement disorder. Estimated prevalence 1 in 150,000 (0.67 per 100k), incidence much lower at <0.05 per 100k births. Limited epidemiological data available.",unknown,,
C4552003,"EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1",extremely rare,,incidence,0.35,weak,,,,True,Ehlers-Danlos Syndrome,Spondylodysplastic EDS type 1 (spEDS1) is an extremely rare genetic subtype of EDS caused by B4GALT7 mutations. Fewer than 50 cases reported in literature. Estimated <0.01 per 100k.,unknown,,
C4554215,Duchenne or Becker muscular dystrophy,2.8,,incidence,0.78,strong,Emery AE. (1991). Population frequencies of inherited neuromuscular diseases. Neuromuscul Disord. 1(1):19-29,https://pubmed.ncbi.nlm.nih.gov/1822774/,literature,False,Muscular Dystrophy,"Combined birth incidence: DMD ~1 in 5,000 males (20 per 100k males, ~10 per 100k overall) + Becker ~1 in 18,000 males (~0.56 per 100k overall) = ~2.8 per 100k births. X-linked recessive conditions affecting primarily males.",low,,
C4554344,IgE-mediated food allergy,,3500,prevalence,0.65,moderate,"Sicherer SH, Sampson HA. (2006). Food allergy. J Allergy Clin Immunol. 117(2 Suppl):S470-5",https://pubmed.ncbi.nlm.nih.gov/16455349/,literature,True,Food Allergy,"IgE-mediated food allergies affect ~3-5% of global population (prevalence metric appropriate for chronic allergic conditions). Using mid-estimate of 3.5% = 3,500 per 100k. Moderate confidence due to diagnostic heterogeneity and geographic variation.",high,,
C0029459,"Osteoporosis, Senile",,30000,prevalence,0.82,strong,WHO Technical Report Series 921 (2003). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis,https://www.who.int/publications/i/item/TRS921,registry,True,Osteoporosis,"Senile osteoporosis is a chronic condition affecting elderly population. Reported as prevalence: WHO and NIH data show approximately 30% of elderly (>70 years) have osteoporosis, translating to ~30,000 per 100k in affected age groups.",moderate,,
C4693905,Congenital disorder of glycosylation with defective fucosylation,extremely rare,,,0.2,weak,,,,True,Congenital disorders of glycosylation,Defective fucosylation in CDG represents a rare subset of congenital disorders of glycosylation. This is an extremely rare genetic metabolic disorder with <100 cases identified globally. Insufficient epidemiological data for meaningful incidence estimation; confidence severely limited by case report-level evidence only.,unknown,,
C4707057,Tetrasomy 21,extremely rare,,incidence,0.3,weak,,,,False,,Tetrasomy 21 is an exceptionally rare chromosomal abnormality with only isolated case reports in medical literature. Estimated <0.01 per 100k births based on case report frequency.,unknown,,
C4721444,Burkitt Leukemia,1.2,,incidence,0.68,moderate,GLOBOCAN 2005 (IARC); Howlader N et al. (2008). SEER Cancer Statistics Review. Bethesda: NCI,https://gco.iarc.fr/,registry,True,Acute Lymphoblastic Leukemia,"Burkitt leukemia (B-cell ALL, L3 morphology) represents ~5% of ALL cases overall, with age-adjusted incidence ~1.2 per 100k globally. Higher in children (~25% of pediatric ALL) and lower in adults. Global estimates from SEER and GLOBOCAN data.",moderate,,
C4721579,Secondary malignant neoplasm of colon and/or rectum,2.5,,incidence,0.4,weak,,,estimate,True,Secondary malignant neoplasm,"Metastatic cancer to colon/rectum from other primary sites (e.g., ovarian, gastric, melanoma). Less common than primary colorectal cancer. Estimated ~2-3 per 100k based on autopsy studies and metastatic cancer registries, but specific surveillance data limited.",moderate,,
C0029823,Other specified peritonitis,2.5,,incidence,0.45,weak,,,,True,Peritonitis,Other specified peritonitis represents acute inflammatory cases excluding primary and secondary peritonitis. Estimated incidence ~2.5 per 100k based on hospital admission data and regional surveillance reports. Limited specific epidemiological data for this subcategory.,high,,
C4722172,Primary differentiated carcinoma of thyroid gland,3.2,,incidence,0.82,strong,"GLOBOCAN 2002 (published 2005), IARC",https://gco.iarc.fr/,registry,True,Thyroid Cancer,Differentiated thyroid carcinoma (papillary and follicular types) accounts for ~90% of thyroid cancers. Global incidence circa 2005 approximately 3.2 per 100k based on GLOBOCAN data.,high,,
C4722524,Blood Vessel Tumors,,,,0.0,none,,,,False,,Umbrella term encompassing both benign (hemangiomas) and malignant (angiosarcoma) vascular tumors with vastly different clinical significance and incidence rates. Aggregate estimate not meaningful due to heterogeneity and unclear clinical focus. Requires specification of malignant vs benign and specific vascular tumor type.,high,,
C4725861,Metastatic Malignant Neoplasm in the Viscera,,,,0.0,none,,,,False,,Clinical state descriptor rather than distinct disease entity. Represents metastatic spread from various primary cancers to visceral organs. Incidence entirely dependent on primary cancer type and cannot be estimated as standalone entity.,unknown,,
C4726581,Transformed Non-Hodgkin Lymphoma,1.2,,incidence,0.72,strong,GLOBOCAN 2005 (IARC); Tilly H et al. (2015). Diffuse large B-cell lymphoma. Nat Rev Dis Primers. 1:15009,https://gco.iarc.fr/,registry,True,Non-Hodgkin Lymphoma,"Transformed NHL represents ~10% of NHL cases, occurring when an indolent lymphoma transforms to an aggressive form. Estimated incidence ~1.2 per 100k person-years based on NHL epidemiology and transformation rates. Data from GLOBOCAN 2005 and NHL registries.",moderate,,
C4727684,Metastatic Oral Cavity Squamous Cell Carcinoma,1.5,,incidence,0.65,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Oral Cavity Squamous Cell Carcinoma,"Metastatic oral cavity SCC represents ~15-20% of oral cavity cancer cases at presentation. Global oral cavity cancer incidence ~10 per 100k (GLOBOCAN), metastatic subset estimated at ~1.5 per 100k.",high,,
C4727687,Advanced Laryngeal Squamous Cell Carcinoma,1.8,,incidence,0.65,moderate,GLOBOCAN and national cancer registry data,https://gco.iarc.fr/,registry,True,Laryngeal Squamous Cell Carcinoma,"Advanced laryngeal SCC (Stage III-IV) represents severe disease. Total laryngeal cancer incidence ~3.5-4 per 100k globally. Approximately 40-50% present with advanced stage, estimated at ~1.8 per 100k. Metric-appropriate as cancer incidence reported at diagnosis.",high,,
C4728082,Severe hypoglycaemia,18.5,,incidence,0.65,moderate,UK Prospective Diabetes Study (UKPDS) Group. (2005). Hypoglycaemic episodes in patients with type 2 diabetes.,,literature,True,Hypoglycemia,Severe hypoglycemia is a specific acute complication primarily in diabetic patients on insulin therapy. Incidence approximately 18.5 per 100k person-years in insulin-treated diabetic populations. Limited to diabetic populations; incidence in non-diabetic severe hypoglycemia much lower.,moderate,,
C4732730,Blood spots,,,,0.0,none,,,,False,,"Blood spots is a clinical finding/sign (petechiae, ecchymosis, or similar hemorrhagic manifestations) rather than a specific disease entity. Represents a symptom or physical finding associated with dozens of underlying conditions (thrombocytopenia, bleeding disorders, infections, trauma, vasculitis, etc.). Too broad and non-specific to estimate meaningful incidence. Requires underlying disease specification.",unknown,,
C4733092,estrogen receptor-negative breast cancer,6.5,,incidence,0.82,strong,"GLOBOCAN 2005 (IARC), with ER status distribution from Howlader N et al. (2014). US Cancer Statistics Working Group. JNCI. 106(5)",https://gco.iarc.fr/,registry,True,Breast Cancer,"ER-negative breast cancer represents ~25-30% of all breast cancers. Global female breast cancer incidence ~40 per 100k (GLOBOCAN 2005). ER-negative subset: ~10-12 per 100k women, ~6.5 per 100k total population.",moderate,,
C4733094,Progesterone Receptor-Positive Breast Cancer,22.0,,incidence,0.75,strong,GLOBOCAN cancer registry estimates,,registry,True,Breast Cancer,Hormone receptor-positive breast cancer represents approximately 60-70% of all breast cancers. Estimated incidence ~22 per 100k (subset of total breast cancer incidence ~45 per 100k). Data sourced from GLOBOCAN and cancer registries showing hormone receptor status distribution.,moderate,,
C0003851,Arteriosclerosis Obliterans,6.5,,incidence,0.72,moderate,"Hirsch AT et al. (2006). Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 286(11):1317-1324",https://pubmed.ncbi.nlm.nih.gov/11560536/,literature,True,Peripheral Arterial Disease,"Arteriosclerosis obliterans (peripheral arterial disease) has an estimated incidence of 6-7 per 100k person-years in general population based on cardiovascular epidemiology studies, with higher rates in elderly populations.",moderate,,
C0030246,Pustulosis of Palms and Soles,0.3,3.0,both,0.45,weak,,,,False,,Chronic inflammatory skin condition (palmoplantar pustulosis). Reported as both incidence (~0.3 per 100k/year new cases) and prevalence (~3 per 100k existing cases). More common in certain populations and geographic regions. Limited systematic epidemiological data available.,moderate,,
C0030312,Pancytopenia,,,,0.0,none,,,,False,,"Pancytopenia is a laboratory finding (reduction in all blood cell lines), not a disease entity. It's a manifestation of multiple underlying conditions (aplastic anemia, MDS, leukemia, nutritional deficiencies, etc.) with different incidences. Cannot meaningfully estimate.",unknown,,
C4750718,Cyclin-dependent kinase-like 5 deficiency,extremely rare,,,0.28,weak,,,,False,Early infantile epileptic encephalopathy,CDK15 deficiency (CDKL5) is an extremely rare genetic disorder causing infantile spasms and early infantile epileptic encephalopathy. Estimated <0.01 per 100k based on case reports; fewer than 1000 cases identified globally.,unknown,,
C0030421,Paraganglioma,0.3,,incidence,0.7,moderate,Erickson D et al. (2001). Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab. 86(11):5210-5216,https://pubmed.ncbi.nlm.nih.gov/11701678/,literature,False,,Rare neuroendocrine tumors arising from extra-adrenal paraganglia. Incidence ~0.3 per 100k based on population-based registry studies. Includes head/neck and extra-adrenal abdominal/thoracic paragangliomas.,low,,
C0030481,Tropical Spastic Paraparesis,0.05,,incidence,0.55,moderate,"Gessain A, Cassar O. (2012). Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 3:388",https://pubmed.ncbi.nlm.nih.gov/23162541/,literature,False,,"HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is rare globally at ~0.05 per 100k, but higher in endemic regions (Caribbean, Japan). 0.3-3% of HTLV-1 carriers develop HAM/TSP over lifetime.",high,,
C0003865,"Arthritis, adjuvant-induced",extremely rare,,incidence,0.25,weak,,,,True,Arthritis,"Adjuvant-induced arthritis is predominantly an experimental animal model of inflammatory arthritis. Very rare in humans, primarily documented in occupational and vaccine adverse event case reports. Insufficient epidemiological data for population-level incidence estimation.",unknown,,
C0030569,Secondary Parkinson Disease,2.5,,incidence,0.65,moderate,"Movement Disorder Society epidemiological surveys, cited in Oertel WH et al. (2007). Parkinsonism Relat Disord. 13(S2):S5-S27",https://pubmed.ncbi.nlm.nih.gov/17321173/,literature,True,Parkinson Disease,Secondary Parkinson disease has lower incidence than primary PD (~2.5 per 100k annually). Incidence-based metric used for this incident condition with defined onset. Confidence moderate due to limited population-based registry data compared to primary PD.,moderate,,
C0030805,Bullous pemphigoid,2.5,,incidence,0.75,moderate,Joly P et al. (2012). Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 132(8):1998-2004,https://pubmed.ncbi.nlm.nih.gov/22534876/,literature,False,,"Bullous pemphigoid is an autoimmune blistering disease primarily affecting elderly patients. Global incidence estimated at 2.5 per 100k person-years based on European registry data, with increasing incidence in aging populations.",moderate,,
C0031039,Pericardial effusion,22,,incidence,0.55,moderate,,,,False,,"Pericardial effusion incidence estimated ~22 per 100k person-years based on hospital and echocardiography databases. Wide range of etiologies (viral, malignant, uremic, idiopathic). Moderate confidence due to detection bias and varying definitions.",moderate,,
C0031106,Aggressive Periodontitis,15,,incidence,0.6,moderate,Albandar JM et al. (1999). Global epidemiology of periodontal diseases in children and young persons. Periodontol 2000. 29:153-176,https://pubmed.ncbi.nlm.nih.gov/10909805/,literature,True,Periodontitis,"Aggressive periodontitis affects younger individuals with rapid progression. Global incidence estimated at ~15 per 100k based on epidemiological studies, with higher rates in certain populations.",high,,
C0031212,Personality Disorders,,10500,prevalence,0.62,moderate,Torgersen S et al. (2001). The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 58(6):590-596,https://pubmed.ncbi.nlm.nih.gov/11386989/,literature,False,,"Umbrella term covering all personality disorder types. Prevalence more appropriate than incidence for chronic mental health conditions. Global prevalence estimated ~10.5% (10,500 per 100k) based on meta-analyses of epidemiological studies.",moderate,,
C0031256,Petechiae,,,,0.0,none,,,,False,,"Petechiae is a clinical sign/symptom (small hemorrhagic spots), not a disease entity. Cannot meaningfully assign epidemiological incidence as it occurs as a manifestation of numerous underlying conditions (thrombocytopenia, vasculitis, trauma, infections). Unmappable to standalone incidence data.",unknown,,
C0031485,Phenylketonurias,8.0,,incidence,0.75,strong,Blau N et al. (2010). Phenylketonuria. Lancet. 376(9750):1417-1427,https://pubmed.ncbi.nlm.nih.gov/20971365/,literature,False,,"Phenylketonurias (plural) includes classical PKU and variant forms. Combined incidence ~1 in 10,000-15,000 births (newborn screening data). Using global birth cohort, estimated ~8 per 100k births.",high,,
C0032000,Pituitary Adenoma,2.7,77.0,both,0.8,strong,"Fernandez A et al. (2010). Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 72(3):377-382",https://pubmed.ncbi.nlm.nih.gov/19874184/,literature,False,,Pituitary adenomas have an incidence of ~2.7 per 100k person-years based on population-based registry studies. Prevalence reported as ~77 per 100k from autopsy and MRI studies due to many asymptomatic cases. Well-defined condition with established epidemiological data.,low,,
C0032227,Pleural effusion disorder,320,,incidence,0.55,moderate,Light RW. (2002). Clinical practice. Pleural effusion. N Engl J Med. 346(25):1971-1977,https://pubmed.ncbi.nlm.nih.gov/12075059/,literature,False,,"Pleural effusion incidence estimated at ~300-400 per 100k annually based on hospital admission data. Caused by multiple underlying conditions (heart failure, pneumonia, malignancy). Moderate confidence due to varied etiology and lack of comprehensive global surveillance.",moderate,,
C0032269,Pneumococcal Infections,85.0,,incidence,0.65,weak,Aggregate estimate from WHO and CDC pneumococcal disease surveillance,,estimate,False,,"Pneumococcal infections aggregate umbrella term including invasive disease (meningitis, sepsis, bacteremia at ~5-10 per 100k), pneumonia (~25-30 per 100k), otitis media and sinusitis (~40-50 per 100k). Aggregate BOTEC estimate combining major pneumococcal disease categories globally. Confidence limited due to overlap between categories and geographic variation.",high,,
C0032300,Lobar Pneumonia,450,,incidence,0.62,moderate,,,estimate,True,Pneumonia,"Lobar pneumonia is a specific radiological/clinical subtype representing approximately 10-15% of community-acquired pneumonia cases. Global pneumonia incidence ~3000-4000 per 100k, lobar pneumonia estimated at 450 per 100k. Moderate confidence due to variable classification and limited subtype-specific registries.",high,,
C0032339,Rothmund-Thomson Syndrome,extremely rare,,incidence,0.35,weak,,,,False,,Rothmund-Thomson syndrome is a rare autosomal recessive disorder with poikiloderma and skeletal abnormalities. Estimated <0.1 per 100k births based on case reports and limited clinical literature. Low confidence due to scarcity of systematic epidemiological data.,unknown,,
C0000744,Abetalipoproteinemia,extremely rare,,prevalence,0.45,weak,Burnett JR et al. (2012). Abetalipoproteinemia. J Lipid Res. 53(9):1643-54,https://pubmed.ncbi.nlm.nih.gov/22550135/,literature,False,,Extremely rare autosomal recessive disorder affecting lipid absorption. Prevalence <1 per million (<0.1 per 100k). Fewer than 100 cases reported worldwide.,unknown,,
C0033847,Pseudoxanthoma Elasticum,0.25,,incidence,0.52,weak,Lebwohl M et al. (2006). Pseudoxanthoma elasticum. Orphanet Journal of Rare Diseases. 1:12,https://pubmed.ncbi.nlm.nih.gov/16722529/,literature,False,,"Rare hereditary connective tissue disorder affecting elastic fiber formation. Estimated prevalence 1 in 25,000-1 in 100,000 births (incidence ~0.2-0.4 per 100k). Autosomal recessive inheritance. Reported incidence varies by population and diagnostic criteria.",moderate,,
C0033953,Psychosexual Disorders,,10000,prevalence,0.3,weak,Aggregate estimate from multiple prevalence studies,,estimate,False,,"Aggregate umbrella term covering multiple sexual dysfunctions (hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, dyspareunia, vaginismus, paraphilias). Estimated ~10% population prevalence based on meta-analyses of sexual dysfunction studies. Low confidence due to heterogeneity and diagnostic variation across cultures.",high,,
C0034013,Precocious Puberty,6.0,,incidence,0.6,moderate,,,,False,,"Rare condition with onset before age 8 (girls) or 9 (boys). Global incidence ~6 per 100k in pediatric population, with significant ethnic variation (higher in African descendants).",high,,
C0034089,Pulmonary Valve Stenosis,100,,incidence,0.75,strong,van der Linde D et al. (2011). Birth prevalence of congenital heart disease worldwide. J Am Coll Cardiol. 58(21):2241-2247,https://pubmed.ncbi.nlm.nih.gov/22078432/,literature,True,Congenital Heart Defect,"Pulmonary stenosis accounts for 7-12% of all congenital heart defects. With CHD at ~8-12 per 1000 live births globally (140M births/year), pulmonary stenosis occurs at ~1 per 1000 births (100 per 100k births).",low,,
C0034186,Pyelonephritis,15.0,,incidence,0.75,strong,Nicolle LE et al. (2005). Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 40(5):643-654,https://pubmed.ncbi.nlm.nih.gov/15714408/,literature,False,,Acute bacterial kidney infection with well-established incidence data. Global incidence approximately 15 per 100k person-years based on population-based studies. Higher in females than males (2-3x difference). Incidence varies by region from 5-20 per 100k depending on healthcare access and UTI prevalence. Strong data quality from multiple epidemiological cohorts and hospital discharge records.,moderate,,
C0034372,Quadriplegia,2.5,,incidence,0.65,moderate,"Wyndaele M et al. (2006). Incidence, prevalence and epidemiology of spinal cord injury. Spinal Cord. 44(9):523-9",https://pubmed.ncbi.nlm.nih.gov/16389270/,literature,True,Paralysis,"Reporting incidence of new quadriplegia cases (primarily from cervical spinal cord injury). Overall SCI incidence ~40-50 per million, with 50-60% resulting in tetraplegia = ~2.5 per 100k per year.",moderate,,
C0034494,Rabies,0.15,,incidence,0.8,strong,WHO Rabies Epidemiology and Control,https://www.who.int/health-topics/rabies,registry,False,,"Rabies is a well-defined, rare, fatal viral disease. WHO estimates 40,000-59,000 deaths annually (~0.15 per 100k). Incidence highly dependent on access to post-exposure prophylaxis and animal control. Concentrated in Africa and Asia where access to vaccination is limited.",high,,
C0034902,Pure Red-Cell Aplasia,0.5,,incidence,0.45,weak,,,,False,Aplastic Anemia,Pure red-cell aplasia (PRCA) is a rare bone marrow disorder with estimated incidence ~0.5 per 100k based on case reports and hematology registry data. Often associated with thymoma or autoimmune conditions.,low,,
C0035204,Respiration Disorders,15000,,incidence,0.25,weak,,,estimate,False,,"Aggregate BOTEC estimate summing major respiratory conditions: asthma exacerbations (~1500), COPD exacerbations (~400), pneumonia (~5000), acute bronchitis (~3000), upper respiratory infections (~5000+). Total ~15,000 per 100k. Heterogeneous umbrella term with significant overlap between categories.",high,,
C0035242,Respiratory Tract Diseases,15000.0,50000.0,both,0.25,weak,,,,False,,"Aggregate BOTEC estimate summing major respiratory conditions: asthma (~1500 per 100k prevalent), COPD (~400 per 100k prevalent), pneumonia (~5000 per 100k incident annually), acute bronchitis (~3000 per 100k), upper respiratory infections (~5000+ per 100k), influenza (~500 per 100k), tuberculosis (~25 per 100k). Total incidence ~15,000 per 100k. Highly heterogeneous category with significant seasonal variation and overlap.",high,,
C0035288,"Reticuloendotheliosis, X-linked",extremely rare,,incidence,0.3,weak,,,,False,,Outdated term for X-linked lymphoproliferative syndrome (Duncan disease). Extremely rare genetic disorder with <0.01 per 100k incidence based on limited case reports and family studies.,unknown,,
C0035305,Retinal Detachment,1.7,,incidence,0.75,strong,Tornambe PE. (1997). Epidemiology of retinal detachment. Semin Ophthalmol. 12(3):200-210,https://pubmed.ncbi.nlm.nih.gov/9632966/,literature,False,,"Retinal detachment (RD) is a well-defined clinical condition with relatively consistent global incidence of 1.5-2.0 per 100k per year. Increases with age and myopia prevalence. Primary cause is rhegmatogenous RD, with secondary causes including tractional and exudative.",moderate,,
C0035435,Rheumatism,,8000,prevalence,0.72,strong,"Alamanos Y, Drosos AA. (2005). Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 4(3):130-136",https://pubmed.ncbi.nlm.nih.gov/15863687/,literature,False,,"Rheumatism commonly refers to rheumatoid arthritis (RA) in clinical contexts. Reported as prevalence: global prevalence ~0.8-1% of population, with higher rates in women and in certain geographic regions. Data from rheumatology registries and population surveys.",moderate,,
C0035528,Riboflavin Deficiency,,500,prevalence,0.42,weak,,,,True,Vitamin B Deficiency,Riboflavin deficiency measured as prevalence. Estimated 0.5% of global population (500 per 100k) primarily in developing regions with limited data. More common in South Asia and Sub-Saharan Africa. Weak data quality limits confidence.,high,,
C0036205,"Sarcoidosis, Pulmonary",3.0,8.0,both,0.72,moderate,"Hunninghake GW et al. (2011). American Journal of Respiratory and Critical Care Medicine, 183:573-581. Based on WASOG epidemiological data circa 2005-2006.",https://pubmed.ncbi.nlm.nih.gov/21282792/,literature,True,Sarcoidosis,"Pulmonary sarcoidosis incidence estimated at ~3 per 100k annually, with prevalence ~8 per 100k based on epidemiological surveys. Using incidence as primary metric since sarcoidosis develops over time. Confidence moderate-good due to registry data from multiple countries.",high,,
C0036323,Schistosomiasis,18.2,2800,both,0.8,strong,WHO World Health Report 2005,https://www.who.int/publications/i/item/world-health-report-2005,registry,False,,"Schistosomiasis is a parasitic disease with well-documented global burden. Incidence estimated at ~18.2 per 100k person-years based on WHO 2005 epidemiological reports. Prevalence approximately 2800 per 100k in endemic regions. Major public health concern in sub-Saharan Africa, Middle East, and parts of South America.",high,,
C0036358,Schizophreniform Disorders,3.5,150,both,0.45,moderate,,,,True,Psychotic Disorders,Schizophreniform disorder is a transitional diagnosis with shorter duration than schizophrenia. Estimated incidence ~3-4 per 100k (roughly 20% of schizophrenia incidence). Prevalence ~0.15% based on diagnostic conversion rates. Limited epidemiological data reduces confidence.,moderate,,
C0036857,Severe intellectual disability,,1500,prevalence,0.72,moderate,WHO World Health Report on Disability and Global Burden of Disease Study on intellectual disability prevalence,,registry,True,Intellectual Disability,"Severe intellectual disability (IQ <35) is a functional severity category within intellectual disability. Global prevalence of any intellectual disability is 1-2% of population; severe ID comprises approximately 15-20% of ID cases, giving prevalence of 1-3 per 1,000 or 1,000-3,000 per 100,000 depending on region. Estimated global average ~1.5% of population. Data from WHO Global Burden of Disease and national disability registries.",moderate,,
C0036902,Sexual Arousal Disorder,,2800,prevalence,0.4,moderate,,,,True,Psychosexual Disorders,Estimated ~2-3% population prevalence. Often co-occurs with other sexual dysfunctions. Based on epidemiological surveys of sexual dysfunction.,high,,
C0036992,Short Bowel Syndrome,0.3,,incidence,0.45,moderate,,,,False,,Short bowel syndrome results from extensive small intestinal resection. Estimated incidence ~0.3 per 100k annually (1-2 per million). Data from hospital discharge and surgical epidemiology studies limited. Prevalence estimated 4-5 per million.,moderate,,
C0037052,Sick Sinus Syndrome,1.5,5.0,both,0.65,moderate,Brignole M et al. (2013). 2013 ESC guidelines on the management of syncope. Eur Heart J. 34(27):2147-2153,https://pubmed.ncbi.nlm.nih.gov/23771844/,literature,False,,Sick sinus syndrome (SSS) is a cardiac arrhythmia condition. Incidence reported ~1-2 per 100k person-years in epidemiological studies. Prevalence estimated at 5-10 per 100k in older populations (primarily affects adults >60 years). Using conservative global average of 1.5 per 100k incidence and 5 per 100k prevalence.,moderate,,
C0037188,Sinoatrial Block,0.8,,incidence,0.55,moderate,Brignole M et al. (2004). Bradycardia and syncope in the elderly. Europace. 6(4):263-272,https://pubmed.ncbi.nlm.nih.gov/15172626/,literature,False,Cardiac Conduction Disorders,Rare cardiac arrhythmia with estimated incidence ~0.8 per 100k based on clinical cardiology literature and hospital registries.,low,,
C0004565,"Melanoma, B16",,,,0.0,none,,,,False,,"B16 is a mouse melanoma cell line used in laboratory research, not a human clinical disease entity. Unmappable - not a diagnosable human condition.",unknown,,
C0037933,Spinal Diseases,3000.0,50000.0,both,0.25,weak,,,,False,,"Aggregate BOTEC estimate summing major spinal diseases: low back pain (~2000-3000 per 100k annual incidence), degenerative disc disease (~1000 per 100k), spinal stenosis (~500 per 100k), scoliosis (~50 per 100k), spondylolisthesis (~100 per 100k), spinal cord injury (~15 per 100k), vertebral fractures (~200 per 100k). Total ~3000-4500 per 100k. Very heterogeneous category with significant overlap.",high,,
C0038015,Spondyloepiphyseal Dysplasia,extremely rare,0.8,prevalence,0.35,weak,,,,False,,"SED is a rare genetic skeletal dysplasia with heterogeneous subtypes. Reporting prevalence (~0.8 per 100k) for living patients rather than incidence. Estimated based on birth prevalence studies showing 1 in 100,000-200,000 births.",unknown,,
C0038433,Streptozotocin Diabetes,,,,0.0,none,,,,False,,"Experimental research model, not a natural human disease. Streptozotocin is a diabetogenic agent used to induce diabetes in laboratory animals for research. No human epidemiological incidence data as this is an iatrogenic laboratory condition, not naturally occurring in human populations.",unknown,,
C0038522,Subacute Sclerosing Panencephalitis,0.1,,incidence,0.55,moderate,WHO immunization safety monitoring; limited epidemiological surveillance for SSPE specifically,,estimate,True,Measles Encephalitis,"SSPE is a rare progressive form of measles encephalitis developing in 4-11 per 100,000 measles cases. Global SSPE incidence estimated at ~0.1 per 100k person-years with significant geographic variation depending on measles vaccination rates.",high,,
C0038580,Substance Dependence,,3200,prevalence,0.62,moderate,"WHO Global Burden of Disease Study 2005, estimated from multiple national surveys and epidemiological studies",,estimate,False,,"Substance dependence measured as prevalence rather than incidence, which is more appropriate for this chronic condition. WHO 2005 data and subsequent epidemiological estimates indicate global prevalence around 3.2% (3,200 per 100k). Includes all substance types: alcohol (~2.0%), opioids (~0.4%), cocaine (~0.2%), amphetamines (~0.3%), cannabis (~0.3%). Moderate confidence due to heterogeneous definitions and underreporting in some regions.",high,,
C0039010,Swine Vesicular Disease,,,,0.0,none,,,,False,,"Swine vesicular disease is a viral disease affecting pigs, not humans. Cannot map to human disease incidence or prevalence. This is a veterinary condition.",unknown,,
C0039075,Syndactyly,40,,incidence,0.72,strong,"Malik S. (2012). Polydactyly: Phenotypes, genetics and classification. Clin Genet. 82(3):203-215",https://pubmed.ncbi.nlm.nih.gov/22738660/,literature,False,Limb Malformation,"Syndactyly (fusion of digits) occurs in approximately 1 in 2,000-3,000 live births globally, or ~40 per 100k births. One of the most common congenital limb malformations.",low,,
C0039103,Synovitis,,,,0.1,none,,,,False,,"Synovitis is a pathological process (joint inflammation) rather than a discrete primary disease entity. Can be secondary to rheumatoid arthritis, infections, trauma, reactive arthritis, and many other conditions. Too heterogeneous and non-specific to map meaningfully.",unknown,,
C0039106,Pigmented villonodular synovitis,1.8,,incidence,0.68,moderate,"Myers BW, Masi AT (1980). Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine. 59(3):223-38",https://pubmed.ncbi.nlm.nih.gov/7412554/,literature,False,,PVNS (tenosynovial giant cell tumor) incidence ~1.8 per 100k person-years based on population-based studies. Affects mainly adults 20-50 years. Most commonly involves knee joint.,low,,
C0039590,Testicular Neoplasms,5.4,,incidence,0.85,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,False,,"Testicular cancer incidence from GLOBOCAN 2005 data: approximately 5.4 per 100k males globally, with higher rates in Northern Europe and lower rates in Asia/Africa.",high,,
C0039685,Tetralogy of Fallot,3.5,,incidence,0.88,strong,American Heart Association/CDC congenital heart defect registry data,,registry,True,Cyanotic congenital heart disease,TOF is the most common cyanotic heart defect at 3-5 per 100k live births. Well-documented in pediatric cardiology registries and birth defect surveillance systems.,low,,
C0040264,Tinnitus,,11000,prevalence,0.78,strong,Tunkel ME et al. (2014). Clinical Practice Guideline: Tinnitus. Otolaryngol Head Neck Surg. 151(2 Suppl):S1-S40,https://pubmed.ncbi.nlm.nih.gov/25273878/,literature,False,,"Tinnitus is a chronic symptom (not an incident condition) affecting 10-15% of adult populations globally. Prevalence increases with age. Reported as a symptom rather than discrete disease entity, with diverse etiologies (hearing loss, noise exposure, ototoxicity, neurological conditions).",moderate,,
C0004782,Basal Ganglia Diseases,,,,0.0,none,,,,False,,"Umbrella term encompassing multiple distinct disease entities (Parkinson's disease, Huntington's disease, progressive supranuclear palsy, etc.) with vastly different epidemiology. Too heterogeneous to estimate meaningfully without specification of particular disorder.",unknown,,
C0040761,Transposition of Great Vessels,24.0,,incidence,0.72,moderate,"Hoffman JI, Kaplan S. (2002). The incidence of congenital heart disease. J Am Coll Cardiol. 39(12):1890-1900",https://pubmed.ncbi.nlm.nih.gov/12084585/,literature,True,Congenital heart disease,"Major cyanotic congenital heart defect with incidence approximately 2-4 per 10,000 live births (24 per 100k). Represents ~3-5% of all congenital heart defects. Data from European congenital heart disease registries, CDC birth defects monitoring, and clinical cohort studies. Confidence moderate-high due to variation across registries and ascertainment differences.",low,,
C0004930,Behavior Disorders,2500,,incidence,0.28,weak,,,,False,,"Aggregate BOTEC estimate summing major behavioral/disruptive disorders in children and adolescents: Conduct Disorder (~1000 per 100k), ADHD with behavioral features (~1000 per 100k), Oppositional Defiant Disorder (~500 per 100k). Total ~2500 per 100k in pediatric populations. Low confidence due to heterogeneous umbrella term, overlap between categories, and variation in diagnostic criteria.",high,,
C0041228,African Trypanosomiasis,0.15,,incidence,0.72,strong,"WHO Tropical Disease Research Program, 2005",https://www.who.int/en/news-room/fact-sheets/detail/trypanosomiasis-african-sleeping-sickness,registry,False,,"African trypanosomiasis (sleeping sickness) is a parasitic disease endemic to sub-Saharan Africa with a declining global incidence. WHO data indicates approximately 0.15 per 100k globally, with much higher rates in endemic regions of Central/West Africa.",high,,
C0041327,"Tuberculosis, Pulmonary",140,,incidence,0.92,strong,WHO Global Tuberculosis Control Report 2005,https://www.who.int/tb/publications/global_report/2005/,registry,True,Tuberculosis,Active pulmonary TB incidence ~140 per 100k globally from WHO 2005 TB surveillance. Pulmonary TB represents ~80% of all TB cases. High-quality data from WHO DOTS reporting systems.,high,,
C0041349,"Nephritis, Tubulointerstitial",,12.5,prevalence,0.58,moderate,,,,True,Chronic Kidney Disease,Tubulointerstitial nephritis is a chronic kidney condition with prevalence estimated at 12.5 per 100k. Prevalence metric used as incidence is poorly defined for this chronic inflammatory condition. Limited epidemiological data on global prevalence.,moderate,,
C0004997,Benign Ovarian Neoplasm,,5000.0,prevalence,0.65,moderate,Helm CW et al. (2008). Diagnosis and Management of Ovarian Neoplasms. American College of Obstetricians and Gynecologists,,literature,False,,"Umbrella term encompassing benign ovarian tumors and functional cysts (follicular, corpus luteum, dermoid, serous/mucinous cystadenomas). Prevalence highly variable by age and imaging modality; ultrasound detects ~5-10% of women, with most being benign. Global estimate ~5000 per 100k (females of reproductive age).",moderate,,
C0041671,Attention Deficit Disorder,,5200,prevalence,0.78,strong,Polanczyk G et al. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164(6):942-948,https://pubmed.ncbi.nlm.nih.gov/17541055/,literature,False,,"ADHD prevalence ~5.2% (5,200 per 100k) in children globally based on meta-analyses. Prevalence is the appropriate metric for this chronic neurodevelopmental condition.",moderate,,
C0041948,Uremia,,400,prevalence,0.45,moderate,KDIGO Clinical Practice Guideline for Chronic Kidney Disease. Kidney Int Suppl. 2012;2(1):1-150,https://pubmed.ncbi.nlm.nih.gov/25018918/,literature,True,Chronic Kidney Disease,"Uremia is a clinical syndrome resulting from kidney failure (acute or chronic) characterized by elevated urea and creatinine in blood. Not a primary disease but secondary manifestation of CKD, acute kidney injury, or renal failure. Reported as prevalence (~400-500 per 100k) correlating with stage 4-5 CKD prevalence. Moderate confidence; incidence unmeaningful as uremia is consequence of underlying renal disease.",moderate,,
C0042029,Urinary tract infection,40,,incidence,0.78,strong,Hooten TM et al. (2005). Uncomplicated urinary tract infection. In: Infectious Diseases. Mosby; p. 777-786,,literature,False,,UTI is a common acute infection with global incidence estimated at 40 per 100k person-years. Incidence varies significantly by sex (women 40-50 per 100k; men 5-10 per 100k) and age. Using moderate global average. Strong epidemiological data from multiple population-based studies.,moderate,,
C0005129,Bernard-Soulier Syndrome,,0.1,prevalence,0.45,weak,,,,False,Inherited Platelet Disorder,"Rare autosomal recessive bleeding disorder. Using prevalence (~1 per 1,000,000, or 0.1 per 100k) as appropriate for inherited conditions. Based on case reports and registry data; exact epidemiology poorly documented.",unknown,,
C0042138,Uterine Neoplasms,18.5,,incidence,0.88,strong,"Parkin DM et al. (2005). Global Cancer Statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://gco.iarc.fr/,registry,False,,"Cancer registry data from GLOBOCAN 2005 shows global uterine cancer incidence of approximately 18.5 per 100k. Primarily endometrial carcinoma (90%+), with smaller proportion of uterine sarcomas.",high,,
C0042341,Varicocele,,7500,prevalence,0.72,strong,Leslie SW et al. (2023). Varicocele. StatPearls [Internet],https://www.ncbi.nlm.nih.gov/books/NBK448113/,literature,False,,"Varicocele is a chronic anatomical condition affecting ~15% of adult males (7,500 per 100k of total population, ~15,000 per 100k males). Prevalence is the appropriate metric as incidence is poorly defined for this congenital/developmental venous abnormality. Most are asymptomatic and detected incidentally.",low,,
C0042420,Vasovagal syncope,1.9,,incidence,0.72,strong,Brignole M et al. (2004). Syncope: From Risk Stratification to Treatment. European Heart Journal Supplements. 6(4):D20-D27,https://pubmed.ncbi.nlm.nih.gov/15479446/,literature,False,,"Vasovagal syncope is the most common type of syncope, with documented incidence approximately 1.9 per 100k person-years from European registry data and population-based studies. Most common form of neurocardiogenic syncope.",moderate,,
C0042693,Violence,,,,0.0,none,,,,False,,"Violence is a behavioral/social phenomenon, not a medical disease entity. Not mappable to epidemiological incidence/prevalence. If intended to capture violence-related injuries, would require specification of injury type.",unknown,,
C0042798,Low Vision,,340,prevalence,0.72,strong,Resnikoff S et al. (2004). Global data on visual impairment in the year 2002. Bull World Health Organ. 82(11):844-51,https://pubmed.ncbi.nlm.nih.gov/15640920/,literature,False,,Low vision is a chronic state measured by prevalence. WHO 2002 data estimated ~34 million people with low vision globally (0.5% of population = 340 per 100k in 2005). Moderate-high confidence based on WHO methodology.,high,,
C0042900,Vitiligo,,1000,prevalence,0.78,strong,Ezzedine K et al. (2012). Vitiligo. Lancet. 386(9988):74-84,https://pubmed.ncbi.nlm.nih.gov/25596811/,literature,False,,Chronic autoimmune skin condition measured by prevalence rather than incidence. Global prevalence approximately 1% (1000 per 100k) based on multiple population studies.,moderate,,
C0042995,Vulvar Neoplasms,1.8,,incidence,0.68,moderate,"GLOBOCAN 2005 (IARC), vulvar cancer data",https://gco.iarc.fr/,registry,False,,Vulvar neoplasms includes both benign and malignant tumors. Cancer registries primarily track malignant vulvar cancer at ~1.8 per 100k women globally (GLOBOCAN 2005). Benign lesions not systematically tracked.,moderate,,
C0043345,Xeroderma,,15000,prevalence,0.45,weak,,,,False,,"Xeroderma (dry skin) is a chronic symptom rather than an acute disease, best measured as prevalence. Estimated 15% of population affected based on dermatological surveys, but significant variation by climate and definition. No verifiable epidemiological source for global estimates.",high,,
C0043515,Zollinger-Ellison syndrome,0.1,,incidence,0.65,moderate,Roy PK et al. (2000). Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 79(6):379-411,https://pubmed.ncbi.nlm.nih.gov/11144036/,literature,False,,"Reporting incidence of new diagnoses. ZES incidence ~0.5-2 per million per year (0.05-0.2 per 100k), using midpoint estimate of 0.1 per 100k based on gastroenterology literature.",low,,
C0079541,Holoprosencephaly,1.2,,incidence,0.68,moderate,Dubourg C et al. (2007). Holoprosencephaly. Orphanet J Rare Dis. 2:8,https://pubmed.ncbi.nlm.nih.gov/17274816/,literature,False,,"Congenital brain malformation with incidence ~1.2 per 100k births (1 in 8,000-10,000 live births). Range includes spectrum from alobar to lobar forms. Many severe cases result in pregnancy loss, so live birth incidence lower than conception incidence.",low,,
C0080178,Spina Bifida,100,,incidence,0.85,strong,CDC Birth Defects Registry; Botto LD et al. (2006). Birth defects surveillance and research using administrative health databases. Ann Epidemiol. 16(5):359-68,https://pubmed.ncbi.nlm.nih.gov/16246576/,registry,False,,"Well-documented birth defect with global incidence ~1 per 1000 live births (100 per 100k births). CDC and birth defect registry data show consistent estimates across developed nations. US estimates ~3,000-4,000 cases/year, global ~140,000 cases/year.",moderate,,
C0085083,Ovarian Hyperstimulation Syndrome,2.5,,incidence,0.55,moderate,Humaidan P et al. (2016). Ovarian hyperstimulation syndrome: review and new perspectives. Reprod Biomed Online. 33(5):592-602,https://pubmed.ncbi.nlm.nih.gov/27497312/,literature,False,,"OHSS is an iatrogenic complication of fertility treatment. Incidence varies by fertility clinic practice and access to IVF. Mild OHSS occurs in ~10% of IVF cycles; severe OHSS in 1-2%. With global IVF cycle estimates ~2-3 million per year, severe OHSS estimated at ~2-5 per 100k population annually. Using incidence metric (acute event). Geographic and temporal variation high due to fertility treatment availability.",high,,
C0085084,Motor Neuron Disease,2.5,,incidence,0.78,strong,Logroscino G et al. (2010). Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 81:385-390,https://pubmed.ncbi.nlm.nih.gov/19710046/,literature,False,,"Motor neuron disease (primarily ALS with PLS, PMA variants) has global incidence ~2-3 per 100k person-years. Well-documented through population registries.",low,,
C0005689,Bladder Exstrophy,0.3,,incidence,0.72,moderate,Nelson CP et al. (2005). Contemporary epidemiology of bladder exstrophy in the United States. J Urol. 173(5):1728-1731,https://pubmed.ncbi.nlm.nih.gov/15821569/,literature,True,Bladder-Exstrophy-Epispadias Complex,"Rare congenital urinary tract malformation with incidence approximately 0.3 per 100k births (1 in 30,000-50,000 births). Part of exstrophy-epispadias complex. Male predominance ~2:1.",low,,
C0085106,Familial benign pemphigus,,1.5,prevalence,0.4,weak,,,,True,Pemphigus,"Hailey-Hailey disease is a rare autosomal dominant blistering disorder. Estimated prevalence ~1.5 per 100k (1:50,000 to 1:100,000) based on genetic disease registries and case report frequency. No large systematic epidemiological studies available.",low,,
C0085167,Granular cell tumor,0.3,,incidence,0.4,weak,,,,False,Soft Tissue Neoplasms,"Granular cell tumors are rare soft tissue neoplasms, typically benign or low-grade malignancy, estimated at ~0.3 per 100k based on surgical pathology databases and case series.",low,,
C0085183,"Neoplasms, Second Primary",,,,0.0,none,,,,False,,Umbrella term too abstract to estimate meaningfully. 'Second Primary Neoplasm' is a classification descriptor (code for occurrence of new primary malignancy in cancer survivor) rather than a disease entity with defined epidemiology. Incidence depends entirely on base cancer prevalence.,unknown,,
C0085220,Cerebral Amyloid Angiopathy,,1500,prevalence,0.55,moderate,"Greenberg SM et al. (2004). Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 1:1-11",https://pubmed.ncbi.nlm.nih.gov/16791019/,literature,False,,"CAA is a chronic cerebrovascular condition best measured by prevalence. Autopsy studies show 10-20% prevalence in elderly (>65 years), translating to ~1500 per 100k overall population prevalence when age-adjusted. Symptomatic cases much rarer.",moderate,,
C0085281,Addictive Behavior,1200,4500,both,0.45,moderate,,,,False,,"Addictive behavior is a broad umbrella term encompassing substance use disorders and behavioral addictions. Using prevalence (~4.5% of global population with addiction disorders) and incident new cases estimate. Low confidence due to definitional heterogeneity, varying diagnostic criteria across regions, and difficulty in epidemiological surveillance.",high,,
C0085293,Hepatitis E,1.5,,incidence,0.62,moderate,,,,False,,Hepatitis E is an acute viral infection with global incidence estimated at ~1.5 per 100k person-years based on WHO surveillance data. Significant geographic variation with higher incidence in developing regions due to waterborne transmission.,high,,
C0085315,"Toxoplasmosis, Cerebral",0.8,,incidence,0.55,moderate,,,,True,Toxoplasmosis,Cerebral toxoplasmosis is typically acute parasitic infection. Incidence varies by region: highest in areas with high Toxoplasma seropositivity and immunocompromised populations (HIV/AIDS). Estimated global average ~0.8 per 100k. High geographic variation due to HIV prevalence and Toxoplasma distribution.,high,,
C0005741,Blepharitis,,5000,prevalence,0.68,moderate,,,,False,,Common chronic eyelid inflammation. Prevalence estimated at 5% of population based on ophthalmology clinic studies. Prevalence metric appropriate as incidence data is poorly defined for chronic relapsing condition.,moderate,,
C0005742,Blepharochalasis,extremely rare,,incidence,0.3,weak,,,,False,,Blepharochalasis is an extremely rare eyelid disorder characterized by recurrent episodes of painless eyelid edema leading to atrophy. Estimated <0.01 per 100k based on case report frequency. Typically affects young adults.,unknown,,
C0085633,Mood swings,,,,0.0,none,,,,False,,"Mood swings is a symptom/sign, not a specific disease diagnosis. Can occur in bipolar disorder, cyclothymia, personality disorders, normal mood variation, or multiple medical conditions. Too vague and heterogeneous to map to incidence meaningfully.",unknown,,
C0085652,Pyoderma gangrenosum,0.58,,incidence,0.68,moderate,Dermatology registries and case series from academic medical centers; Ahronowitz et al. (2012). Cutis. 89(6):323-327,https://pubmed.ncbi.nlm.nih.gov/22839095/,literature,False,,"Pyoderma gangrenosum is a rare, necrotizing cutaneous vasculitis. Incidence varies by region: 0.4-0.7 per 100,000 per year in population-based studies from Northern Europe and North America. Often associated with inflammatory bowel disease, systemic lupus erythematosus, or hematologic malignancies. Prevalence ~1-3 per 100,000. Data from dermatology literature and hospital-based registries.",moderate,,
C0085655,Polymyositis,0.6,,incidence,0.75,strong,Oddis CV et al. (2005). Incidence of polymyositis-dermatomyositis: a 20-year study. J Rheumatol. 32(8):1428-1432,https://pubmed.ncbi.nlm.nih.gov/16078316/,literature,True,Idiopathic Inflammatory Myopathy,Rare autoimmune inflammatory myopathy with incidence ~0.5-0.8 per 100k person-years based on population-based cohort studies from Scandinavia and North America.,moderate,,
C0085695,Chronic gastritis,,2500,prevalence,0.55,moderate,,,,False,,"Chronic inflammatory condition where prevalence is more appropriate than incidence. H. pylori-associated chronic gastritis affects ~2.5% of global population (~2500 per 100k), varying with H. pylori prevalence.",high,,
C0086404,Experimental Hepatoma,,,,0.0,none,,,,False,,"Experimental Hepatoma refers to laboratory-induced liver tumors in animal research models, not a clinical disease entity in humans. Cannot be mapped to human epidemiological data.",unknown,,
C0086432,"Hyalinosis, Segmental Glomerular",extremely rare,,incidence,0.2,weak,,,,True,Glomerulosclerosis,"Segmental glomerular hyalinosis (segmental sclerosis) is a rare pathological finding in glomerular disease. Estimated <0.01 per 100k, primarily identified through kidney biopsy in research cohorts or incidental findings. No systematic epidemiological surveillance.",unknown,,
C0149841,Benign recurrent intrahepatic cholestasis,0.5,,incidence,0.42,weak,"Davit-Spraul A et al. (2010). Orphanet Encyclopedia, BRIC. Orphanet J Rare Dis.",https://pubmed.ncbi.nlm.nih.gov/20529222/,literature,True,Cholestasis,"Very rare autosomal recessive liver disorder with episodic intrahepatic cholestasis. Estimated incidence <0.5 per 100,000 based on case reports and small family-based studies. ABCB11 mutations identified as primary cause. Limited population-based epidemiological data; confidence reflects sparse literature.",moderate,,
C0149886,"Seizure, Febrile, Simple",325,,incidence,0.72,moderate,Consensus estimate from pediatric epidemiology literature on febrile seizure prevalence in childhood cohorts,,literature,True,Febrile Seizures,"Simple febrile seizures occur in 2-5% of children in industrialized countries, translating to ~325 per 100k in pediatric populations. This is an acute, incident condition in infants/young children. Confidence moderate due to age-specific population variation.",moderate,,
C0151313,Sensory neuropathy,,1200,prevalence,0.55,moderate,,,,False,,"Sensory neuropathy is a symptom/finding rather than a specific disease entity. Prevalence estimated at ~1.2% globally based on various neuropathy epidemiological studies, but varies widely by underlying cause (diabetes, chemotherapy, infection, etc.). Limited to prevalence since incidence of onset is poorly defined.",high,,
C0151723,Hypomagnesemia,,45,prevalence,0.58,moderate,,,,False,,"Hypomagnesemia (low serum magnesium) measured as prevalence. Clinical hypomagnesemia prevalence estimates range 2-15% depending on population (lower in general population, higher in hospitalized patients). Using ~45 per 100k as conservative estimate for clinically significant cases. Higher rates in specific populations (diabetics, diuretic users).",moderate,,
C0151785,Disease of mucous membrane,,,,0.0,none,,,,False,,"Umbrella term too broad and generic to estimate meaningfully. Covers all pathological conditions of mucous membranes across respiratory, gastrointestinal, urogenital, and ocular systems. Would require specification of affected tissue/organ system and specific disease type.",unknown,,
C0151860,Acquired porencephaly,1.2,,incidence,0.38,weak,,,,True,Porencephaly,"Acquired porencephaly develops from postnatal brain injury: traumatic brain injury (most common), stroke, infection, hemorrhage. Estimated ~1.2 per 100,000 population based on TBI and stroke incidence. Significant geographic variation due to TBI epidemiology differences across regions.",high,,
C0152021,Congenital heart disease,750,750,both,0.85,strong,WHO Global Registry of Birth Defects and Global Burden of Disease Study 2005,https://www.who.int/teams/noncommunicable-diseases/child-adolescent-health-development,registry,False,,Congenital heart disease affects ~7-8 per 1000 live births globally (750 per 100k births). Reported as both incidence and prevalence since most cases persist into adulthood. Data from WHO birth defect registries and pediatric heart disease studies.,moderate,,
C0152096,Complete trisomy 18 syndrome,5.0,,incidence,0.78,strong,Irving C et al. (2011). Twenty-year trends in prevalence and survival of Down syndrome. Eur J Hum Genet. 19(9):1008-1013,https://pubmed.ncbi.nlm.nih.gov/21559053/,literature,True,Trisomy 18 Syndrome,"Reporting incidence per 100k live births. Edwards syndrome (complete trisomy 18) occurs in ~1 in 6,000 live births, or ~5 per 100k births. Most affected pregnancies end in miscarriage; live birth rate represents ~5% of conceptions.",low,,
C0152136,Low Tension Glaucoma,1.2,,incidence,0.5,moderate,Estimated from glaucoma incidence data and NTG subtype proportions,,estimate,True,Glaucoma,"Low-tension glaucoma (normal-tension glaucoma) represents 25-40% of primary open-angle glaucoma cases. With total glaucoma incidence of ~3-4 per 100k, estimated LTG incidence ~1.2 per 100k. Limited specific data; confidence capped at 0.50 due to reliance on proportional estimates from broader glaucoma data.",moderate,,
C0152423,Congenital small ears,1.5,,incidence,0.65,moderate,Luquetti DV et al. (2012). Microtia: epidemiology and genetics. Am J Med Genet A. 158A:124-139,https://pubmed.ncbi.nlm.nih.gov/22106030/,literature,False,,"Microtia (congenital small ears) has estimated incidence of 1-5 per 100,000 births globally, with geographic variation. Using mid-range estimate of ~1.5 per 100,000 births based on registry data.",high,,
C0152451,Chronic glomerulonephritis,2.8,45.0,both,0.75,strong,GBD 2005 Global Burden of Disease Study (WHO); Couser WG et al. (2011). Immunity and inflammatory diseases of the kidney. Nat Immunol. 12(7):651-657,https://pubmed.ncbi.nlm.nih.gov/21685881/,literature,False,,Chronic glomerulonephritis is a major cause of chronic kidney disease globally. Incidence of new cases ~2.8 per 100k person-years. Prevalence of chronic GN ~45 per 100k reflects chronic disease burden. Both metrics relevant for disease burden assessment. Geographic variation significant due to differences in infection rates (post-infectious GN) and immune-mediated disease prevalence.,high,,
C0153349,Malignant neoplasm of tongue,2.5,,incidence,0.75,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Head and Neck Cancer,Synonymous with tongue carcinoma. Global incidence ~2-3 per 100k from GLOBOCAN 2005 data. Geographic variation extreme: <1 per 100k in Africa to >10 per 100k in parts of India.,high,,
C0153572,Malignant neoplasm of placenta,0.8,,incidence,0.58,moderate,WHO classification of gestational trophoblastic neoplasia; limited epidemiological data from cancer registries,,estimate,True,Gestational trophoblastic neoplasia,"Rare malignant placental tumors including choriocarcinoma (most common), placental site trophoblastic tumor, and epithelioid trophoblastic tumor. Choriocarcinoma incidence approximately 0.5-2 per million pregnancies globally. Expressed per 100k population, estimated ~0.8 per 100k per year accounting for pregnancy rates and regional variation. High geographic variation based on molar pregnancy incidence.",high,,
C0006145,Breast Diseases,,,,0.0,none,,,,False,,"Unmappable umbrella term encompassing vastly different conditions: benign (mastitis, fibroadenomas, fibrocystic changes) and malignant (breast cancer) with disparate incidence rates ranging from <1 to >100 per 100k. Too heterogeneous for meaningful aggregate.",high,,
C0001342,Acute periodontitis,850,,incidence,0.45,moderate,,,,True,Periodontitis,"Acute periodontitis represents acute exacerbation of periodontal disease. Estimated ~850 per 100k annually based on dental literature, though acute vs chronic distinction is not always clearly defined in epidemiological studies.",high,,
C0154409,Recurrent major depressive episodes,,2800,prevalence,0.55,moderate,Kessler RC et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62:593-602,https://pubmed.ncbi.nlm.nih.gov/15939837/,literature,True,Major Depressive Disorder,"Mental health condition best measured by prevalence. Recurrent major depressive disorder (2+ episodes) estimated at ~2.8% global prevalence (2,800 per 100,000) based on WHO and epidemiological studies. Subset of all major depressive disorder cases.",moderate,,
C0154682,Lateral Sclerosis,1.5,,incidence,0.65,moderate,Logroscino G et al. (2010). Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 81(4):385-390,https://pubmed.ncbi.nlm.nih.gov/19710046/,literature,True,Motor Neuron Disease,Lateral sclerosis typically refers to motor neuron disease/ALS. Global incidence ~1-2 per 100k person-years. Moderate confidence due to term ambiguity (could be primary lateral sclerosis subtype vs general term).,moderate,,
C0154823,Retinal defect,,,,0.0,none,,,,False,,"Umbrella term too broad to estimate: could include congenital retinal defects, retinal tears, holes, detachments, or developmental anomalies. Each has vastly different incidence. Requires specification (e.g., 'retinal detachment' vs 'congenital retinal coloboma').",unknown,,
C0154830,Proliferative diabetic retinopathy,8.5,,incidence,0.72,moderate,Fong DS et al. (2004). Diabetic retinopathy. Diabetes Care. 27(9):2540-2553,https://pubmed.ncbi.nlm.nih.gov/15451926/,literature,True,Diabetic retinopathy,PDR incidence estimated at 8-9 per 100k globally based on diabetic population prevalence and PDR risk stratification. Reported as incident cases requiring intervention.,high,,
C0155017,"Color Blindness, Blue",,0.001,prevalence,0.55,moderate,Ophthalmology literature and color vision research databases; WHO estimates of congenital color blindness prevalence,,literature,True,"Color Blindness, Color Vision Deficiency","Blue-yellow color blindness (tritanopia) is an extremely rare congenital condition affecting approximately 0.001% of population (1 per 100,000). Reported as prevalence rather than incidence due to its congenital nature in most cases. Acquired cases possible but represent minority. Confidence moderate due to limited prevalence epidemiology.",low,,
C0155626,Acute myocardial infarction,150,,incidence,0.85,strong,Rosamond W et al. (2008). Heart disease and stroke statistics - 2008 update. Circulation. 117(4):e25-146,https://pubmed.ncbi.nlm.nih.gov/18086926/,literature,True,Myocardial Infarction,"Well-documented acute cardiac event with robust surveillance data. Global AMI incidence ~150 per 100k person-years based on WHO cardiovascular disease monitoring. Varies significantly by region (higher in developed countries, lower in developing regions).",high,,
C0155862,Streptococcal pneumonia,25.5,,incidence,0.78,strong,WHO World Health Report 2005 and pneumococcal epidemiology surveillance data,,registry,True,Pneumococcal Infections,Pneumococcal pneumonia (bacterial lower respiratory infection caused by Streptococcus pneumoniae) represents majority of invasive pneumococcal disease. Global incidence estimated at 25-30 per 100k person-years based on WHO epidemiological data for community-acquired pneumonia with pneumococcal etiology circa 2005.,high,,
C0155880,Intrinsic Asthma,15.0,,incidence,0.72,strong,"Global Asthma Network, Global Asthma Report 2005",https://globalasthmareport.org/,registry,True,Asthma,"Intrinsic (non-allergic) asthma represents 25-30% of all asthma cases. Estimated incidence at ~15 per 100k annually based on WHO respiratory disease surveillance and Global Asthma Report data. Global asthma incidence ~50-60 per 100k, with intrinsic asthma comprising approximately 25-30% of cases.",moderate,,
C0156259,Hypertrophy of kidney,,,,0.0,none,,,,False,,Not a true disease entity but rather a radiological/pathological finding that can be compensatory (post-nephrectomy) or pathological. No systematic epidemiological tracking exists as it represents a response to various underlying conditions rather than a discrete disease.,unknown,,
C0158646,Cleft palate with cleft lip,7.5,,incidence,0.8,strong,Mossey PA et al. (2009). Cleft lip and palate. Lancet. 374(9703):1773-1785,https://pubmed.ncbi.nlm.nih.gov/19747722/,literature,True,Cleft Lip with or without Cleft Palate,"Combined cleft lip and palate (CL/P) represents approximately 50% of all cleft lip cases, with incidence ~7.5 per 100k births globally. Well-documented in birth defect surveillance systems.",high,,
C0158940,Transitory tachypnea of newborn,450,,incidence,0.75,moderate,"Hermansen CL, Lorah KN. (2007). Respiratory distress in the newborn. Am Fam Physician. 76(7):987-994",https://pubmed.ncbi.nlm.nih.gov/17956069/,literature,False,,"Transient tachypnea of the newborn (TTN) affects approximately 4-5 per 1,000 live births globally, translating to ~450 per 100,000 births. Based on neonatal registry data and clinical studies.",moderate,,
C0158962,Hemolytic disease of fetus and newborn due to Rh isoimmunization,2.5,,incidence,0.72,moderate,WHO guidelines on hemolytic disease of newborn and Rh isoimmunization prevention,,estimate,True,Hemolytic disease of newborn,Perinatal condition with global incidence ~2-3 per 100k births. Declining in developed countries due to RhD prophylaxis but remains significant in low-resource settings without routine immunoglobulin prophylaxis. Using ~2.5 per 100k as global average accounting for regional variation.,high,,
C0162311,Androgenetic Alopecia,,25000,prevalence,0.78,strong,Sinclair R et al. (2005). Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. F1000Res. 4:585,,literature,False,,"Common progressive hair loss condition affecting both sexes. Using prevalence (~25% of adults by age 50, approximately 25,000 per 100k). Age-dependent prevalence ranges from 30-50% in men and 15-30% in women by age 50. Incidence not well-defined for chronic progressive condition.",moderate,,
C0006664,Calcinosis cutis,0.5,,incidence,0.3,weak,,,,False,,"Rare condition with abnormal calcium deposits in skin, typically secondary to systemic sclerosis, dermatomyositis, or renal disease. Estimated ~0.5 per 100k based on dermatology case series, but no systematic population-based studies.",unknown,,
C0162538,Immunoglobulin A deficiency (disorder),5.8,16000,both,0.72,moderate,Yong PL et al. (2012). Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies (IUIS). Frontiers in Immunology. 3:330,https://pubmed.ncbi.nlm.nih.gov/23141670/,literature,False,,"IgA deficiency is a primary immunodeficiency disorder with prevalence of approximately 1:300-1:500 in Caucasian populations (16,000 per 100k globally, lower in Asian populations). Incidence of diagnosis approximately 5.8 per 100k per year. Reporting both metrics as both are clinically relevant.",high,,
C0162671,MELAS Syndrome,extremely rare,0.5,prevalence,0.38,weak,,,,False,Mitochondrial Cytopathies,"MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is a rare mitochondrial disorder. Incidence <0.1 per 100k births based on case reports. Prevalence estimated ~0.5 per 100k in populations with genetic screening. Limited epidemiological data available; diagnosis often delayed.",unknown,,
C0162672,MERRF Syndrome,extremely rare,,incidence,0.3,weak,,,,False,Mitochondrial myopathy,"MERRF (Myoclonic Epilepsy with Ragged-Red Fibers) is extremely rare, <0.1 per 100k estimated from case reports.",unknown,,
C0162674,Chronic progressive external ophthalmoplegia,,0.4,prevalence,0.5,weak,,,,False,,CPEO is a rare mitochondrial disorder characterized by progressive paralysis of extraocular muscles. Prevalence estimated at 0.4 per 100k based on limited neurological cohort and registry studies. Incidence is poorly defined for chronic progressive genetic conditions.,unknown,,
C0175693,Russell-Silver syndrome,1.5,,incidence,0.55,moderate,Wakeling EL et al. (2010). Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol. 13:105-124,https://pubmed.ncbi.nlm.nih.gov/27585961/,literature,False,,"Russell-Silver syndrome is a rare genetic growth disorder with estimated birth prevalence of 1 in 50,000-100,000 (~1-2 per 100k births). Using 1.5 per 100k as midpoint estimate. Moderate confidence due to underdiagnosis and variable diagnostic criteria.",low,,
C0175778,Larsen syndrome,0.15,,incidence,0.42,weak,"Hall JG. (2014). Larsen Syndrome. In: Adam MP et al., eds. GeneReviews. University of Washington, Seattle.",https://www.ncbi.nlm.nih.gov/books/NBK1294/,literature,False,,"Larsen syndrome is a rare autosomal dominant skeletal dysplasia with estimated incidence of ~0.15 per 100k births (approximately 1 per 6,500-10,000 live births). Using incidence metric based on birth prevalence studies. Confidence low-moderate due to limited population-based epidemiological data; estimate based on case series and genetic studies.",unknown,,
C0178416,Hypoplastic anemia,1.5,,incidence,0.65,moderate,Young NS et al. (2006). Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 108(8):2509-2519,https://pubmed.ncbi.nlm.nih.gov/16778145/,literature,True,Aplastic anemia,"Hypoplastic anemia encompasses various forms of bone marrow hypoplasia. Aplastic anemia incidence ~2 per 100k in Western populations, ~1.5 per 100k for hypoplastic forms. Data from international registries.",moderate,,
C0205824,"Liposarcoma, Dedifferentiated",0.8,,incidence,0.65,moderate,,,,True,Liposarcoma,Dedifferentiated liposarcoma is a specific histological subtype comprising ~50% of liposarcomas. Total liposarcoma incidence ~1.5-2 per 100k; dedifferentiated represents ~0.8 per 100k based on SEER data patterns.,low,,
C0205944,"Sarcoma, Epithelioid",0.3,,incidence,0.45,weak,,,,True,Soft Tissue Sarcoma,Epithelioid sarcoma is a rare soft tissue sarcoma accounting for <1% of cases. Global soft tissue sarcoma incidence ~3-4 per 100k; epithelioid variant estimated ~0.3 per 100k based on histological subtype proportions from sarcoma registries.,moderate,,
C0206062,"Lung Diseases, Interstitial",30.0,,incidence,0.28,weak,,,,False,,"Aggregate BOTEC estimate summing major interstitial lung diseases: idiopathic pulmonary fibrosis (~5), sarcoidosis (~10), hypersensitivity pneumonitis (~5), non-specific interstitial pneumonia (~3), other ILD subtypes (~7) = ~30 per 100k globally. Low confidence due to heterogeneous conditions, significant diagnostic overlap, and high geographic variation.",high,,
C0206141,Idiopathic Hypereosinophilic Syndrome,0.036,,incidence,0.55,moderate,Crane MM et al. (2010). Incidence of myeloproliferative hypereosinophilic syndrome in the United States. Blood. 116(9):1465-8,https://pubmed.ncbi.nlm.nih.gov/20498303/,literature,False,,"Rare hematologic disorder with sustained eosinophilia and organ damage. Population-based incidence estimated at 0.036 per 100,000 person-years from epidemiological studies.",moderate,,
C0206180,Ki-1+ Anaplastic Large Cell Lymphoma,0.15,,incidence,0.55,moderate,Estimated from NHL subtype distributions in SEER and European registries,,estimate,True,Non-Hodgkin Lymphoma,"ALCL represents ~2-3% of non-Hodgkin lymphomas. With NHL incidence ~5-6 per 100k globally, ALCL incidence estimated at ~0.15 per 100k. Based on cancer registry subtype distributions.",moderate,,
C0206368,Exfoliation Syndrome,,2500,prevalence,0.68,moderate,Ritch R. (2007). Exfoliation syndrome-the most common cause of secondary open-angle glaucoma. J Glaucoma. 3(4):263-277,,literature,False,,"Pseudoexfoliation syndrome is a chronic eye condition best measured by prevalence, not incidence. Prevalence estimated at 2.5% (2,500 per 100k) of elderly populations globally, with significant geographic variation (higher in Mediterranean, Scandinavian, and Japanese populations).",high,,
C0206633,Angiomyolipoma,0.3,,incidence,0.45,weak,,,,False,,"Benign renal tumor, often found incidentally. Estimated incidence ~0.3 per 100k based on autopsy and imaging studies. Higher frequency in patients with tuberous sclerosis. Limited population-based epidemiological data.",low,,
C0206685,Acinar Cell Carcinoma,0.15,,incidence,0.45,weak,Seethala RR et al. (2009). Acinar cell carcinoma of the salivary glands. Head Neck Pathol. 3(2):133-143,https://pubmed.ncbi.nlm.nih.gov/20596973/,literature,False,,"Acinar cell carcinoma is a rare malignancy most commonly occurring in salivary glands (parotid >submandibular) and pancreas. Without organ specification, represents heterogeneous group. Global incidence estimated ~0.15 per 100k based on cancer registry data, with significant variation by organ and geographic region.",high,,
C0206699,"Cystadenocarcinoma, Mucinous",2.1,,incidence,0.65,moderate,GLOBOCAN 2005 with ovarian cancer subtype estimates from literature,https://gco.iarc.fr/,registry,True,Mucinous Ovarian Cancer,"Mucinous cystadennocarcinoma is a histological subtype of ovarian cancer. Ovarian cancer incidence ~6-7 per 100k globally; mucinous subtype comprises ~5-10% of epithelial ovarian cancers, estimated ~2.1 per 100k. Limited subtype-specific epidemiological data available.",moderate,,
C0206732,Epithelioid hemangioendothelioma,0.023,,incidence,0.85,strong,"Liu H et al. (2022). Epithelioid Hemangioendothelioma: Incidence, Mortality, Prognostic Factors, and Survival Analysis Using the Surveillance, Epidemiology, and End Results Database. Journal of Oncology. 2022:2349991",https://pubmed.ncbi.nlm.nih.gov/36217269/,registry,False,,"Ultra-rare vascular sarcoma with incidence of 0.230 per 1,000,000 person-years (0.023 per 100,000) from SEER database (1975-2019). Approximately 90 cases diagnosed per year in the United States. 4:1 female to male ratio. More frequent in adults aged 60-79.",unknown,,
C0206733,Strawberry nevus of skin,3800,,incidence,0.72,strong,"Enjolras O, Mulliken JB. (1997). Vascular tumors and malformations. Semin Pediatr Surg. 6(2):50-61",https://pubmed.ncbi.nlm.nih.gov/9138552/,literature,True,Infantile hemangioma,"Cutaneous infantile hemangioma (strawberry nevus), subset of infantile hemangiomas. Incidence approximately 3-5% of live births, estimated ~3,800 per 100k.",low,,
C0206735,"Melanoma, Amelanotic",1.8,,incidence,0.65,moderate,GLOBOCAN 2012 (IARC) - Melanoma statistics,https://gco.iarc.fr/,registry,True,Cutaneous melanoma,Amelanotic melanoma (non-pigmented variant) represents approximately 5-15% of all melanomas. Global melanoma incidence ~12-20 per 100k. Amelanotic subset estimated at 1.5-2.5 per 100k based on histological series.,high,,
C0206750,Coronavirus Infections,8000,,incidence,0.28,weak,,,estimate,False,,"Aggregate BOTEC estimate for 2005 (pre-SARS-CoV-2). Common cold coronaviruses (HCoV-229E, OC43, NL63, HKU1) cause ~15-30% of common colds globally. Estimating ~8,000 per 100k accounting for endemic coronavirus respiratory infections. Low confidence due to heterogeneity and limited surveillance data for common cold viruses in 2005.",moderate,,
C0206754,Neuroendocrine Tumors,5.25,,incidence,0.7,strong,"Yao JC et al. (2008). One hundred years after 'carcinoid': epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 26(18):3063-72",https://pubmed.ncbi.nlm.nih.gov/18565894/,literature,False,,"Neuroendocrine tumors (all sites combined) incidence ~5.25 per 100k person-years based on SEER data from 2000-2004. Includes gastroenteropancreatic, bronchopulmonary, and other sites. Incidence has been rising due to improved detection.",moderate,,
C0206769,Nevi and Melanomas,,,,0.0,none,,,,False,,"Unmappable compound term combining benign nevi (common skin lesions, prevalence-based) with malignant melanomas (cancer, incidence-based). These are fundamentally different conditions with different metrics that cannot be meaningfully combined into a single estimate.",unknown,,
C0220658,Pfeiffer Syndrome,extremely rare,,incidence,0.4,weak,,,,True,Craniofacial Dysostosis,Rare autosomal dominant FGFR1/FGFR2 mutation disorder with craniofacial and skeletal features. Estimated <1 per 100k births globally based on case reports and genetic epidemiology studies.,unknown,,
C0220666,"Arthrogryposis multiplex congenita, distal, type IIA",1.5,,incidence,0.45,weak,,,,True,Arthrogryposis multiplex congenita,"Rare congenital joint contracture disorder. Distal type IIA is a specific subtype of AMC. Estimated ~1-2 per 100k births based on overall AMC incidence of ~1 in 3000 births, with type IIA representing a minority. Limited systematic epidemiological data available.",unknown,,
C0220697,"POLYDACTYLY, POSTAXIAL",150,,incidence,0.7,strong,"Malik S. (2014). Polydactyly: Phenotypes, genetics and classification. Clin Genet. 85(3):203-212",https://pubmed.ncbi.nlm.nih.gov/22738660/,literature,True,Polydactyly,"Postaxial polydactyly (extra digits on ulnar/pinky side) is the most common form, occurring at 1-2 per 1000 births globally (~150 per 100k births). Significantly higher incidence in African populations (up to 1 in 300).",high,,
C0220701,RETINITIS PIGMENTOSA 1,0.3,,incidence,0.42,weak,,,,True,Retinitis Pigmentosa,RP1 is a specific genetic subtype of retinitis pigmentosa (RHO gene mutations). Estimated ~0.3 per 100k for this specific subtype; overall RP incidence ~1-2 per 100k.,unknown,,
C0220993,Cystathioninuria,1.0,,incidence,0.5,moderate,Newborn screening survey data; metabolic disease registries,,registry,False,,"Rare inherited disorder of methionine metabolism. Estimated incidence ~1 per 100,000 births based on newborn screening programs. Limited epidemiological data; most estimates from metabolic disease surveys and newborn screening registries.",high,,
C0221016,Red blood cell disorder,850,3500,both,0.28,weak,WHO (2006). Genetic variation and human disease. World Health Organization reports,,estimate,False,,"Aggregate BOTEC estimate summing major RBC disorders: Hereditary spherocytosis (~25 per 100k incidence), G6PD deficiency (~200 million prevalence globally, ~2500 per 100k), Sickle cell disease (~200-300 per 100k in affected populations), Thalassemia (~100 per 100k), Hemolytic anemias (~500 per 100k aggregate), hereditary elliptocytosis (~50 per 100k). Umbrella term with highly heterogeneous and overlapping subcategories. Low confidence due to broad scope and significant geographic variation.",high,,
C0221056,Adult type dermatomyositis,0.65,,incidence,0.58,moderate,Bendewald MJ et al. (2010). Incidence and prevalence of inflammatory myopathies. Muscle Nerve. 42(4):579-584,https://pubmed.ncbi.nlm.nih.gov/20730866/,literature,True,Dermatomyositis,Adult-onset dermatomyositis represents approximately 80% of all dermatomyositis cases. Estimated ~0.65 per 100k based on parent disease incidence distribution.,moderate,,
C0221505,Lesion of brain,,,,0.0,none,,,,False,,"Umbrella term too heterogeneous to estimate meaningfully. Brain lesions include vastly different etiologies: neoplasms (benign/malignant), stroke, trauma, infections, demyelination, vascular malformations - each with different incidence rates ranging from <1 to >100 per 100k.",unknown,,
C0221765,Chronic schizophrenia,,4500,prevalence,0.72,moderate,,,,True,Schizophrenia,"Chronic form of schizophrenia with persistent symptoms. Global prevalence estimated at 0.45% of population (~4500 per 100k). Reporting prevalence rather than incidence, as is standard for mental health conditions with poorly defined onset.",low,,
C0221775,Lumbar disc disease,300,,incidence,0.62,moderate,Frymoyer JW (1992). Lumbar disk disease: epidemiology. Instr Course Lect. 41:217-223,https://pubmed.ncbi.nlm.nih.gov/1534104/,literature,True,Intervertebral disc disorder,"Reporting incidence of symptomatic lumbar disc herniation/degeneration requiring medical attention. Estimated ~300 per 100k person-years based on population studies, though prevalence of asymptomatic degenerative changes is much higher.",moderate,,
C0233475,Euthymic mood,,,,0.0,none,,,,False,,"Euthymic mood is a descriptor of normal, stable mood state - not a disease entity. This is the absence of mood disorder, not a medical condition that can be incidenced or prevalenced.",unknown,,
C0233514,Abnormal behavior,,,,0.0,none,,,,False,,Vague descriptive term rather than specific disease entity. Too generic and non-specific to estimate meaningful epidemiological data.,unknown,,
C0007282,Carotid Stenosis,2.5,,incidence,0.72,moderate,Bravata DM et al. (2007). Asymptomatic carotid artery stenosis: a systematic review and meta-analysis. Ann Intern Med. 146(9):666-672,https://pubmed.ncbi.nlm.nih.gov/17502633/,literature,False,,Symptomatic carotid stenosis incidence estimated at 2-3 per 100k person-years based on stroke epidemiology literature. Carotid stenosis accounts for 5-10% of ischemic stroke etiology.,moderate,,
C0007302,Cartilage Diseases,,,,0.0,none,,,,False,,"Umbrella term too heterogeneous to estimate meaningfully. Includes osteoarthritis, chondromalacia, costochondritis, polychondritis, and other cartilage pathologies with vastly different incidence rates, age distributions, and clinical significance.",unknown,,
C0235394,Wasting,,,,0.0,none,,,,False,,"Wasting is a clinical symptom/syndrome rather than a specific disease entity. It can occur in multiple contexts: cancer cachexia, HIV/AIDS wasting syndrome, malnutrition, chronic diseases, etc. Each underlying cause has different epidemiology. Unmappable without specification of underlying etiology.",unknown,,
C0238033,Carcinoma of Male Breast,1.0,,incidence,0.85,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Breast Cancer,"Male breast cancer incidence approximately 1 per 100k person-years globally from GLOBOCAN 2005, representing <1% of all breast cancers.",low,,
C0238065,Secondary Biliary Cholangitis,0.5,,incidence,0.35,weak,,,,True,Biliary Cholangitis,"Secondary biliary cholangitis occurs as complication of biliary obstruction, infection, or stricture; incidence estimated ~0.5 per 100k based on hospital registries and gastroenterology literature, though data is limited.",moderate,,
C0238198,Gastrointestinal Stromal Tumors,1.5,,incidence,0.75,strong,"Nilsson B et al. (2005). Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib era. Cancer. 103(4):821-829",https://pubmed.ncbi.nlm.nih.gov/15648083/,literature,True,Gastrointestinal Neoplasms,GIST incidence approximately 1-2 per 100k person-years based on population-based cancer registries. Using midpoint estimate of 1.5 per 100k from multiple registry studies.,low,,
C0238358,Hypokalemic periodic paralysis,extremely rare,0.5,prevalence,0.45,weak,"Venance SL et al. (2006). The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 129(1):8-17",https://pubmed.ncbi.nlm.nih.gov/16195244/,literature,True,Periodic paralysis,Rare genetic channelopathy. Prevalence estimated at ~0.5 per 100k based on European neuromuscular registries. Most common form of familial periodic paralysis but still extremely rare.,low,,
C0238378,Desquamative interstitial pneumonia,0.5,,incidence,0.65,moderate,American Thoracic Society Registry,,registry,True,Interstitial lung disease,DIP is a rare form of interstitial pneumonia affecting approximately 0.5 per 100k. Reported incidence based on pulmonary fibrosis registries and case series from hospital databases.,low,,
C0238506,Congenital posterior urethral valves,0.004,,incidence,0.72,moderate,CDC Birth Defects Surveillance and epidemiological literature on congenital urinary tract anomalies,,registry,True,Congenital urinary tract abnormalities,"Congenital posterior urethral valves (PUV) is a rare male-specific congenital urogenital anomaly. Incidence estimated at approximately 1 in 25,000 male births (~0.004 per 100k total population per year). Data from pediatric urology registries and birth defect surveillance systems.",low,,
C0238644,"Anemia, severe",,250,prevalence,0.4,weak,,,,True,Anemia,"Severe anemia is a severity designation of anemia rather than a specific disease entity. Reported as prevalence (~2-3 per 1000 or ~250 per 100k) since severity is a clinical state classification. Low confidence due to being a secondary severity classification; underlying causes (hemolytic anemia, nutritional deficiency, bleeding, renal disease, etc.) are heterogeneous. Difficult to estimate independent of primary etiology.",high,,
C0238694,Peripheral arthritis,50.0,200.0,both,0.45,weak,,,,False,Arthritis,"Peripheral arthritis is an umbrella term covering joint inflammation in peripheral joints (rheumatoid arthritis, osteoarthritis, inflammatory arthropathies). Aggregate BOTEC estimate combining RA (~15 per 100k), OA (~35 per 100k), and other inflammatory arthropathies (~10 per 100k). Low confidence due to heterogeneity and potential overlap.",high,,
C0240912,Vertical Talus,0.6,,incidence,0.45,weak,,,,False,Congenital Foot Deformities,"Vertical talus (also called rocker-bottom foot or congenital convex foot deformity) is rare congenital musculoskeletal condition. Estimated incidence approximately 0.6 per 100k births (1 per 10,000 to 1 per 30,000 births globally based on orthopedic literature). Can occur as isolated deformity or as part of syndromes (trisomy 13, trisomy 18, arthrogryposis). Data limited to case reports and small orthopedic series.",low,,
C0241961,Angiomyolipoma of kidney,,200,prevalence,0.6,moderate,Steiner MS et al. (1993). The natural history of renal angiomyolipoma. J Urol. 150(6):1782-1786,https://pubmed.ncbi.nlm.nih.gov/8230504/,literature,False,,"Renal angiomyolipomas are benign tumors found in 0.1-0.3% of general population (autopsy/imaging studies), with higher prevalence (80%) in tuberous sclerosis patients. Using 0.2% (200 per 100k) as population prevalence estimate. Prevalence more appropriate than incidence for these often-asymptomatic tumors.",low,,
C0242381,Lyme Arthritis,3.0,,incidence,0.65,moderate,Steere AC et al. (2004). Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum. 20(1):7-17,https://pubmed.ncbi.nlm.nih.gov/1235979/,literature,True,Lyme Disease,"Lyme arthritis occurs in approximately 60% of untreated Lyme disease cases. Global Lyme disease incidence ~5 per 100k (heavily concentrated in endemic areas: Northeast US, Central Europe), so Lyme arthritis ~3 per 100k globally.",high,,
C0242422,Parkinsonian Disorders,25,,incidence,0.28,weak,,,estimate,False,,"Aggregate BOTEC summing major parkinsonian syndromes: Parkinson's disease (~18 per 100k), drug-induced parkinsonism (~3 per 100k), vascular parkinsonism (~2 per 100k), progressive supranuclear palsy (~1 per 100k), multiple system atrophy (~1 per 100k). Total ~25 per 100k. Heterogeneous group with some overlap.",moderate,,
C0242723,Parasitemia,,,,0.15,none,,,,False,Parasitic Infections,"Parasitemia is a clinical finding (parasites in bloodstream) rather than a specific disease entity. Could represent multiple distinct parasitic infections: malaria, sleeping sickness (trypanosomiasis), toxoplasmosis, filariasis, schistosomiasis, etc. Cannot meaningfully estimate aggregate incidence without specifying the parasitic disease. Concept is too broad for epidemiological quantification.",high,,
C0242787,Malignant neoplasm of male breast,1.0,,incidence,0.85,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Breast Cancer,Male breast cancer incidence approximately 1 per 100k person-years globally from GLOBOCAN 2005. Semantically equivalent to C0238033.,low,,
C0242852,Proliferative vitreoretinopathy,0.5,,incidence,0.58,moderate,Estimated based on retinal detachment epidemiology and PVR complication rates from ophthalmology literature,,estimate,True,Vitreoretinopathy,"PVR is a complication of retinal detachment surgery affecting 5-10% of RD cases. With global RD incidence ~6-7 per 100k, PVR incidence estimated at ~0.5 per 100k. Moderate confidence due to limited population-based incidence studies and high case-selection bias in published data.",moderate,,
C0242994,Hantavirus Infections,0.08,,incidence,0.45,moderate,,,,False,,"Hantavirus infections are zoonotic diseases transmitted from infected rodents, with sporadic cases worldwide. Estimated global incidence ~0.08 per 100k based on surveillance reports from endemic regions in Americas, Asia, and Europe. Geographic clustering in high-risk areas.",high,,
C0243010,Viral Encephalitis,3.5,,incidence,0.72,moderate,Solomon T et al. (2012). Management of suspected viral encephalitis in adults. J Infect. 64(4):347-373,https://pubmed.ncbi.nlm.nih.gov/22120062/,literature,False,,"Viral encephalitis incidence varies by geographic region and viral etiology. Global estimate ~3.5 per 100k person-years, includes HSV, VZV, enteroviruses, and arboviruses.",high,,
C0243038,"Carcinoma, Lewis Lung",,,,0.0,none,,,,False,,"Lewis Lung Carcinoma is a transplantable tumor line used in laboratory mice for cancer research, not a naturally occurring human disease. No human epidemiological data exists.",unknown,,
C0262376,anxiety generalized,450,2800,both,0.68,strong,Kessler RC et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62(6):593-602,https://pubmed.ncbi.nlm.nih.gov/15939837/,literature,True,Anxiety Disorders,"Generalized Anxiety Disorder (GAD) has 12-month prevalence ~2.8% (2,800 per 100k) and annual incidence ~450 per 100k based on WHO World Mental Health Survey data. Prevalence is the more commonly reported and stable metric for chronic mental health conditions.",moderate,,
C0262385,Autonomic nervous system imbalance,,,,0.0,none,,,,False,,"Umbrella term for dysautonomia/autonomic dysfunction without specific disease entity. Could refer to POTS, orthostatic hypotension, neurogenic syncope, or multiple other conditions. Too vague and heterogeneous to estimate meaningfully without specification.",unknown,,
C0262404,Cerebellar degeneration,1.5,,incidence,0.55,moderate,Harding AE. (1993). Clinical features and classification of inherited ataxias. In: Inherited Neurological Disorders. Oxford University Press,,literature,False,Neurodegenerative disease,"Cerebellar degeneration encompasses inherited ataxias, acquired forms, and progressive conditions. Estimated combined incidence ~1-2 per 100k based on autosomal dominant spinocerebellar ataxia and idiopathic cerebellar atrophy literature. Confidence limited by heterogeneity of underlying causes.",moderate,,
C0263361,Psoriasis vulgaris,15.2,20000,both,0.78,strong,Parisi R et al. (2013). Global epidemiology of psoriasis: a systematic review and meta-analysis. J Invest Dermatol. 133(2):377-385,https://pubmed.ncbi.nlm.nih.gov/22930884/,literature,True,Psoriasis,"Psoriasis vulgaris (plaque-type) is the most common form, representing ~90% of all psoriasis cases. Global incidence ~15-20 per 100k per year, prevalence ~2% of population (20,000 per 100k).",moderate,,
C0263477,Female pattern alopecia (disorder),,25000,prevalence,0.72,moderate,Blume-Peytavi U et al. (2011). European Dermatology Forum consensus on female pattern hair loss. J Eur Acad Dermatol Venereol. 25(10):1141-1147,https://pubmed.ncbi.nlm.nih.gov/21492182/,literature,True,Androgenetic Alopecia,"Female pattern hair loss (androgenetic alopecia in females) is best measured as prevalence rather than incidence, as it is a chronic condition affecting 20-50% of women depending on age and genetics. Global prevalence estimated at approximately 25% of women (25,000 per 100k). Prevalence increases with age: 5-10% in women aged 20-29 years, 15-25% in women 40-49 years, up to 50% by age 70. Strong genetic component with androgen sensitivity. Data quality moderate due to variable diagnostic criteria across studies.",moderate,,
C0001486,Adenovirus Infections,15000,,incidence,0.58,moderate,,,,False,,"Adenovirus infections are common viral illnesses affecting respiratory and gastrointestinal systems, particularly in children and military recruits. Estimated ~15,000 per 100k person-years globally based on surveillance data and cohort studies, with significant geographic and seasonal variation.",high,,
C0264490,Acute respiratory failure,45.0,,incidence,0.65,moderate,,,,False,,Acute condition with variable etiology. Global estimate ~45 per 100k based on ICU admissions and respiratory disease epidemiology. Confidence limited by heterogeneous causes and geographic variation.,high,,
C0264936,Secondary pulmonary hypertension,25,,incidence,0.48,moderate,,,,True,Pulmonary Hypertension,"Secondary PH is pulmonary hypertension due to left heart disease, lung disease, sleep apnea, or other conditions. More common than primary PH. Estimated incidence of clinically diagnosed secondary PH ~20-30 per 100k per year based on registry data. Moderate-low confidence due to variable diagnostic thresholds and underdiagnosis.",moderate,,
C0265219,Miller Dieker syndrome,1.0,,incidence,0.45,moderate,Dobyns WB et al. (1993). Lissencephaly: a human brain malformation associated with deletion of the LIS1 gene. JAMA. 270(23):2838-42,https://pubmed.ncbi.nlm.nih.gov/7907669/,literature,True,Lissencephaly,"Chromosomal deletion syndrome (17p13.3) causing lissencephaly. Birth incidence estimated at ~1 per 100,000 live births based on registry data and case series.",low,,
C0265221,Walker-Warburg congenital muscular dystrophy,extremely rare,,incidence,0.28,weak,Clinical case series and genetic studies,,literature,True,Congenital Muscular Dystrophy,"Walker-Warburg syndrome is a severe congenital muscular dystrophy characterized by muscle weakness, brain malformations (agyria/pachygyria), and eye abnormalities. Estimated incidence <0.05 per 100k births in most populations, with higher rates in consanguineous populations. Autosomal recessive inheritance with mutations in genes like POMT1, FKTN, FKRP, etc.",moderate,,
C0265233,Cryptophthalmos syndrome,extremely rare,,incidence,0.4,weak,"Slavotinek AM, Tifft CJ. (2002). Fraser syndrome and cryptophthalmos: review of the diagnostic criteria and evidence for phenotypic modules in complex malformation syndromes. J Med Genet. 39:623-633",https://pubmed.ncbi.nlm.nih.gov/12205104/,literature,False,,"Fraser syndrome (cryptophthalmos syndrome) is extremely rare with estimated incidence <0.5 per 100,000 births. Characterized by cryptophthalmos, syndactyly, and urogenital defects. Based on case series and birth defects registries.",unknown,,
C0265264,Holt-Oram syndrome,,1.0,prevalence,0.5,moderate,Basson CT et al. (1994). The clinical and genetic spectrum of the Holt-Oram syndrome. N Engl J Med. 330:885-891,https://pubmed.ncbi.nlm.nih.gov/8114858/,literature,False,Congenital Heart-Hand Syndrome,"Rare autosomal dominant disorder with cardiac and upper limb abnormalities. Birth prevalence ~1 per 100,000 live births based on congenital malformation registries. Using prevalence as appropriate for congenital conditions.",low,,
C0008311,Cholangitis,2.5,,incidence,0.5,moderate,,,,False,,"Acute and chronic bile duct inflammation. Incidence estimated ~2-5 per 100k based on hospital admission data. Moderate confidence due to variable definitions (includes acute bacterial cholangitis, primary sclerosing cholangitis, etc.) and underreporting.",high,,
C0265279,Kniest dysplasia,0.4,,incidence,0.42,weak,,,,True,Skeletal Dysplasia,"Rare skeletal dysplasia caused by COL2A1 mutations, estimated ~0.4 per 100k births. Characterized by short stature, kyphoscoliosis, and joint limitation. Confidence reflects limited epidemiological data from clinical genetics literature.",low,,
C0265316,Neurocutaneous Syndromes,2.5,,incidence,0.45,weak,,,,False,,"Aggregate BOTEC estimate summing major neurocutaneous syndromes: Neurofibromatosis Type 1 (~1.0 per 100k), Tuberous Sclerosis Complex (~1.0 per 100k), Von Hippel-Lindau (~0.3 per 100k), Sturge-Weber (~0.2 per 100k) = ~2.5 per 100k. Heterogeneous group of genetic conditions with variable inheritance and presentation.",moderate,,
C0265326,Bannayan-Riley-Ruvalcaba Syndrome,extremely rare,,incidence,0.35,weak,,,,True,PTEN Hamartoma Tumor Syndrome,Rare genetic disorder caused by PTEN mutations. Estimated incidence <0.1 per 100k based on case report frequency and clinical genetics literature. Well-defined entity but extremely rare with limited epidemiological data.,unknown,,
C0265970,"Porokeratosis, Disseminated Superficial Actinic",,75.0,prevalence,0.45,weak,,,,True,Porokeratosis,"DSAP is a chronic skin condition best measured by prevalence. Estimated 0.075% prevalence (75 per 100k) in adults over 40, though data quality limited. More common in fair-skinned populations with sun exposure.",moderate,,
C0008373,Cholesteatoma,6.0,,incidence,0.72,strong,Kuo CL et al. (2015). Updates and knowledge gaps in cholesteatoma research. Biomed Res Int. 2015:854024,https://pubmed.ncbi.nlm.nih.gov/26185755/,literature,False,,"Acquired cholesteatoma (abnormal skin growth in middle ear) has well-documented incidence from ENT registries. Pediatric incidence ~9-12 per 100k, adult incidence ~3 per 100k. Overall population incidence ~6 per 100k per year based on European registry data.",low,,
C0266294,Unilateral agenesis of kidney,85.0,,incidence,0.65,moderate,Westland R et al. (2013). Renal agenesis and severe congenital renal insufficiency. Clin J Am Soc Nephrol. 8(5):784-791,https://pubmed.ncbi.nlm.nih.gov/23220430/,literature,True,Renal agenesis,Congenital anomaly with incidence approximately 0.085% of live births (1 per 1150-1200 births). Reported from multiple birth defect registries including CDC's National Birth Defects Prevention Network. Limited to live birth incidence; confidence moderate due to variable ascertainment across registries.,low,,
C0266383,Uterine Anomalies,0.3,300,prevalence,0.65,moderate,,,,False,,"Congenital uterine anomalies detected in 0.3-3% of women (prevalence ~300-3000 per 100k). Wide prevalence range depends on detection method. Using 0.3% (300 per 100k) as conservative estimate. Reported as prevalence, not incidence, as these are lifelong congenital conditions.",moderate,,
C0008476,"Chondromatosis, Synovial",0.18,,incidence,0.4,weak,,,,False,,Synovial chondromatosis is essentially synonymous with synovial osteochondromatosis. Rare condition with estimated incidence ~0.18 per 100k based on orthopedic case series.,unknown,,
C0266589,Congenital ear anomaly NOS (disorder),2.0,,incidence,0.5,moderate,,,,False,,"Non-specific congenital ear anomaly term. Overall congenital ear anomalies occur at ~2-3 per 100k births. This NOS category excludes specific types (e.g., microtia, anotia) and represents unspecified congenital ear malformations. Incidence estimate ~2 per 100k.",low,,
C0008487,Chordoma,0.08,,incidence,0.72,strong,"McMaster ML et al. (2001). Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 12(1):1-11",https://pubmed.ncbi.nlm.nih.gov/11227920/,literature,True,Bone and Cartilage Neoplasm,Extremely rare malignant bone tumor arising from notochord remnants. Incidence ~0.08 per 100k based on SEER and European cancer registry data.,low,,
C0008495,Chorioamnionitis,15.0,,incidence,0.72,moderate,Obstetric and Gynecological Survey literature (2000-2005),,literature,False,,"Chorioamnionitis incidence reported as ~1.5-2% of all pregnancies globally, equivalent to approximately 15 per 100k deliveries per year. Based on obstetric epidemiology literature and surveillance data from developed healthcare systems.",high,,
C0267375,Chronic colitis,18.0,350,both,0.55,moderate,"Loftus EV Jr. (2004). Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 126:1504-1517",https://pubmed.ncbi.nlm.nih.gov/15168363/,literature,False,,Chronic colitis primarily encompasses inflammatory bowel disease (UC + Crohn's colitis). Combined IBD incidence ~15-20 per 100k globally (higher in developed nations). Prevalence ~350 per 100k. Heterogeneous umbrella term reduces confidence.,high,,
C0267797,Acute hepatitis,85.0,,incidence,0.65,moderate,"WHO Global Hepatitis Report, viral hepatitis surveillance data",,registry,False,,"Acute hepatitis is somewhat of an umbrella term encompassing viral (HAV, HBV, HCV, HEV), drug-induced, and autoimmune causes. Global incidence estimated at ~85 per 100k person-years based on WHO viral hepatitis surveillance data from mid-2000s (HAV ~25, acute HBV ~15, HEV ~40, plus drug-induced/other ~5). Confidence reduced due to heterogeneous etiology and data quality variation across regions.",high,,
C0008533,Hemophilia B,0.33,,incidence,0.72,strong,Srivastava A et al. (2013). Guidelines for the management of hemophilia. Haemophilia. 19(1):e1-47,https://pubmed.ncbi.nlm.nih.gov/22776238/,literature,True,Hemophilia,"Hemophilia B (Factor IX deficiency) represents ~15-20% of all hemophilia cases. Incidence ~1 in 30,000 male births (0.33 per 100k). Data from hemophilia registries and genetic studies.",low,,
C0268079,Hyperphosphaturia,,,,0.15,weak,,,,False,Renal Tubular Disorders,"Hyperphosphaturia (excessive urinary phosphate excretion) is primarily a laboratory finding rather than a named clinical disease. Often associated with hypophosphatemic rickets, renal tubular disorders, or dietary excess. Not reported as independent disease entity with incidence data.",unknown,,
C0268306,Unconjugated hyperbilirubinemia,,5000,prevalence,0.65,moderate,"Strassburg CP (2008). Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome). Best Pract Res Clin Gastroenterol. 22(5):921-942",https://pubmed.ncbi.nlm.nih.gov/18790437/,literature,False,,"Reporting prevalence. Most common form is Gilbert's syndrome affecting 3-7% of population (~5,000 per 100k). Includes rare severe forms (Crigler-Najjar). Using prevalence as these are chronic/lifelong conditions.",moderate,,
C0268312,Progressive intrahepatic cholestasis (disorder),0.5,,incidence,0.55,moderate,Jacquemin E. (2012). Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 36 Suppl 1:S26-35,https://pubmed.ncbi.nlm.nih.gov/23141891/,literature,False,,"Progressive familial intrahepatic cholestasis (PFIC) encompasses multiple genetic subtypes (PFIC1, PFIC2, PFIC3). Estimated incidence 0.5-1 per 100k births based on registry data from multiple countries. Higher in consanguineous populations.",high,,
C0268446,Thyrotoxic periodic paralysis,0.2,,incidence,0.5,moderate,Kung AW. (2006). Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 91(7):2490-5,https://pubmed.ncbi.nlm.nih.gov/16608889/,literature,False,,"Acquired periodic paralysis associated with hyperthyroidism. Global incidence ~0.2 per 100k but varies dramatically by ethnicity (much higher in Asian males, 1-2% of thyrotoxic patients). Reporting global average.",high,,
C0268450,Gitelman Syndrome,2.5,,incidence,0.4,moderate,,,,False,,"Rare autosomal recessive renal tubular disorder affecting salt reabsorption. Estimated incidence ~1 in 40,000 (2.5 per 100k) based on carrier frequency, but likely underdiagnosed due to mild symptoms. SLC12A3 gene mutations.",low,,
C0008925,Cleft Palate,13.0,,incidence,0.75,strong,WHO global burden of disease estimates and birth defect registries,,registry,False,,Common congenital anomaly with global incidence ~13 per 100k births. Includes isolated cleft palate and cleft palate with cleft lip. Variation by ethnicity and geography.,moderate,,
C0268601,HMG CoA lyase deficiency,extremely rare,,incidence,0.25,weak,,,,True,Mitochondrial metabolic disorders,3-Hydroxy-3-methylglutaryl-CoA lyase deficiency is a rare autosomal recessive disorder of ketogenesis. Estimated <0.001 per 100k births based on case reports. Fewer than 100 cases reported worldwide in medical literature.,unknown,,
C0268616,Gamma-cystathionase deficiency,extremely rare,,incidence,0.35,weak,,,,True,Cystathioninuria,Specific enzymatic deficiency causing cystathioninuria. Much rarer than overall cystathioninuria; represents <20% of cystathioninuria cases. Estimated <0.1 per 100k births. Limited case report data available.,unknown,,
C0009086,Cluster B personality disorder,,2000,prevalence,0.6,moderate,"Grant BF et al. (2004). Prevalence, correlates, and disability of personality disorders in the United States. J Clin Psychiatry. 65(7):948-958",https://pubmed.ncbi.nlm.nih.gov/15291684/,literature,True,Personality Disorders,"Cluster B includes antisocial, borderline, histrionic, and narcissistic personality disorders. Prevalence metric appropriate. Estimated ~2% (2,000 per 100k) based on epidemiological literature.",moderate,,
C0009087,Cluster C personality disorder,,6000,prevalence,0.58,moderate,"Grant BF et al. (2004). Prevalence, correlates, and disability of personality disorders in the United States. J Clin Psychiatry. 65(7):948-958",https://pubmed.ncbi.nlm.nih.gov/15291684/,literature,True,Personality Disorders,"Cluster C includes avoidant, dependent, and obsessive-compulsive personality disorders. Prevalence metric appropriate for chronic conditions. Estimated ~6% (6,000 per 100k) based on epidemiological studies.",moderate,,
C0270715,"Degenerative Diseases, Central Nervous System",65,,incidence,0.25,weak,,,estimate,False,,"Aggregate BOTEC estimate summing major CNS degenerative diseases: Alzheimer's disease (~15), Parkinson's disease (~13), ALS (~2), Multiple System Atrophy (~3), Huntington's disease (~0.5), Lewy Body Dementia (~5), Progressive Supranuclear Palsy (~5), Frontotemporal Dementia (~3), other conditions (~18.5). Total ~65 per 100k. Low confidence due to heterogeneity, overlap, and composite estimation.",high,,
C0001622,Adrenal Gland Hyperfunction,12.0,,incidence,0.45,moderate,,,,False,,"Heterogeneous umbrella term including primary aldosteronism (~8 per 100k), Cushing's syndrome (~1.5 per 100k), pheochromocytoma (~0.5 per 100k), and other causes. Aggregate estimate ~12 per 100k. Limited by heterogeneity of conditions.",moderate,,
C0009207,Cockayne Syndrome,extremely rare,,incidence,0.4,weak,Laugel V. (2013). Cockayne syndrome: the expanding clinical and mutational spectrum. Mech Ageing Dev. 134(5-6):161-170,https://pubmed.ncbi.nlm.nih.gov/23428416/,literature,False,,Cockayne syndrome is a rare autosomal recessive disorder causing premature aging and developmental abnormalities. Birth prevalence estimated at 0.05-0.2 per 100k births based on Western European data.,unknown,,
C0271183,Severe myopia,,2000,prevalence,0.68,moderate,Holden BA et al. (2008). Global vision impairment due to uncorrected presbyopia. Arch Ophthalmol. 126(12):1731-1739,,literature,True,Myopia,"Severe myopia (>-6.0 diopters) measured as prevalence. Global prevalence ~2% (2,000 per 100k), with higher rates in East Asia (3-5%) and lower in Europe/Americas (1-2%). Using prevalence as myopia is a chronic refractive condition.",high,,
C0271429,Acute otitis media,10900,,incidence,0.83,strong,Monasta L et al. (2012). Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 7(4):e36226,https://pubmed.ncbi.nlm.nih.gov/22558393/,literature,False,,"Extremely common pediatric infection. Global incidence ~10,900 per 100k person-years (709 million cases annually, 51% <5 years old). Much higher in children <5 years (>20,000 per 100k), lower in adults. WHO systematic review data.",moderate,,
C0272138,Erythroblastosis,1.5,,incidence,0.55,moderate,,,,False,,"Erythroblastosis fetalis (hemolytic disease of newborn). With RhoGAM prophylaxis widespread by 2005, incidence dramatically reduced to ~1-2 per 100k births globally, though higher in areas with limited prenatal care.",high,,
C0272242,Complement deficiency disease,extremely rare,,incidence,0.28,weak,,,,False,,"Umbrella term for inherited complement system deficiencies (C1-C9, Factor H, Factor I, etc.). Individual deficiencies are extremely rare (<0.01-1 per 100k), with C2 deficiency being most common. Aggregate estimate difficult due to heterogeneity and diagnostic underascertainment.",moderate,,
C0009663,Condylomata Acuminata,165.0,,incidence,0.75,strong,Patel H et al. (2013). Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 13:39,https://pubmed.ncbi.nlm.nih.gov/23347441/,literature,False,Human Papillomavirus Infection,Genital warts (anogenital warts) caused by HPV types 6 and 11. Incidence approximately 165 per 100k per year based on CDC surveillance and European studies. Common sexually transmitted infection with good epidemiological data.,moderate,,
C0276340,Respiratory syncytial virus bronchiolitis,18.0,,incidence,0.65,moderate,Nair H et al. (2010). Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children. Lancet. 375:1545-55,https://pubmed.ncbi.nlm.nih.gov/20399493/,literature,True,Bronchiolitis,"RSV bronchiolitis primarily affects infants/children. Global population-weighted incidence approximately 18 per 100k, though much higher in children under 2 years (140+ per 100k in that age group).",high,,
C0276434,Acute type A viral hepatitis,7.5,,incidence,0.78,strong,WHO Immunization Safety Surveillance,https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases-and-vaccines/hepatitis-a,registry,True,Acute viral hepatitis,"Hepatitis A incidence varies widely by region (0.5-15 per 100k), reflecting vaccination coverage and sanitation differences. Global average ~7.5 per 100k based on WHO epidemiological data. More specific than umbrella term but still shows geographic variation.",high,,
C0276609,Acute type B viral hepatitis,1.8,,incidence,0.75,strong,"WHO. (2008). Hepatitis B Fact Sheet. World Health Organization, based on 2005 surveillance data.",https://www.who.int/news-room/fact-sheets/detail/hepatitis-b,registry,True,Acute Viral Hepatitis,Acute Hepatitis B incidence estimated at ~1.8 per 100k globally based on WHO surveillance. Using incidence metric appropriate for acute infectious disease. Confidence good due to WHO disease surveillance data and vaccination program tracking.,high,,
C0276622,Acute viral hepatitis,12.0,,incidence,0.35,weak,,,,False,,"Aggregate BOTEC estimate summing major hepatitis virus types: HAV (~7.5), HBV (~2.0), HCV (~1.5), HEV (~1.0+) = ~12 per 100k globally. Umbrella term with heterogeneous epidemiology; includes benign (HAV, HEV) and chronic (HBV, HCV) infections with vastly different clinical significance.",high,,
C0276623,Chronic viral hepatitis,,3200,prevalence,0.65,moderate,"WHO Global Hepatitis Report 2017, citing prevalence data from multiple sources",,registry,False,,"Chronic viral hepatitis is an umbrella term covering chronic B, C, D, and E. Prevalence approach appropriate for chronic conditions. WHO estimates ~257M with chronic HBV and ~71M with chronic HCV globally, combined ~3.2% of population.",high,,
C0276655,Infection by Aspergillus fumigatus,2.5,,incidence,0.55,moderate,,,,True,Aspergillosis,"Invasive aspergillosis caused by A. fumigatus estimated at ~2-3 per 100k globally, primarily in immunocompromised patients. Significant underreporting and geographic variation. No 2005-specific data, using general estimates from clinical literature.",high,,
C0009691,Congenital cataract,150,,incidence,0.65,moderate,WHO World Health Report on Vision 2019 and Global Burden of Disease registry data on congenital cataracts,,registry,False,,"Congenital cataracts occur at incidence of 1-3 per 10,000 live births globally (varies by region: 1-2 per 10,000 in developed countries, 3-6 per 10,000 in developing countries due to malnutrition and rubella). Converted to ~1.5 per 100,000 person-years. Higher in regions with high rubella prevalence and lower vitamin A intake.",high,,
C0276926,Schistosoma hematobium infection,,120,prevalence,0.72,strong,"Steinmann P et al. (2006). Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 6(7):411-425",https://pubmed.ncbi.nlm.nih.gov/16790382/,literature,True,Schistosomiasis,"S. hematobium measured by prevalence in endemic populations. WHO 2005 data estimates ~112 million infected globally (global prevalence ~120 per 100k). Highly endemic in sub-Saharan Africa and Middle East, with prevalence up to 50% in some communities.",high,,
C0278061,Abnormal mental state,,,,0.0,none,,,,False,,"Umbrella term too vague and generic to map meaningfully. 'Abnormal mental state' could refer to any psychiatric symptom, neurological condition, or psychological abnormality without specificity. Requires definition of specific mental disorder or condition.",unknown,,
C0009714,"Hepatic Fibrosis, Congenital",extremely rare,,incidence,0.3,weak,,,,True,Congenital Liver Disease,"Congenital hepatic fibrosis is a rare developmental disorder often associated with polycystic kidney disease or ciliopathies, estimated <0.05 per 100k births based on autopsy and imaging studies.",low,,
C0278480,Stage III Colon Cancer,8.0,,incidence,0.68,strong,SEER Cancer Statistics (colorectal cancer staging),https://seer.cancer.gov/,registry,True,Colorectal Cancer,Stage III colon cancer incidence estimated at ~8 per 100k based on stage-specific distributions from cancer registries. Represents regional lymph node involvement without distant metastasis.,moderate,,
C0278484,Malignant neoplasm of colon stage IV,7.2,,incidence,0.64,moderate,,,,True,Malignant neoplasm of colon,"Stage IV colorectal cancer represents approximately 18-22% of colorectal cancer diagnoses at presentation. With global colorectal cancer incidence ~35 per 100k, stage IV incidence estimated at ~7.2 per 100k. Cancer registries provide reasonable data on stage distribution.",moderate,,
C0278493,Breast cancer recurrent,8.5,,incidence,0.45,weak,,,estimate,True,Breast cancer,"Breast cancer recurrence estimated at ~20% of primary breast cancer incidence (~42 per 100k  0.20 = 8.4 per 100k). This is a rough estimate as recurrence depends on stage, treatment, and time since diagnosis. Limited by lack of systematic recurrence registries separate from primary incidence data.",moderate,,
C0278519,Recurrent Childhood Acute Lymphoblastic Leukemia,0.6,,incidence,0.65,moderate,Pui CH et al. (2006). Treatment of acute lymphoblastic leukemia. N Engl J Med. 354(2):166-78,https://pubmed.ncbi.nlm.nih.gov/16407512/,literature,True,Childhood Acute Lymphoblastic Leukemia,"Relapsed childhood ALL. Primary childhood ALL incidence ~4 per 100,000 children per year; relapse occurs in ~15% of cases, yielding recurrence incidence ~0.6 per 100,000 children annually.",low,,
C0278652,Childhood Craniopharyngioma,0.13,,incidence,0.62,moderate,Clinical registry data and surgical case series,,registry,True,Craniopharyngioma,Craniopharyngiomas have bimodal age distribution with childhood peak. Estimated ~0.13 per 100k/year in pediatric population. Limited epidemiological data; confidence based on clinical registry estimates and case series.,low,,
C0278727,Small cell lung cancer recurrent,2.5,,incidence,0.55,moderate,GLOBOCAN 2005 lung cancer data; SCLC recurrence rates from clinical literature,https://gco.iarc.fr/,registry,True,Small cell lung cancer,"SCLC represents ~15% of lung cancers. With lung cancer incidence of ~30 per 100k globally (2005 GLOBOCAN data), SCLC incidence is ~4-5 per 100k. Approximately 60-70% of SCLC patients experience recurrence within 2 years. Recurrence 'incidence' estimated at ~2.5 per 100k person-years. Confidence reduced because recurrence is conditional on prior SCLC diagnosis rather than true population-based incidence.",moderate,,
C0278875,Adult Craniopharyngioma,0.08,,incidence,0.58,moderate,Neurosurgical registry data and clinical case series,,registry,True,Craniopharyngioma,Adult-onset craniopharyngioma shows second peak in older adults. Estimated ~0.08 per 100k/year. Limited population-based epidemiological data; estimate based on clinical series and neurosurgical registries.,low,,
C0279530,Malignant Bone Neoplasm,0.9,,incidence,0.78,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Bone Neoplasm,"Primary malignant bone tumors (osteosarcoma, Ewing sarcoma, chondrosarcoma) have combined incidence ~0.9 per 100k person-years globally based on cancer registry data. Excludes bone metastases which are much more common. Most common in adolescents and elderly.",low,,
C0279544,Adult Alveolar Soft Part Sarcoma,extremely rare,,incidence,0.35,weak,,,,True,Alveolar Soft Part Sarcoma,"Rare adult soft tissue sarcoma, <0.01 per 100k. Alveolar soft part sarcoma represents approximately 0.5% of adult soft tissue sarcomas based on soft tissue sarcoma registries.",unknown,,
C0279545,Adult Epithelioid Sarcoma,extremely rare,,incidence,0.25,weak,,,,True,Epithelioid Sarcoma,Adult-onset epithelioid sarcoma is extremely rare with <100-200 cases reported annually worldwide. Estimated <0.01 per 100k based on case report frequency and sarcoma registry data. Limited epidemiological studies available.,unknown,,
C0279563,Lobular carcinoma in situ of breast,1.5,,incidence,0.68,moderate,SEER Cancer Statistics Review 1975-2005,https://seer.cancer.gov/,registry,True,Carcinoma in situ of breast,LCIS incidence ~1.5 per 100k overall population (~3 per 100k women). Detection increased with mammography screening. Less common than DCIS. Based on SEER cancer registry data.,moderate,,
C0279565,Invasive Lobular Breast Carcinoma,12.5,,incidence,0.82,strong,,,,True,Invasive breast carcinoma,"Invasive lobular carcinoma (ILC) represents approximately 10-15% of invasive breast cancers. With global invasive breast cancer incidence ~80-90 per 100k (females), ILC incidence is estimated ~12-15 per 100k. Data from GLOBOCAN and cancer registry sources with good geographic coverage.",moderate,,
C0279582,Childhood Burkitt Leukemia,5.0,,incidence,0.75,strong,SEER Cancer Statistics (2005); Smith MA et al. (2006). Childhood Cancer Incidence and Survival. Oncology. 20(12):1459-1466,https://seer.cancer.gov/,registry,True,Burkitt Leukemia,"Childhood Burkitt leukemia (pediatric B-ALL, L3 type) represents ~20-25% of childhood ALL with incidence ~5 per 100k in pediatric populations (ages 0-19). Higher proportion of ALL in children compared to adults. Based on pediatric cancer registries and SEER data.",low,,
C0279591,Adult Burkitt Leukemia,0.4,,incidence,0.66,moderate,SEER Cancer Statistics (2005); Hoelzer D et al. (2002). Acute Lymphoblastic Leukemia. Lancet. 360(9345):1617-1629,https://pubmed.ncbi.nlm.nih.gov/12443515/,literature,True,Burkitt Leukemia,"Adult Burkitt leukemia (adult B-ALL, L3 morphology) is rare, representing ~1-2% of adult ALL cases with incidence ~0.4 per 100k in adult populations (ages 20+). Considerably lower incidence than childhood form. Based on SEER and WHO classification data.",moderate,,
C0279646,,0.35,,incidence,0.78,strong,"Surveillance, Epidemiology, and End Results (SEER) Program Database, National Cancer Institute",https://seer.cancer.gov/,registry,True,Acute Monocytic Leukemia,AML M5 subtype in children (ages 0-14). Incidence ~0.3-0.4 per 100k children per year. Monocytic leukemia represents ~10-15% of childhood AML cases. Data from pediatric cancer registries and SEER.,low,,
C0279751,Adenoid cystic carcinoma of salivary gland,0.8,,incidence,0.6,moderate,,,,True,Salivary gland neoplasm,"Adenoid cystic carcinoma (ACC) is the most common malignant salivary gland tumor, representing ~5-10% of all salivary gland tumors. Global salivary gland cancer incidence is ~8-10 per 100k, with ACC accounting for ~0.8 per 100k. Data derived from cancer registries and hospital-based studies.",low,,
C0279763,endometrial adenoacanthoma,1.8,,incidence,0.55,moderate,,,,True,Endometrial carcinoma,"Adenoacanthoma (adenosquamous carcinoma) of endometrium is a rare histological subtype, comprising approximately 5-10% of endometrial cancers. With global endometrial cancer incidence ~20 per 100k, adenoacanthoma represents ~1.5-2 per 100k. Data primarily from cancer registries with limited geographic coverage.",moderate,,
C0279985,Childhood Alveolar Soft Part Sarcoma,extremely rare,,incidence,0.35,weak,,,,True,Alveolar Soft Part Sarcoma,"Rare pediatric soft tissue sarcoma, <0.01 per 100k children. Alveolar soft part sarcoma represents approximately 1% of all soft tissue sarcomas in children based on pediatric cancer registries.",unknown,,
C0010051,Coronary Aneurysm,0.8,,incidence,0.45,moderate,,,,False,Coronary Artery Disease,"Coronary aneurysms are rare vascular abnormalities. Population-based incidence estimated at ~0.5-1.0 per 100k based on autopsy and angiographic studies, though systematic epidemiological data is limited.",moderate,,
C0280255,"stage, endometrial carcinoma",,,,0.0,none,,,,False,,"Unmappable: This is a staging descriptor, not a disease entity. Without specification of which stage (I, II, III, or IV), cannot provide meaningful incidence estimate. Each stage has different proportions of overall endometrial cancer cases.",unknown,,
C0280313,Squamous cell carcinoma of oropharynx,5.2,,incidence,0.78,strong,,,,True,Oropharyngeal Cancer,Oropharyngeal SCC incidence approximately 5-6 per 100k globally from GLOBOCAN-type registries. Higher in areas with HPV and tobacco prevalence. Represents majority of oropharyngeal cancers.,high,,
C0010072,Coronary Thrombosis,150,,incidence,0.7,strong,WHO Global Burden of Disease 2005,https://www.who.int/healthinfo/global_burden_disease/en/,registry,True,Coronary Artery Disease,Coronary thrombosis closely related to acute MI. Global MI incidence ~150 per 100k person-years from WHO 2005 data. Moderate confidence as coronary thrombosis is one mechanism of MI.,high,,
C0280483,Adult Anaplastic Astrocytoma,0.8,,incidence,0.75,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Astrocytoma,Anaplastic astrocytoma (Grade III) accounts for approximately 0.8 per 100k of intracranial neoplasms based on GLOBOCAN 2005 brain cancer data. Age-specific incidence in adults.,moderate,,
C0280634,,0.8,,incidence,0.8,strong,"Surveillance, Epidemiology, and End Results (SEER) Program Database, National Cancer Institute",https://seer.cancer.gov/,registry,True,Acute Monocytic Leukemia,AML M5 subtype in adults (ages 15+). Incidence ~0.7-0.9 per 100k person-years. Monocytic leukemia represents ~10-15% of adult AML cases (adult AML incidence ~3-4 per 100k). Data from SEER and national cancer registries.,low,,
C0280785,Diffuse Astrocytoma,0.4,,incidence,0.72,strong,Central Brain Tumor Registry of the United States (CBTRUS) 2005-2006 Statistical Report,https://www.cbtrus.org/,registry,True,Astrocytoma,WHO Grade II diffuse astrocytoma with incidence ~0.4 per 100k from CNS tumor registries. Represents subset of all astrocytic tumors. Data from CBTRUS and SEER registries circa 2005.,low,,
C0281267,Bilateral Breast Cancer,8.5,,incidence,0.72,moderate,GLOBOCAN 2005 (IARC); bilateral proportion from Carmichael et al. (2003),https://gco.iarc.fr/,registry,True,Breast Cancer,Bilateral breast cancer represents 5-10% of all breast cancers. Estimated global incidence approximately 8.5 per 100k based on proportion of bilateral cases among total breast cancer incidence (~90 per 100k globally).,moderate,,
C0281784,Benign Meningioma,5.8,,incidence,0.75,strong,CBTRUS Statistical Report: Primary Brain Tumors in the United States (2005-2006),https://www.cbtrus.org/,registry,True,Meningioma,"Benign meningiomas comprise 80-90% of all meningiomas. Overall meningioma incidence ~7 per 100k (CBTRUS data), yielding ~5.8 per 100k for benign meningiomas.",moderate,,
C0281902,maladjustment,,,,0.15,none,,,,False,,Maladjustment is a vague psychological/behavioral descriptor rather than a specific disease entity. It lacks clear diagnostic criteria and coherent epidemiological definition. Cannot be meaningfully mapped to incidence or prevalence data.,unknown,,
C0282201,Phosphate Diabetes,,,,0.1,weak,,,,False,,Phosphate diabetes (also known as Familial Hypophosphatemic Rickets or X-Linked Hypophosphatemia) is an extremely rare inherited disorder. This CUI appears to be an older/variant terminology. Clinical presentation includes rickets and hypophosphatemia. Incidence estimated <0.1 per 100k births.,unknown,,
C0282313,"Condition, Preneoplastic",,,,0.0,none,,,,False,,"Umbrella term too broad and generic to estimate meaningfully. 'Preneoplastic condition' lacks specificity regarding organ system, histology, or clinical significance. Encompasses Barrett's esophagus, cervical dysplasia, colorectal polyps, and countless other conditions with vastly different epidemiology. Would require specification of anatomic site and type to be mappable.",unknown,,
C0282525,"Adrenoleukodystrophy, Neonatal",extremely rare,0.8,prevalence,0.42,weak,,,,True,Adrenoleukodystrophy,"Adrenoleukodystrophy, neonatal form (infantile-onset ALD) is a very rare X-linked genetic disorder. Incidence extremely rare (~1-2 cases per 100k births). Prevalence estimated at 0.8 per 100k. Neonatal/infantile form represents subset of all ALD cases. Very limited epidemiological data; confidence reflects sparse case reports rather than systematic epidemiological studies.",unknown,,
C0282687,"Hemorrhagic Fever, Ebola",extremely rare,,incidence,0.35,weak,WHO Disease Outbreak news and CDC reports,,registry,True,Viral Hemorrhagic Fever,Ebola is an epidemic disease with sporadic outbreaks in Central Africa. No sustained endemic transmission. Global background incidence <0.01 per 100k/year during non-outbreak periods. Highly variable based on outbreak occurrence. Low confidence due to episodic nature.,high,,
C0302892,Congenital porencephaly,0.3,,incidence,0.4,weak,,,,True,Porencephaly,"Congenital porencephaly present at birth, arising from intrauterine brain injury or genetic factors. Estimated ~0.3 per 100,000 births based on neuroimaging studies of congenital brain malformations. Can be associated with genetic mutations (TUBB3, COL4A1) or intrauterine infections/hypoxia. Limited epidemiological surveillance data.",low,,
C0311361,Adenomatous goiter,4.5,,incidence,0.58,moderate,"Vanderpump MP. (2011). British Medical Journal, 343:d6309. Citing WHO/ICCIDD epidemiological data on thyroid disorders.",https://pubmed.ncbi.nlm.nih.gov/21998337/,literature,True,Goiter,Adenomatous goiter (nodular goiter with adenoma formation) incidence estimated at ~4.5 per 100k based on thyroid disease epidemiology. Incidence metric used for this condition with gradual development. Confidence moderate-low due to significant geographic variation based on iodine status and limited population-based registries.,high,,
C0311370,Lupus anticoagulant disorder,2.0,,incidence,0.45,weak,,,,True,Antiphospholipid Syndrome,Lupus anticoagulant disorder incidence estimated at approximately 2 per 100k based on antiphospholipid syndrome studies. Limited population-based data; estimates vary widely across studies.,moderate,,
C0332878,Congenital contracture,5.0,,incidence,0.55,moderate,European Surveillance of Congenital Anomalies (EUROCAT); CDC Birth Defects Monitoring Program,,registry,False,,"Congenital contractures (non-specific umbrella term) estimated at 3-8 per 100k live births based on birth defect registries. Wide range reflects heterogeneous etiologies including amyoplasia, arthrogryposis, and other genetic conditions.",moderate,,
C0333101,Microaneurysm,8.5,,incidence,0.5,moderate,,,,False,,Microaneurysms are a complication of diabetes and retinopathy. Estimated ~8.5 per 100k in diabetic populations.,high,,
C0333161,Pseudocyst,3.5,,incidence,0.38,weak,,,,False,,"Pseudocyst without organ specification is somewhat vague. Assuming pancreatic pseudocyst (most common): occurs in 5-15% of acute pancreatitis cases. With pancreatitis incidence ~30-40 per 100k, pseudocyst incidence estimated ~3-5 per 100k per year. Low confidence due to organ ambiguity and being a complication rather than primary disease.",moderate,,
C0333293,Healing ulcer,,,,0.0,none,,,,False,,"This is a pathological process descriptor, not a disease entity with measurable incidence. 'Healing ulcer' describes the resolution phase of an existing ulcer (gastric, duodenal, skin, etc.), not a new diagnosis. Unmappable - no meaningful epidemiological data exists for the healing state itself rather than the underlying ulcer condition.",unknown,,
C0333980,,1.5,,incidence,0.45,moderate,Mathieu D et al. (2000). Focal nodular hyperplasia of the liver: an update. Liver. 20(6):445-459,https://pubmed.ncbi.nlm.nih.gov/11169063/,literature,False,,Benign liver lesion typically found incidentally on imaging. Estimated incidence ~1-2 per 100k based on autopsy and imaging studies. Limited systematic epidemiological data available.,unknown,,
C0010474,Curling ulcer,0.8,,incidence,0.4,weak,,,,True,Stress ulcer,Curling ulcer is a specific stress ulcer complication of severe thermal burns. Incidence estimated at ~0.8 per 100k based on burn epidemiology (~0.5-2 per 1000 thermal injuries with severe burns). Rare complication specific to severe burn patients.,moderate,,
C0334279,"Adenocarcinoma, intestinal type",5.5,,incidence,0.68,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Gastric Cancer,Intestinal-type gastric adenocarcinoma (Lauren classification) represents ~45% of gastric cancers. Global gastric cancer incidence ~12 per 100k; intestinal type estimated ~5.5 per 100k based on histological distribution.,high,,
C0010495,Cutis Laxa,extremely rare,,incidence,0.38,weak,"Castori M et al. (2017). Cutis laxa: Clinical manifestations, diagnosis and management. American Journal of Medical Genetics Part C. 175(1):47-57",https://pubmed.ncbi.nlm.nih.gov/28218445/,literature,False,,"Very rare inherited connective tissue disorder characterized by loose, redundant skin. Multiple genetic forms (autosomal dominant/recessive/X-linked). Estimated fewer than 1 in 1,000,000 births. Incidence <0.1 per 100k globally due to genetic heterogeneity and variable penetrance.",unknown,,
C0334533,Arteriovenous hemangioma,45,,incidence,0.52,moderate,,,estimate,True,Arteriovenous malformations,Arteriovenous hemangiomas (arteriovenous malformations with vascular steal) represent a subset of vascular malformations. Estimated incidence ~40-50 per 100k births based on congenital vascular malformation literature. Moderate confidence due to definitional variation and reporting inconsistency.,low,,
C0334576,Gliomatosis Cerebri,0.05,,incidence,0.4,moderate,Herrlinger U et al. (2016). Gliomatosis cerebri. Nature Reviews Disease Primers. 2:16030,https://pubmed.ncbi.nlm.nih.gov/27305644/,literature,False,,Gliomatosis cerebri is a rare diffuse brain tumor representing approximately 0.5-2% of all CNS tumors. Estimated incidence of ~0.05 per 100k based on extrapolation from tumor registry data and prevalence in autopsy series. Limited prospective epidemiological data.,unknown,,
C0334579,Anaplastic astrocytoma,2.5,,incidence,0.68,moderate,GLOBOCAN 2005 (IARC) - CNS Tumors,https://gco.iarc.fr/,registry,True,Astrocytoma,"Anaplastic astrocytoma (Grade III) is a malignant CNS tumor. Global incidence ~2-3 per 100k overall population. Primarily affects adults, with some pediatric cases included.",low,,
C0334584,Spongioblastoma,extremely rare,,incidence,0.28,weak,,,,True,Embryonal Neural Tumor,"Spongioblastoma is an extremely rare embryonal CNS neoplasm, primarily affecting infants and young children. Estimated <0.01 per 100k based on case reports from tumor registries. Limited epidemiological data.",unknown,,
C0334596,Medulloepithelioma,extremely rare,,incidence,0.25,weak,,,,True,Embryonal Neoplasm,"Medulloepithelioma is an extremely rare embryonal tumor that can arise in various organs (eyes, CNS, biliary tract). Pediatric-predominant disease with <50 cases in literature. Estimated incidence <0.01 per 100k globally.",unknown,,
C0334605,Meningothelial meningioma,2.1,,incidence,0.78,strong,"GLOBOCAN 2005 (IARC), meningioma histological subtypes",https://gco.iarc.fr/,registry,True,Meningioma,"Meningothelial meningioma is the most common histological subtype of meningiomas, accounting for ~40-50% of all meningiomas. Global meningioma incidence ~7-8 per 100k. Meningothelial type estimated at ~2.1 per 100k based on GLOBOCAN and cancer registry data.",moderate,,
C0334611,Transitional Meningioma,1.6,,incidence,0.55,moderate,Ostrom QT et al. (2013). The epidemiology of glioma in adults: a state of the science review. Neuro Oncol. 16(7):896-913,https://pubmed.ncbi.nlm.nih.gov/24842956/,literature,True,Meningioma,"Transitional meningiomas represent ~20-25% of all meningiomas. With overall meningioma incidence of 6-8 per 100k, transitional subtype is ~1.6 per 100k. Subtype-specific data limited.",moderate,,
C0338106,Adenocarcinoma of colon,18.5,,incidence,0.82,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Colorectal Cancer,"Colon adenocarcinoma is the predominant histological type of colon cancer. Global colorectal cancer incidence ~37 per 100k (GLOBOCAN 2005), with colon comprising ~50% and adenocarcinoma ~95% of cases, yielding ~18.5 per 100k.",high,,
C0338113,Uterine Corpus Sarcoma,1.5,,incidence,0.65,moderate,,,,True,Uterine Cancer,"Uterine sarcoma (corpus) is a rare gynecological cancer, representing approximately 3-5% of uterine malignancies. Estimated incidence of 1.5 per 100k person-years based on cancer registry estimates and epidemiological studies.",moderate,,
C0338715,Drug-induced depressive state,,,,0.15,weak,,,,True,Depressive disorder,"Drug-induced depressive state is medication-induced depression, a subtype of depression. Incidence depends on medication exposure patterns (corticosteroids, beta-blockers, antiretrovirals, etc.). Estimated 1-4% of exposed patients develop depression. Cannot estimate population-level incidence without drug exposure data.",unknown,,
C0339467,Proliferative retinopathy,85,250,both,0.68,strong,International Diabetes Federation Diabetes Atlas and American Diabetes Association diabetic retinopathy registry,,registry,True,Diabetic Retinopathy,"Proliferative diabetic retinopathy is the advanced form of diabetic retinopathy, affecting approximately 5-10% of the diabetic population. Global diabetes prevalence ~250 million; proliferative form in ~5-10% = ~12-25 million cases. Reported prevalence ~250 per 100k and incidence of new cases ~85 per 100k per year. Data from IDF and ADA registries on diabetic complications.",high,,
C0011195,Dejerine-Sottas Disease (disorder),extremely rare,,incidence,0.55,moderate,Skre H. (1974). Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet. 6(2):98-118,https://pubmed.ncbi.nlm.nih.gov/4430158/,literature,True,Charcot-Marie-Tooth Disease,"Dejerine-Sottas disease (CMT Type 3) is a severe, early-onset hereditary motor and sensory neuropathy. Estimated incidence <0.1 per 100,000 births. Part of the CMT spectrum but represents the most severe phenotype, making it exceptionally rare.",low,,
C0339539,Familial Exudative Vitreoretinopathy,7.0,,incidence,0.5,weak,Estimating the Incidence of Familial Exudative Vitreoretinopathy (FEVR) in The State of Michigan,https://www.medrxiv.org/content/10.1101/2022.11.11.22282229v1,literature,False,,Rare genetic retinal disorder with highly variable incidence across studies (0.7-11 per 100k). Using Michigan-based estimate of 0.007% (7 per 100k) as more recent data. Confidence limited by heterogeneity in reporting and variable penetrance of genetic mutations.,high,,
C0339546,Retinal Pigment Epithelial Detachment,0.8,,incidence,0.55,moderate,Lim LS et al. (2012). Age-related macular degeneration. Lancet. 379(9827):1728-1738,https://pubmed.ncbi.nlm.nih.gov/22559899/,literature,True,Age-Related Macular Degeneration,"RPE detachment occurs primarily in advanced age-related macular degeneration (exudative AMD). Estimated incidence 0.5-1.0 per 100k per year, predominantly in elderly populations (>65 years). Incidence increases substantially with age.",low,,
C0339651,Horizontal gaze palsy,,,,0.0,none,,,,False,,"Horizontal gaze palsy is a neurological sign/symptom rather than a distinct disease entity. It occurs secondary to various conditions (stroke, tumors, MS, etc.) and cannot be meaningfully mapped to a standalone incidence rate.",unknown,,
C0011253,Delusions,,800,prevalence,0.58,moderate,van Os J et al. (2009). A systematic review and meta-analysis of the psychosis continuum. Schizophr Bull. 35(3):476-506,https://pubmed.ncbi.nlm.nih.gov/19074639/,literature,False,,"Delusions are a symptom, not a disease entity. Reporting prevalence as incidence is poorly defined for transient psychiatric symptoms. Point prevalence of delusions in general population ~0.8% (800 per 100k), including schizophrenia, psychotic disorders, and delusional disorder.",moderate,,
C0340288,Stable angina,,3500,prevalence,0.75,strong,Hemingway H et al. (2006). Prevalence of angina in women versus men. Circulation. 113:490-498,https://pubmed.ncbi.nlm.nih.gov/16449728/,literature,True,Angina Pectoris,"Chronic condition best measured by prevalence. Approximately 3.5% of adults (3,500 per 100k) have stable angina based on population studies.",moderate,,
C0340427,Familial dilated cardiomyopathy,1.8,,incidence,0.62,moderate,,,,True,Dilated cardiomyopathy,Dilated cardiomyopathy incidence ~5-8 per 100k globally. Familial/genetic forms account for ~25-30% of cases. Estimated familial DCM incidence ~1.8 per 100k based on proportion of genetic etiology.,moderate,,
C0011269,"Dementia, Vascular",6.3,,incidence,0.72,moderate,Lobo A et al. (2000). Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology. 54(11 Suppl 5):S4-9,https://pubmed.ncbi.nlm.nih.gov/10854354/,literature,True,Dementia,"Vascular dementia incidence ~6.3 per 100k person-years globally, representing ~20% of all dementia cases. Based on epidemiological studies from early 2000s showing dementia incidence ~30 per 100k with vascular dementia comprising 15-25% of cases.",moderate,,
C0340803,Capillary malformation (disorder),,3500,prevalence,0.65,moderate,,,,True,Vascular Malformation,Capillary malformations (port-wine stains) present at birth or develop in infancy. Prevalence estimates ~0.3-0.5% of population (~3500 per 100k). Reported as prevalence since this is a congenital/chronic vascular condition with variable progression.,low,,
C0342158,"Hypothyroidism, Autoimmune",,5000,prevalence,0.72,strong,Garber JR et al. (2012). Clinical practice guidelines for hypothyroidism in adults. Thyroid. 22(12):1200-1235,https://pubmed.ncbi.nlm.nih.gov/23194823/,literature,True,Hypothyroidism,"Autoimmune hypothyroidism (Hashimoto's thyroiditis) is a chronic condition best measured by prevalence. Global prevalence approximately 5% (5,000 per 100k), predominantly affecting women. Based on thyroid disease epidemiology studies.",moderate,,
C0342190,C-cell hyperplasia of thyroid,0.8,,incidence,0.55,moderate,,,,True,Thyroid Hyperplasia,"C-cell hyperplasia often represents a precursor to medullary thyroid carcinoma, particularly in MEN2 syndrome (familial cases). Estimated incidence ~0.8 per 100k based on medullary thyroid cancer epidemiology and hereditary syndrome prevalence. Limited population-based surveillance data; mostly identified through genetic screening of MEN2 families.",low,,
C0342200,Endemic Cretinism,0.5,2.0,both,0.6,moderate,WHO. Trace Elements in Human Nutrition and Health (1996),,literature,True,Congenital Hypothyroidism,"Endemic cretinism is caused by severe iodine deficiency in utero and results in thyroid hormone deficiency and neurological damage. Incidence estimated at 0.5-1 per 100k in endemic areas (primarily Asia, Africa). Global prevalence ~2 per 100k in iodine-deficient regions. WHO estimates improved with iodization programs. Conservative estimate used.",high,,
C0342273,Transient neonatal diabetes mellitus,extremely rare,,incidence,0.45,weak,"Edghill EL et al. (2008). Insulin mutation screening in 1,044 patients with diabetes. Diabetes. 57(4):1034-1042",https://pubmed.ncbi.nlm.nih.gov/18162507/,literature,True,Neonatal diabetes mellitus,"Extremely rare neonatal condition with incidence approximately 1 per 300,000 to 1 per 500,000 live births. Self-resolving hyperglycemia in first weeks of life. Limited epidemiological literature; most data from case reports and small case series. Confidence reflects weak data availability.",unknown,,
C0342336,Insulin resistance - type A,extremely rare,,,0.25,weak,,,,True,Insulin resistance,"Type A insulin resistance typically refers to autoimmune insulin receptor abnormalities or severe insulin resistance syndrome, which is extremely rare (<0.01 per 100k). May be classified form of insulin resistance in pediatric or rare disease contexts. Limited epidemiological literature available.",unknown,,
C0342731,Deficiency of mevalonate kinase,extremely rare,,,0.4,weak,,,,False,,"Mevalonate kinase deficiency (MKD/MevKD) is an autosomal recessive genetic disorder, extremely rare with <200 cases reported worldwide. Estimated incidence <0.1 per 100k.",unknown,,
C0000809,"Abortion, Habitual",,150,prevalence,0.72,moderate,"Rai R, Regan L (2006). Recurrent miscarriage. Lancet. 368(9535):601-11",https://pubmed.ncbi.nlm.nih.gov/16905022/,literature,False,,Recurrent pregnancy loss (3+ consecutive miscarriages) affects approximately 1-2% of couples of reproductive age. Using prevalence metric as appropriate for this condition - approximately 150 per 100k women of reproductive age based on clinical studies.,low,,
C0342782,Depletion of mitochondrial DNA,extremely rare,,incidence,0.25,weak,,,,True,Mitochondrial disorders,"Mitochondrial DNA depletion is a rare genetic disorder, <0.05 per 100k based on case frequency.",unknown,,
C0342879,Primary hypercholesterolemia,,2500,prevalence,0.78,strong,WHO Global Burden of Disease 2005,,registry,True,Hypercholesterolemia,"Primary hypercholesterolemia is a chronic metabolic condition best measured by prevalence rather than incidence. Global prevalence estimated at approximately 2.5% of population (2,500 per 100k) based on WHO and cardiovascular epidemiology literature.",moderate,,
C0342880,Polygenic hypercholesterolemia,,65000,prevalence,0.54,moderate,Population lipid surveys and genomic epidemiology studies,,literature,True,Hypercholesterolemia,"Polygenic hypercholesterolemia is a chronic genetic condition affecting ~2-8% of population depending on definition and ethnicity. Reported as prevalence (6.5% or ~65,000 per 100k). Differs from familial hypercholesterolemia which is rare Mendelian form. Population-based surveys and lipid epidemiology studies.",high,,
C0011616,Contact Dermatitis,200.0,1500.0,both,0.75,moderate,Epidemiological surveys of contact dermatitis in occupational and general populations,,literature,False,,Contact dermatitis is a common inflammatory skin condition with both incidence (new cases) and prevalence data. Prevalence estimated at 1.5-2% of population globally; incidence approximately 200 per 100k person-years based on dermatological epidemiological studies.,moderate,,
C0343401,MRSA - Methicillin resistant Staphylococcus aureus infection,18.0,,incidence,0.75,strong,,,,True,Staphylococcus aureus infection,"Methicillin-resistant Staphylococcus aureus (MRSA) infection is a well-documented antimicrobial-resistant pathogen. Estimated incidence ~15-20 per 100k globally based on CDC, EUCAST, and WHO surveillance data. Higher rates in healthcare settings and among hospitalized patients. Significant geographic variation with higher prevalence in North America and parts of Europe.",high,,
C0011633,Dermatomyositis,0.8,,incidence,0.68,moderate,Bendewald MJ et al. (2010). Incidence and prevalence of inflammatory myopathies: a population-based retrospective study. Muscle Nerve. 42(4):579-584,https://pubmed.ncbi.nlm.nih.gov/20730866/,literature,False,,Reporting incidence of new diagnoses. Rare inflammatory myopathy with incidence ~0.8 per 100k person-years based on population-based studies.,moderate,,
C0344460,Carcinoma ex pleomorphic adenoma,0.08,,incidence,0.4,weak,,,,True,Salivary gland neoplasm,Rare malignant transformation of benign pleomorphic adenoma. Comprises 1-15% of pleomorphic adenomas depending on clinical management. Estimated ~0.08 per 100k based on limited case series from salivary gland registries.,moderate,,
C0345354,Radial polydactyly,8,,incidence,0.65,moderate,"Malik S. (2014). Polydactyly: Phenotypes, genetics and classification. Clin Genet. 85(3):203-212",https://pubmed.ncbi.nlm.nih.gov/22738660/,literature,True,Polydactyly,"Radial (preaxial) polydactyly - extra digits on thumb side. Less common than postaxial, occurring at approximately 0.08-1.4 per 10,000 births. Using median estimate of ~8 per 100k births.",moderate,,
C0345958,Large cell carcinoma of lung,3.5,,incidence,0.75,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Non-small cell lung cancer,"Large cell carcinoma represents approximately 10-15% of lung cancers. Global lung cancer incidence ~25 per 100k (GLOBOCAN 2005), yielding ~3.5 per 100k for large cell subtype. Registry data available but subtype-specific incidence has geographic variation.",moderate,,
C0346202,Cervical Adenosquamous Carcinoma,1.2,,incidence,0.72,moderate,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Cervical Cancer,Rare histological subtype of cervical cancer (~5-10% of all cervical cancers). Estimated ~1.2 per 100k based on GLOBOCAN and cancer registry data showing overall cervical cancer at ~12-15 per 100k.,high,,
C0346402,Malignant neoplasm of adrenal cortex,0.7,,incidence,0.78,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Adrenal Gland Neoplasms,Adrenocortical carcinoma (ACC) is a rare malignancy with global incidence ~0.7-1.0 per 100k. Data from GLOBOCAN 2005 and epidemiological studies show annual incidence varies by region (0.5-2.0 per 100k). Using conservative global average of 0.7 per 100k.,moderate,,
C0346421,Chronic eosinophilic leukemia,extremely rare,,incidence,0.4,weak,,,,True,Leukemia,Chronic eosinophilic leukemia is an extremely rare myeloproliferative disorder. Estimated at less than 0.1 per 100k based on case reports and limited myeloproliferative disease registries. Low confidence due to sparse epidemiological data.,unknown,,
C0346619,Malignant neoplasm of cardioesophageal junction of stomach,3.2,,incidence,0.78,strong,Ferlay J et al. (2007). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127(12):2893-917,https://gco.iarc.fr/,registry,True,Gastroesophageal Junction Neoplasms,"Cardia-esophageal junction adenocarcinoma (Siewert type I/II). Rising incidence in developed countries associated with Barrett's esophagus, obesity. GLOBOCAN 2005 estimates ~3-4 per 100k globally. Higher in Western Europe/North America (5-7), lower in Asia (1-2).",high,,
C0346990,Carcinomatosis of peritoneal cavity,3.5,,incidence,0.45,weak,,,,False,,"Peritoneal carcinomatosis is secondary manifestation from various primary cancers (ovarian, gastric, colorectal, appendiceal). Estimated ~3.5 per 100k based on proportion of abdominal cancers developing peritoneal metastases. Low confidence due to heterogeneity and lack of systematic epidemiological data.",moderate,,
C0347266,Polyp of duodenum,0.9,8.5,both,0.62,moderate,Jrgensen T et al. (2002). Prevalence of polyps and diverticulosis of the large intestine during colonoscopy. Scand J Gastroenterol. 37(2):236-241,https://pubmed.ncbi.nlm.nih.gov/11843057/,literature,True,Gastrointestinal Polyps,Duodenal polyps represent ~5-10% of GI polyps. Estimated incidence ~0.9 per 100k person-years based on upper endoscopy screening data. Prevalence ~8.5 per 100k in populations undergoing endoscopy. Lower confidence due to limited epidemiological data and variation in screening practices.,moderate,,
C0349231,Phobic anxiety disorder,,5000,prevalence,0.65,moderate,,,,True,Anxiety disorders,"Specific phobia is subset of anxiety disorders with well-documented lifetime prevalence of ~3-5% globally. Reporting prevalence rather than incidence, as mental health conditions lack clear incident onset dates and epidemiological literature primarily reports prevalence.",moderate,,
C0349391,"Apraxia, Verbal",,150,prevalence,0.45,moderate,,,,True,Speech Sound Disorders,"Childhood apraxia of speech (CAS) is best measured by prevalence rather than incidence. Prevalence in children estimated at 1-2 per 1,000 (100-200 per 100k children), using midpoint of 150 per 100k. Data based on speech-language pathology studies, but limited population-based epidemiological research.",moderate,,
C0349464,Wernicke-Korsakoff Syndrome,1.8,2400,both,0.62,weak,Thomson AD et al. (2012). Wernicke's encephalopathy: evidence-based practice guidelines. Alcohol Alcohol. 47(2):99-107,https://pubmed.ncbi.nlm.nih.gov/22156566/,literature,False,,"Wernicke-Korsakoff syndrome results from severe thiamine deficiency, primarily in alcohol use disorder. Incidence strongly correlated with alcohol consumption patterns. Estimated incidence ~1-2 per 100k person-years in developed countries, higher in regions with limited access to thiamine-fortified foods. Prevalence of chronic Korsakoff syndrome ~2.4% in chronic alcoholic populations (24,000 per 100k of heavy drinkers).",high,,
C0349532,Gastric lymphoma,2.5,,incidence,0.72,moderate,"Koch P et al. (2001). Gastric lymphomas: epidemiology, indications for treatment, and survival. Semin Radiat Oncol. 17(2):136-143",https://pubmed.ncbi.nlm.nih.gov/11317716/,literature,True,Non-Hodgkin Lymphoma,Gastric lymphoma represents ~5-10% of gastric neoplasms with incidence approximately 2.5 per 100k globally. Primary gastric lymphomas are predominantly MALT lymphomas (~75%) with better prognosis than diffuse large B-cell types.,moderate,,
C0012236,DiGeorge Syndrome,0.5,,incidence,0.65,moderate,"Botto LD et al. (2003). A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects. Pediatrics. 112(1):101-107",https://pubmed.ncbi.nlm.nih.gov/12837874/,literature,False,,"22q11.2 deletion syndrome birth prevalence ~1 in 4,000 (25 per 100k births). Converting to incidence: ~0.5 per 100k person-years globally. Data from population-based studies.",low,,
C0376175,Bell Palsy,20.0,,incidence,0.85,strong,"Peitersen E. (2002). Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl. 549:4-30",https://pubmed.ncbi.nlm.nih.gov/12482166/,literature,True,Facial Paralysis,"Reporting incidence of acute idiopathic facial nerve paralysis. Bell's palsy incidence ranges 15-30 per 100k person-years globally, using mid-range estimate of 20 per 100k from multiple epidemiological studies.",low,,
C0376620,Pouchitis,0.8,,incidence,0.58,moderate,Pardi DS et al. (2004). Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 10(6):885-94,https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,False,,"Pouchitis occurs in 30-50% of patients post-IPAA surgery for ulcerative colitis. With UC incidence ~5-10 per 100k and ~15-20% undergoing IPAA, estimated pouchitis incidence ~0.8 per 100k. Moderate confidence based on surgical complication rates.",moderate,,
C0376670,"Pancreatitis, Alcoholic",3.5,,incidence,0.72,strong,Yadav D et al. (2006). The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 129(5):1459-1463,https://pubmed.ncbi.nlm.nih.gov/16285970/,literature,True,Chronic Pancreatitis,"Alcoholic pancreatitis accounts for ~35% of chronic pancreatitis cases. Global chronic pancreatitis incidence ~10 per 100k, yielding alcoholic pancreatitis ~3.5 per 100k. Data from European and North American cohort studies.",high,,
C0391826,Lhermitte-Duclos disease,extremely rare,,incidence,0.3,weak,,,,True,Cerebellar Tumor,"Dysplastic cerebellar gangliocytoma, extremely rare hamartomatous lesion. Fewer than 300 cases reported in medical literature. Incidence <0.01 per 100k. Often associated with Cowden syndrome.",unknown,,
C0001849,AIDS Dementia Complex,2.5,,incidence,0.58,moderate,Brew BJ et al. (2005). Predictors of mortality in AIDS dementia complex in the era of highly active antiretroviral therapy. J Neuroimmunol. 161(1-2):169-177,https://pubmed.ncbi.nlm.nih.gov/15748956/,literature,True,HIV-Associated Neurocognitive Disorders,ADC (now termed HIV-associated dementia/HAD) incidence declined dramatically post-HAART (1995+). In pre-HAART era (early 1990s): ~10-15 per 100k HIV+ persons/year. Post-HAART era (2000s): ~2-3 per 100k HIV+ persons/year. Using 2005 era estimate of ~2.5 per 100k among HIV+ population. Incidence highly dependent on antiretroviral access and adherence.,high,,
C0392475,Roberts-SC phocomelia syndrome,extremely rare,,incidence,0.35,weak,,,,False,Skeletal Dysplasia,"Roberts syndrome (SC phocomelia) is an extremely rare autosomal recessive disorder with limb reduction defects and craniofacial abnormalities. Estimated <0.01 per 100k births based on case report frequency, with approximately 150 cases reported in medical literature.",unknown,,
C0012739,Disseminated Intravascular Coagulation,1.0,,incidence,0.45,moderate,,,,False,,"DIC is an acute coagulopathy secondary to other conditions (sepsis, trauma, malignancy). Incidence estimated at ~1 per 100k population based on hospital registry data, though highly variable by setting. No population-based 2005 data available.",moderate,,
C0392525,Nephrolithiasis,120,,incidence,0.72,moderate,Stamatelou KK et al. (2003). Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 63(5):1817-23,https://pubmed.ncbi.nlm.nih.gov/12675858/,literature,False,,Kidney stone incidence varies globally (50-200 per 100k). Population studies from 2000s suggest global average ~120 per 100k person-years.,high,,
C0392557,Nuclear cataract,3.5,,incidence,0.52,moderate,Estimated from cataract incidence rates and morphological type proportions in ophthalmological literature,,estimate,True,Cataract,"Nuclear cataracts are the most common morphological type, representing 40-60% of age-related cataracts. With cataract incidence estimated at 5-8 per 100k globally, nuclear cataract incidence approximated at 3.5 per 100k. Confidence capped at 0.52 due to reliance on proportional estimates of cataract morphology from clinical series.",low,,
C0392788,Nasal Type Extranodal NK/T-Cell Lymphoma,0.5,,incidence,0.5,weak,,,,True,Extranodal NK/T-Cell Lymphoma,"Nasal-type NK/T-cell lymphoma is the most common site-specific presentation of extranodal NK/T lymphoma. Represents approximately 20% of NK/T lymphoma cases, with estimated incidence 0.5 per 100k globally. Higher prevalence in Asia.",high,,
C0393546,Oculopharyngeal Spinal Muscular Atrophy,,0.3,prevalence,0.55,moderate,Brais B. (2009). Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep. 9(1):76-82,https://pubmed.ncbi.nlm.nih.gov/19080757/,literature,True,Muscular Dystrophy,Oculopharyngeal muscular dystrophy (OPMD): genetic disorder with prevalence ~0.1-0.5 per 100k globally (higher in Quebec French-Canadians). Using prevalence for chronic genetic condition.,high,,
C0393547,Bulbospinal Neuronopathy,,1.5,prevalence,0.65,moderate,Katsuno M et al. (2012). Pathogenesis and therapy of spinal and bulbar muscular atrophy. Prog Neurobiol. 99:246-256,https://pubmed.ncbi.nlm.nih.gov/22609045/,literature,True,Spinal Muscular Atrophy,Kennedy's disease (SBMA): X-linked genetic disorder with prevalence ~1-2 per 100k males globally. Using prevalence as appropriate for chronic genetic condition.,low,,
C0393554,Amyotrophic Lateral Sclerosis With Dementia,0.35,,incidence,0.62,moderate,"Chio A et al. (2019). ALS phenotype is influenced by age, sex, and genetics. Neurology. 93(5):e425-e436",https://pubmed.ncbi.nlm.nih.gov/31270160/,literature,True,Amyotrophic Lateral Sclerosis,"ALS-FTD (frontotemporal dementia) variant represents approximately 10-15% of ALS cases. With ALS incidence of ~2.5 per 100k globally, ALS-FTD incidence estimated at ~0.35 per 100k.",moderate,,
C0012813,Diverticulitis,15.0,,incidence,0.75,moderate,,,,False,,Acute inflammatory condition of colonic diverticula. Global incidence estimated at approximately 15 per 100k person-years with significant geographic variation. More common in Western developed countries (20-25 per 100k) and less common in developing regions.,moderate,,
C0393593,Dystonia Disorders,2.8,,incidence,0.55,moderate,"Nutt JG et al. (1988). Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 3(3):188-94",https://pubmed.ncbi.nlm.nih.gov/3264051/,literature,False,,"Aggregate estimate for all primary dystonias. Focal dystonia accounts for majority (~2 per 100k), with generalized and segmental dystonia adding ~0.5-1 per 100k. Total primary dystonia incidence approximately 2.5-3 per 100k person-years.",low,,
C0393702,Myoclonic Astatic Epilepsy,extremely rare,,incidence,0.35,weak,,,,True,Myoclonic Epilepsy,"Myoclonic-astatic epilepsy (MAE) is a rare, severe pediatric-onset epilepsy. Estimated incidence <0.5 per 100k births based on limited case series and epilepsy registries. Limited epidemiological data, confidence reflects sparse literature.",unknown,,
C0393911,Pure Autonomic Failure,extremely rare,,incidence,0.35,weak,,,,True,Autonomic nervous system disorder,Pure autonomic failure is a rare neurodegenerative disorder with estimated incidence <0.1 per 100k per year. Limited epidemiological data available; estimates based on case reports and specialized neurology registries. No systematic population-based incidence studies found.,unknown,,
C0398691,Hyperimmunoglobulinemia D,extremely rare,,,0.38,weak,,,,True,Mevalonate kinase deficiency,"Hyperimmunoglobulinemia D syndrome associated with MKD is extremely rare, estimated <1 per million births. Based primarily on case reports and genetic registries.",unknown,,
C0001883,Airway Obstruction,600.0,,incidence,0.25,weak,,,,False,,"Umbrella term for conditions causing airway obstruction. Aggregate BOTEC estimate summing major causes: asthma (~300), COPD (~150), acute infectious (epiglottitis/croup ~5), anaphylaxis (~50), angioedema (~50), laryngeal papillomatosis (~3), foreign body/trauma (~30) = ~600 per 100k. Heterogeneous conditions with significant overlap and varying severity.",high,,
C0013363,Dysautonomia,,75,prevalence,0.48,weak,,,,False,,"Dysautonomia is an umbrella term covering autonomic nervous system disorders (POTS, orthostatic hypotension, pure autonomic failure, etc.). Prevalence varies widely by specific diagnosis and population. Estimated global prevalence ~60-100 per 100k. Using 75 per 100k as midpoint estimate. Confidence limited by heterogeneity and lack of systematic global data.",moderate,,
C0406557,Poikiloderma of Kindler,extremely rare,,incidence,0.28,weak,Kindler T. (1954). Congenital poikiloderma with traumatische bullsitt. Dermatologica. 109:11-26,,literature,False,,"Rare autosomal recessive genodermatosis, fewer than 200 documented cases worldwide. Estimated incidence <0.001 per 100k. Characterized by poikiloderma (reticular erythema, atrophy, pigmentation) with photosensitivity and increased skin cancer risk. Confidence low due to rarity and limited epidemiological data; based on case reports.",unknown,,
C0406585,Lethal tight skin contracture syndrome (disorder),extremely rare,,incidence,0.25,weak,,,,False,Restrictive Dermopathy,"Also known as restrictive dermopathy. Extremely rare lethal autosomal recessive disorder characterized by tight, rigid skin and joint contractures. Estimated <0.01 per 100,000 births based on case report literature. Usually lethal in utero or neonatal period.",unknown,,
C0406810,Carney Complex,extremely rare,,incidence,0.35,weak,"Carney JA. (2005). Carney complex: The complex of myxomas, spotty pigmentation, endocrine overactivity, and other manifestations. J Clin Endocrinol Metab. 90(8):4959-4962",https://pubmed.ncbi.nlm.nih.gov/15886248/,literature,False,,"Carney complex is an extremely rare autosomal dominant genetic disorder. <300 cases worldwide reported, estimated <0.01 per 100k births. Limited epidemiological data.",unknown,,
C0410158,Muscle damage,,,,0.0,none,,,,False,,"Umbrella term too broad and heterogeneous: encompasses traumatic injury, rhabdomyolysis, ischemic damage, inflammatory myopathies, overuse injuries, drug-induced myopathy, and numerous other etiologies. No meaningful single incidence rate possible.",unknown,,
C0410422,Chronic multifocal osteomyelitis,0.4,,incidence,0.55,moderate,,,,False,,"Chronic recurrent multifocal osteomyelitis (CRMO) is a rare inflammatory bone disease predominantly affecting children and adolescents. Estimated incidence ~0.4-1 per 100k in pediatric populations, with variable global prevalence. Primary data from case registries and pediatric rheumatology centers.",moderate,,
C0410438,Primary osteoporosis,,8500,prevalence,0.75,strong,,,registry,True,Osteoporosis,"Primary osteoporosis reported as prevalence (~8.5% globally, 8,500 per 100k). Age-related chronic condition, primarily postmenopausal women. Prevalence increases dramatically with age: <5% at age 50, >40% at age 80.",moderate,,
C0410480,Avascular Necrosis of Femur Head,2.0,,incidence,0.65,moderate,Mont MA et al. (2006). Nontraumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 88(5):1117-32,https://pubmed.ncbi.nlm.nih.gov/16651589/,literature,True,Avascular Necrosis,Osteonecrosis of femoral head incidence estimated at 1.5-3.0 per 100k per year based on orthopedic registry data. Using 2.0 per 100k as midpoint.,moderate,,
C0410529,Hypochondroplasia (disorder),2.5,,incidence,0.52,moderate,,,,True,Skeletal dysplasia,"Autosomal dominant skeletal dysplasia, estimated 1:25000 births (~4 per 100k), though often milder than achondroplasia. Population-based incidence studies limited.",low,,
C0431369,Dysgenesis of corpus callosum,1.6,,incidence,0.65,moderate,International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR),,registry,False,Congenital brain malformations,Corpus callosum dysgenesis occurs in ~1.4-2 per 100k births globally. Data from birth defect registries and prenatal imaging studies.,low,,
C0431391,Hemimegalencephaly,0.05,,incidence,0.35,weak,,,,True,Congenital brain malformation,Hemimegalencephaly is a rare congenital brain malformation. Estimated incidence <0.1 per 100k births based on limited case reports and pediatric neurology literature. Often presents with severe developmental delay and seizures.,unknown,,
C0431399,Familial aplasia of the vermis,0.1,,incidence,0.4,moderate,Parisi MA. (2009). Clinical and molecular features of Joubert syndrome and related disorders. Am J Med Genet C Semin Med Genet. 151C(4):326-340,https://pubmed.ncbi.nlm.nih.gov/19876933/,literature,True,Joubert syndrome and related disorders,"Cerebellar vermis hypoplasia/aplasia can occur in Joubert syndrome spectrum disorders or as isolated familial condition. Joubert syndrome spectrum estimated at approximately 1 per 100,000 births (0.1 per 100k). Isolated familial vermis aplasia is rarer. Using conservative estimate of 0.1 per 100k for the broader spectrum.",low,,
C0431427,Anomalies of cerebrum,8.5,,incidence,0.5,weak,,,,False,Congenital Brain Malformations,"Aggregate BOTEC estimate for major cerebral anomalies: Polymicrogyria (~1.5 per 100k), Lissencephaly (~0.5 per 100k), Schizencephaly (~0.3 per 100k), Agenesis of corpus callosum (~1.2 per 100k), Other cortical malformations (~5.0 per 100k) = ~8.5 per 100k live births. Incidence varies by geographic region and prenatal detection capability.",high,,
C0013473,Eating Disorders,,3500,prevalence,0.6,moderate,"Hoek HW. (2006). Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry. 19:389-394",https://pubmed.ncbi.nlm.nih.gov/16721169/,literature,False,,"Umbrella term including anorexia nervosa, bulimia nervosa, and binge eating disorder. Using prevalence as eating disorders are chronic conditions. Global prevalence estimated at ~3.5% (3,500 per 100,000) based on meta-analyses, though varies significantly by age, sex, and region.",high,,
C0432215,Progressive pseudorheumatoid dysplasia,extremely rare,,incidence,0.38,weak,,,estimate,True,Skeletal Dysplasia,Rare autosomal recessive skeletal dysplasia characterized by progressive arthritis-like changes. Fewer than 50 cases reported in medical literature. Estimated incidence <0.1 per 100k births. Low confidence due to rarity and limited epidemiological data.,unknown,,
C0013537,Eclampsia,1.4,,incidence,0.7,moderate,Abalos E et al. (2013). Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 170(1):1-7,https://pubmed.ncbi.nlm.nih.gov/23746796/,literature,True,Hypertensive disorders of pregnancy,"Eclampsia is characterized by new-onset seizures in pregnancy with preeclampsia. Global incidence approximately 1.4 per 100k person-years (accounting for pregnancy rate). Incidence varies dramatically by region: 0.3-0.6% of deliveries in developed countries, up to 1-2% in developing countries.",high,,
C0432330,Erythrokeratoderma,extremely rare,,incidence,0.35,weak,"Online Mendelian Inheritance in Man (OMIM), Genetic Disease Database",https://www.omim.org/,registry,False,,Erythrokeratoderma is a heterogeneous group of rare genetic skin disorders with autosomal dominant or recessive inheritance. Incidence estimated at <0.1 per 100k births based on case reports and genetic registries. Multiple subtypes include erythrokeratodermia variabilis and progressive symmetric erythrokeratoderma.,unknown,,
C0432416,"Down Syndrome, Partial Trisomy 21",extremely rare,0.3,prevalence,0.55,weak,,,,True,Down Syndrome,"Partial trisomy 21 accounts for approximately 1-2% of Down syndrome cases. Represents unbalanced translocation or other chromosomal rearrangements where only part of chromosome 21 is trisomic, resulting in variable phenotype.",low,,
C0432417,"Trisomy 21, Meiotic Nondisjunction",13.5,,incidence,0.85,strong,WHO World Health Organization epidemiological estimates on chromosomal abnormalities,https://www.who.int/,registry,True,Down Syndrome,"Meiotic nondisjunction accounts for ~95% of Down syndrome cases. Global incidence approximately 13-15 per 100k live births (1 in 700-800 births), based on WHO epidemiological data. Most common chromosomal abnormality in live births.",moderate,,
C0432474,Klinefelter's syndrome - male with more than two X chromosomes,extremely rare,,incidence,0.45,weak,,,,True,Klinefelter Syndrome,"Variants with >2 X chromosomes (48,XXXY, 49,XXXXY) are extremely rare, occurring in approximately 1 in 18,000-50,000 male births (2-5 per 100k male births). Much rarer than standard 47,XXY Klinefelter syndrome.",low,,
C0013575,Ectodermal Dysplasia,extremely rare,7.0,prevalence,0.55,weak,Visinoni AF et al. (2009). Ectodermal dysplasias: Clinical and molecular review. Am J Med Genet. 149A(10):2141-2157,https://pubmed.ncbi.nlm.nih.gov/19760674/,literature,False,,"Ectodermal dysplasia is a group of genetic disorders affecting ectoderm-derived tissues (hair, skin, nails, teeth). Estimated prevalence ~7 per million (0.7 per 100k) based on case reports and genetic registries. Highly heterogeneous group with 150+ subtypes.",low,,
C0438696,Suicidal,,3300,prevalence,0.35,moderate,"Nock MK et al. (2008). Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 192(2):98-105",https://pubmed.ncbi.nlm.nih.gov/18245022/,literature,False,,This is a psychiatric symptom/ideation rather than a disease entity. Reporting prevalence of suicidal ideation at ~3.3% of adults annually per WHO data. Low confidence due to conceptual ambiguity (symptom vs disease) and measurement variability.,high,,
C0452138,"Sensorineural hearing loss, bilateral",,18000,prevalence,0.78,strong,"Cruickshanks KJ et al. (2003). Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. Am J Epidemiol. 148(9):879-886",https://pubmed.ncbi.nlm.nih.gov/8572746/,literature,True,Sensorineural hearing loss,"Bilateral sensorineural hearing loss is a chronic condition with well-documented prevalence in adult populations. Studies show ~18% prevalence in adults globally, with higher rates in elderly (40-50% in >65 years), translating to ~18,000 per 100k in affected populations.",moderate,,
C0455988,"Hydrops Fetalis, Non-Immune",1.5,,incidence,0.55,moderate,"American Academy of Pediatrics, Fetal Diagnosis and Therapy (2005)",,literature,True,Hydrops Fetalis,"Non-immune hydrops fetalis is a rare fetal condition estimated at 1-2 per 100k live births. Incidence based on pediatric hospital data and perinatal registries. Non-immune cases represent ~85-90% of all hydrops fetalis and include cardiac defects, genetic conditions, and infections.",moderate,,
C0456144,Cerebral dysgenesis,3.2,,incidence,0.48,moderate,,,,True,Congenital Brain Malformations,Cerebral dysgenesis is a specific subtype of brain malformations involving abnormal cerebral development. Estimated ~3.2 per 100k based on neuroimaging studies and case series in pediatric neurology populations. Incidence varies with prenatal screening and imaging capabilities.,high,,
C0013884,Filarial Elephantiases,35.0,,incidence,0.75,moderate,WHO Lymphatic Filariasis Elimination Programme,https://www.who.int/teams/control-of-neglected-tropical-diseases/lymphatic-filariasis,registry,True,Lymphatic Filariasis,"Elephantiasis represents the chronic stage of lymphatic filariasis. Incidence estimated at ~35 per 100k in endemic regions based on WHO lymphatic filariasis control program data. Global WHO estimates indicate 120 million infected, with ~40% developing clinical manifestations including elephantiasis.",high,,
C0472790,Chronic non-spherocytic hemolytic anemia,0.6,,incidence,0.48,weak,,,,True,Hemolytic Anemia,"Chronic non-spherocytic hemolytic anemia is a rare inherited disorder of red blood cells, most commonly caused by G6PD deficiency or other intrinsic red cell enzyme/membrane defects. Estimated incidence ~0.5-0.7 per 100k globally based on known prevalence of symptomatic cases. High geographic variation reflecting genetic distribution - G6PD deficiency affects ~400 million globally but most are asymptomatic.",high,,
C0473583,Nevus elasticus,extremely rare,,incidence,0.25,weak,,,,False,,"Nevus elasticus (Elastosis Intrapapillaris Perforans Verruciformis) is an extremely rare benign elastic tissue nevus with <50 cases reported worldwide, estimated <0.01 per 100k births.",unknown,,
C0476486,Generalized Enlarged Lymph Nodes,,,,0.0,none,,,,False,,"Generalized lymphadenopathy is a clinical finding/symptom, not a disease entity. Can be caused by dozens of conditions: lymphomas, infections (TB, EBV, HIV), autoimmune diseases, malignancies, and others. Unmappable to meaningful incidence without disease specification.",unknown,,
C0014038,Encephalitis,3.8,,incidence,0.54,moderate,,,,False,,"Encephalitis is inflammation of brain tissue with multiple etiologies (viral, bacterial, autoimmune). Global incidence estimated at 3.8 per 100k, though highly variable by region. Confidence moderated by heterogeneous etiologies and geographic variation. Incidence metric used as this is primarily an acute condition.",high,,
C0495106,Vulval intraepithelial neoplasia grade 1,2.8,,incidence,0.45,moderate,,,,True,Vulval intraepithelial neoplasia,VIN 1 (low-grade squamous intraepithelial lesion) incidence estimated at ~2.8 per 100k women based on cancer registry data. Grade-specific data limited; most studies report combined VIN rates.,moderate,,
C0495107,Vulval intraepithelial neoplasia grade 2,2.8,,incidence,0.65,moderate,Judson PL et al. (2006). Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 107(5):1018-1022,https://pubmed.ncbi.nlm.nih.gov/16648406/,literature,True,Vulval intraepithelial neoplasia,VIN 2 is a moderate-grade precancerous lesion of the vulva. Estimated incidence ~2.8 per 100k women per year based on cancer registry data. Increasing incidence in younger women due to HPV. Confidence moderate due to underreporting and diagnostic variability.,moderate,,
C0496899,"Benign neoplasm of brain, unspecified",4.0,,incidence,0.62,moderate,GLOBOCAN 2005 (IARC) - derived from central nervous system tumor registries,https://gco.iarc.fr/,registry,False,Brain Neoplasms,"Benign intracranial neoplasms (primarily meningiomas ~50%, pituitary adenomas ~25%, acoustic neuromas ~20% of diagnosed benign tumors) have combined incidence ~3-5 per 100k. Many benign tumors remain undiagnosed. Using conservative estimate of 4.0 per 100k for clinically diagnosed benign brain tumors. Specificity limited by 'unspecified' classification.",low,,
C0497391,Atopic Eczema/Dermatitis,180.0,15000,both,0.7,strong,Dermatological epidemiology studies and health surveys,,literature,False,,"Common chronic inflammatory skin condition with dual metrics: prevalence ~15% of global population (15,000 per 100k) and annual incidence of new diagnoses ~180 per 100k. Both metrics widely reported in dermatological epidemiology literature.",moderate,,
C0520998,Accommodation Phosphene Disorder,,,,0.0,none,,,,False,,"This CUI term is not a well-established disease entity in standard medical nomenclature. It may refer to a vision phenomenon (phosphenes during accommodation), but lacks clear epidemiological definition and diagnostic criteria. Term too vague and non-standard for meaningful incidence estimation.",unknown,,
C0014067,Occipital Encephalocele,1.5,,incidence,0.55,moderate,"Agthong S, Wiwanitkit V. (2002). Encephalocele: a review of 102 cases. J Clin Neurosci. 9(6):716-8",https://pubmed.ncbi.nlm.nih.gov/12604290/,literature,True,Encephalocele,"Occipital encephaloceles represent ~70-80% of encephaloceles in Western populations. Total encephalocele incidence ~1-3 per 10,000 births. Estimated ~1.5 per 100k births for occipital subtype specifically. Moderate confidence due to geographic variation and limited population-based registries.",high,,
C0014070,Encephalomyelitis,0.8,,incidence,0.45,weak,,,estimate,False,,"Encephalomyelitis encompasses multiple etiologies (viral, post-infectious ADEM, autoimmune). ADEM incidence ~0.4-0.8 per 100k; viral encephalomyelitis varies widely. Estimated ~0.8 per 100k combining major forms. Limited by heterogeneous definition and underreporting.",moderate,,
C0524582,Mulibrey Nanism,extremely rare,,incidence,0.35,weak,,,,False,,"Mulibrey nanism is a rare autosomal recessive genetic disorder (Muscle-Liver-Brain-Eye nanism). Fewer than 100 cases reported worldwide, primarily in Finnish and other Northern European populations. Estimated incidence <0.01 per 100k births.",high,,
C0524662,Opiate Addiction,,12,prevalence,0.65,moderate,,,,True,Substance use disorders,Opioid use disorder/addiction measured as prevalence (current cases) rather than incidence. Global prevalence estimated at ~10-15 per 100k based on epidemiological surveys. Using 12 per 100k as global average. High variation by region (2-40 per 100k depending on country).,high,,
C0543699,ASA intolerant asthma,,140,prevalence,0.55,moderate,Rajan JP et al. (2015). Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. J Allergy Clin Immunol. 135(3):676-81,https://pubmed.ncbi.nlm.nih.gov/25282015/,literature,True,Asthma,"Aspirin-exacerbated respiratory disease (AERD) affects ~7% of asthmatic adults globally. With adult asthma prevalence ~2000 per 100k, AERD prevalence ~140 per 100k. Prevalence used as condition is chronic; limited confidence due to diagnostic variability.",moderate,,
C0543859,"Amyotrophic Lateral Sclerosis, Guam Form",extremely rare,,incidence,0.45,moderate,"Steele JC, McGeer PL (2008). The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 70(21):1984-90",https://pubmed.ncbi.nlm.nih.gov/18490621/,literature,True,Amyotrophic Lateral Sclerosis,ALS-PDC (Parkinsonism-Dementia Complex) historically endemic to Guam and Western Pacific. Peak incidence in Guam was ~50-100 per 100k in 1950s but has declined dramatically to near-zero. Globally extremely rare (<0.01 per 100k). Historical epidemiological documentation is strong but current global incidence is negligible.,high,,
C0014145,Yolk Sac Tumor,0.15,,incidence,0.62,moderate,,,registry,True,Germ Cell Tumors,"Yolk sac tumor (endodermal sinus tumor) incidence ~0.15 per 100k, most common in children under 3 years (testicular/ovarian) and young adults. Part of germ cell tumor spectrum. Data from pediatric cancer registries.",low,,
C0549523,Oropharynx (excludes nasopharynx),,,,0.0,none,,,,False,,"This is an anatomical structure, not a disease entity. Cannot map incidence/prevalence for anatomical regions. If referring to oropharyngeal cancer, that would be a separate CUI (C0751690).",unknown,,
C0553694,Oropharyngeal disorders,,,,0.0,none,,,,False,,"Umbrella term too heterogeneous to estimate meaningfully. Encompasses infections, inflammatory conditions, cancers, trauma, and structural abnormalities with vastly different incidence rates and clinical significance.",unknown,,
C0554985,Aggressive outburst,,,,0.0,none,,,,False,,"Aggressive outburst is a behavioral symptom that occurs across numerous psychiatric, neurological, and developmental conditions. Not a distinct disease entity and cannot be meaningfully mapped to a specific incidence rate.",unknown,,
C0558353,Tongue Carcinoma,2.5,,incidence,0.75,strong,GLOBOCAN 2005 (IARC) - Oral cavity and pharynx cancer subsites,https://gco.iarc.fr/,registry,True,Oral Cavity Cancer,"Tongue cancer is the most common oral cavity cancer subsite. Global incidence ~2-3 per 100k from cancer registry data, with higher rates in South Asia due to tobacco/betel quid use.",high,,
C0578159,Antibiotic-associated diarrhea,2500,,incidence,0.7,moderate,Bartlett JG. (2002). Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 346(5):334-339,https://pubmed.ncbi.nlm.nih.gov/11821511/,literature,False,,"Common complication of antibiotic therapy. Incidence ~5-25% of antibiotic recipients. Estimated ~2,500 per 100k general population annually (25% of ~10,000 per 100k receiving antibiotics).",high,,
C0014356,Enterocolitis,12000,,incidence,0.35,weak,,,,False,,"Aggregate BOTEC estimate: Enterocolitis encompasses infectious and inflammatory causes. Estimated components: viral gastroenteritis (~5000), bacterial enterocolitis (~300), parasitic (~500), inflammatory (~2000), necrotizing enterocolitis in neonates (~200), other (~4000) = ~12,000 per 100k. Heterogeneous umbrella term.",high,,
C0581384,Chronic anemia,,8500,prevalence,0.48,weak,,,,False,,"Umbrella term covering chronic anemias: iron deficiency anemia (most common ~5000 per 100k), hemolytic anemia, aplastic anemia, anemia of chronic disease. Aggregate prevalence ~8500 per 100k globally. Reported as prevalence since these are chronic persistent conditions, not acute events.",high,,
C0582415,Acute asthma,8500,,incidence,0.45,moderate,,,,True,Asthma,"Acute asthma exacerbations are common clinical events. Estimated ~8.5% of population experiences acute asthma episodes annually (~8,500 per 100k) based on emergency department visits and hospital admissions from multiple studies, though definition of 'acute episode' varies. Confidence moderate due to variability in how acute exacerbations are counted across populations.",high,,
C0589110,Postoperative Deep Vein Thrombosis,150.0,,incidence,0.6,moderate,Surgical complication registries and thromboembolism epidemiology,,registry,True,Deep Vein Thrombosis,"Post-surgical venous thromboembolism complication with incidence ~1-2% of major surgical procedures, translating to ~150 per 100k of surgical population. Estimated from surgical complication registries and VTE epidemiology studies.",high,,
C0595948,Atypical absence seizure,1.8,,incidence,0.58,moderate,Covanis A. (2005). Childhood and juvenile absence epilepsy: an update. Current Opinion in Neurology. 18(2):135-140,https://pubmed.ncbi.nlm.nih.gov/15791145/,literature,True,Absence Seizure,"Atypical absence seizures are a subtype of generalized onset seizures, typically in Lennox-Gastaut syndrome. Incidence estimated at 1-2 per 100k in pediatric populations. Rarer than typical childhood absence seizures. Used incidence as metric for acute seizure onset events.",low,,
C0014458,"Eosinophilia, Tropical",15.0,,incidence,0.5,moderate,WHO World Health Organization Parasitic Diseases Program,,registry,False,,"Tropical eosinophilia typically refers to parasitic-induced eosinophilia endemic to tropical/subtropical regions (strongyloidiasis, filariasis, hookworm). Global incidence estimated at ~15 per 100k based on WHO parasitic infection data, but highly geography-dependent. Incidence ranges from <1 per 100k in non-endemic areas to 50-100+ per 100k in endemic regions.",high,,
C0598608,Hyperhomocysteinemia,,500,prevalence,0.5,moderate,,,,False,,"Hyperhomocysteinemia (elevated homocysteine) is measured as prevalence, not incidence. Estimated ~0.5% prevalence (500 per 100k) for moderate elevations. Higher in elderly and those with folate/B12 deficiency.",moderate,,
C0598798,Lymphoid neoplasm,25.0,,incidence,0.28,weak,,,estimate,False,Hematologic Malignancy,"Aggregate BOTEC estimate summing major lymphoid cancers: Non-Hodgkin lymphoma (~12), Hodgkin lymphoma (~2.5), chronic lymphocytic leukemia (~4.5), acute lymphoblastic leukemia (~1.5), multiple myeloma (~4.5) = ~25 per 100k. Low confidence due to heterogeneity of included neoplasms.",moderate,,
C0600104,Obsessive compulsive behavior,,15000,prevalence,0.76,strong,"Kessler RC et al. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62(6):617-627",https://pubmed.ncbi.nlm.nih.gov/15939839/,literature,False,,"Obsessive-compulsive behaviors/OCD is a chronic mental health condition reported via prevalence. Global prevalence estimates range 1-2% of population (~15,000 per 100k). Data from psychiatric epidemiology studies and DSM-based population surveys.",moderate,,
C0600327,Toxic Shock Syndrome,0.25,,incidence,0.58,moderate,,,,False,,"Toxic Shock Syndrome is a rare, acute life-threatening infection caused by toxin-producing Staphylococcus aureus or Streptococcus pyogenes. CDC surveillance indicates incidence approximately 0.2-0.3 per 100k person-years in developed countries, lower in resource-limited settings. Peak incidence in 1980s with tampon-associated cases; rates declined significantly after.",moderate,,
C0600427,Cocaine Dependence,,400,prevalence,0.65,moderate,WHO World Drug Report 2005,https://www.unodc.org/,registry,True,Substance Use Disorder,"Cocaine dependence better measured as prevalence than incidence. WHO 2005 data estimates approximately 0.4% of global adults (400 per 100k) with cocaine dependence, though data quality varies significantly by region.",high,,
C0677055,CARCINOMA OF VULVA,1.2,,incidence,0.78,strong,"Jemal A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin. 55(1):10-30",https://pubmed.ncbi.nlm.nih.gov/15291684/,literature,True,Gynecologic Cancer,Vulvar carcinoma is a relatively rare gynecologic cancer. Global incidence ~1.2 per 100k women based on cancer registry data circa 2005. Primarily affects older women.,moderate,,
C0677483,Carcinoma testes,6.2,,incidence,0.92,strong,Znaor A et al. (2022). Global patterns in testicular cancer incidence and mortality in 2020. International Journal of Cancer. 151(5):719-729,https://pubmed.ncbi.nlm.nih.gov/35277970/,literature,True,Testicular Cancer,"Testicular cancer is a well-documented malignancy with global incidence of 6.2 per 100,000 men (US data 2021). Incidence varies geographically from <2 in Asia/Africa to >8 in Northern Europe. Using standardized US rate from SEER.",high,,
C0677608,Chorioangioma,50,,incidence,0.5,moderate,Benirschke K. (2000). Pathology of the Human Placenta. Springer-Verlag,,literature,True,Placental tumor,Chorioangioma (placental hemangioma) occurs in approximately 0.6-1% of placentas (~50-100 per 100k pregnancies). Rare benign vascular placental tumor.,low,,
C0677936,Refractory cancer,,,,0.0,none,,,,False,,"Unmappable: 'Refractory' is a treatment response descriptor, not a disease entity. Refers to cancers resistant to therapy across all cancer types - too heterogeneous to provide meaningful incidence estimate.",unknown,,
C0677949,Stage III Colorectal Cancer,6.5,,incidence,0.72,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Colorectal Cancer,"Stage III represents ~25-30% of CRC cases at diagnosis. Global CRC incidence ~22 per 100k (GLOBOCAN 2005), thus Stage III incidence ~6.5 per 100k. Moderate confidence due to staging distribution variability across regions.",moderate,,
C0677950,Stage IV Colorectal Cancer,5.0,,incidence,0.65,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Colorectal Cancer,"Stage IV (metastatic) CRC represents approximately 20-25% of all CRC cases at diagnosis. Global CRC incidence ~20 per 100k (GLOBOCAN 2005), estimated Stage IV at ~5 per 100k. Moderate confidence due to stage-specific estimation.",moderate,,
C0683322,Mental impairment,15000,,incidence,0.28,weak,,,,False,,"Aggregate BOTEC estimate summing major categories of mental impairment: intellectual disability (~1.5% prevalence = 15000 per 100k), developmental disabilities, and significant cognitive impairment from neurological causes. Heterogeneous umbrella term with significant overlap between categories and uncertain boundaries.",high,,
C0683381,Inflammatory joint disease,25.0,,incidence,0.35,weak,,,,False,,"Aggregate BOTEC estimate summing major inflammatory joint diseases: rheumatoid arthritis (~5-10), seronegative spondyloarthropathies (~8-12), other inflammatory arthritides (~5-8). Total estimated ~25 per 100k. Low confidence due to heterogeneity and overlap between conditions.",high,,
C0014549,Tonic-Clonic Epilepsy,12.5,,incidence,0.78,strong,Sander JW. (2003). The epidemiology of epilepsy revisited. Curr Opin Neurol. 16(2):165-170,https://pubmed.ncbi.nlm.nih.gov/12644746/,literature,False,,"Tonic-clonic seizures are the most common seizure type in epilepsy. Global incidence approximately 10-15 per 100k person-years, with significant geographic variation. Well-established seizure classification with clear clinical definition.",moderate,,
C0687720,Central Diabetes Insipidus,1.2,3.5,both,0.48,weak,,,,True,Diabetes Insipidus,"Central diabetes insipidus is a rare endocrine disorder resulting from inadequate antidiuretic hormone (ADH) production. Incidence estimated at 1.2 per 100k, prevalence at 3.5 per 100k. Limited epidemiological data; confidence reduced due to sparse registry information and high misdiagnosis rates.",unknown,,
C0687751,Acanthocytosis,extremely rare,,incidence,0.35,weak,,,,False,,Acanthocytosis represents a rare morphologic finding (spiculated RBCs) associated with multiple rare conditions. <0.1 per 100k based on case reports of primary acanthocytosis syndromes.,unknown,,
C0699889,Malignant Female Reproductive System Neoplasm,26.5,,incidence,0.55,moderate,GLOBOCAN 2005 (IARC) - aggregated female reproductive malignancies,https://gco.iarc.fr/,registry,False,,"Aggregate BOTEC estimate summing major female reproductive system malignancies: cervical cancer (~13 per 100k globally, high variation), ovarian cancer (~8 per 100k), uterine cancer (~3 per 100k), vaginal/vulvar cancer (~1.5 per 100k) = ~25.5 per 100k. Marked geographic variation, particularly for cervical cancer (higher in developing nations due to HPV prevalence and screening differences). Low-moderate confidence due to heterogeneous subcategories and overlap potential.",high,,
C0700345,"Candidiasis, Vulvovaginal",6000,,incidence,0.55,moderate,Sobel JD. (1997). Vaginitis. N Engl J Med. 337:1896-1903,https://pubmed.ncbi.nlm.nih.gov/9407158/,literature,True,Candidiasis,Vulvovaginal candidiasis incidence estimated at ~6000 per 100k women per year (affects ~75% of women at least once in lifetime). Limited population surveillance; mostly clinic-based studies. Per 100k calculated for total population.,moderate,,
C0700367,Ependymoblastoma,extremely rare,,incidence,0.26,weak,,,,True,Pediatric Brain Neoplasm,"Ependymoblastoma is an extremely rare, highly aggressive malignant tumor of the ependymal cells, almost exclusively occurring in children under 5 years. Estimated <0.01 per 100k based on limited case series in pediatric oncology literature.",unknown,,
C0700636,Focal nodular hyperplasia of liver,,15000,prevalence,0.6,moderate,"Imaging-based prevalence studies of hepatic lesions, multiple radiology literature",,literature,False,,"FNH is a benign hepatic lesion found in 0.5-2% of imaged livers. Reported as prevalence in imaging studies (~1-1.5% = 10,000-15,000 per 100k of population with imaging). Well-defined specific lesion, but incidence varies based on imaging frequency.",moderate,,
C0729531,Viral respiratory infection,50000,,incidence,0.35,weak,,,,False,,"Aggregate BOTEC estimate summing major viral respiratory infections: common cold (~45,000 per 100k), influenza (~5,000 per 100k), RSV (~3,000 per 100k), parainfluenza (~2,000 per 100k) with substantial overlap = ~50,000+ per 100k. Umbrella term with high heterogeneity and population overlap; confidence limited by lack of unified epidemiological source.",moderate,,
C0730285,Diabetic macular edema,22.3,28000,both,0.78,strong,Congdon NG et al. (2003). Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 121(12):1017-1023,https://pubmed.ncbi.nlm.nih.gov/14557107/,literature,True,Diabetic Retinopathy,"Diabetic macular edema (DME) is a major cause of vision loss in type 2 diabetes. Prevalence approximately 28,000 per 100k among diabetic populations (2.8% of all diabetics). Annual incidence of clinically significant DME approximately 22.3 per 100k among those with diabetic retinopathy.",moderate,,
C0014740,Erythema Chronicum Migrans,8.0,,incidence,0.68,moderate,CDC Lyme Disease Surveillance (2005),https://www.cdc.gov/lyme/stats/,registry,True,Lyme Disease,"Erythema migrans is the characteristic rash of early Lyme disease. Using Lyme disease incidence as proxy: ~8 per 100k globally (2005 estimate), though varies dramatically by region (<0.1 in non-endemic areas to >100 per 100k in hyperendemic regions of northeastern US and central Europe).",high,,
C0733682,"Hypophosphatemic Rickets, X-Linked Dominant",0.5,,incidence,0.7,moderate,Carpenter TO. (2011). The Expanding Family of Hypophosphatemic Syndromes. J Bone Miner Metab. 29(1):1-9,https://pubmed.ncbi.nlm.nih.gov/20972641/,literature,True,Hypophosphatemic Rickets,"X-linked hypophosphatemic rickets (XLH) is the most common form of inherited rickets with incidence ~1 in 20,000 births. Global population ~8 billion, ~100 million births annually yields ~5,000 cases per year. Estimated at ~0.5 per 100k population.",low,,
C0014742,Erythema Multiforme,0.24,,incidence,0.62,moderate,Lamoreux MR et al. (2003). Erythema multiforme. American Family Physician. 68(1):87-94,https://pubmed.ncbi.nlm.nih.gov/12887112/,literature,False,,"Acute inflammatory skin condition with incidence estimated at 0.24-0.6 per 100k globally (1-6 cases per million). Triggered by infections (HSV, streptococcal) or medications. Geographic variation significant due to infection prevalence.",moderate,,
C0740345,Germ Cell Cancer,4.5,,incidence,0.58,moderate,,,,False,,"Germ cell cancer includes testicular cancer (most common, ~5-6 per 100k in males aged 15-40) and ovarian germ cell tumors (rare). Global aggregate estimate ~4.5 per 100k accounting for sex-specific incidence distribution. Heterogeneous across geographic regions.",moderate,,
C0740391,Middle Cerebral Artery Occlusion,28.0,,incidence,0.78,strong,WHO Global Burden of Disease Study 2005,https://www.who.int/,registry,True,Stroke,"MCA occlusion represents approximately 20-30% of all ischemic strokes. With global stroke incidence around 140 per 100k, MCAO incidence is estimated at 28 per 100k based on WHO stroke registries and epidemiological data.",moderate,,
C0002152,Alloxan Diabetes,,,,0.0,none,,,,False,,"Experimental research model, not a natural human disease. Alloxan is a chemical used to induce diabetes in laboratory animals for research purposes. No human epidemiological data exists as this is not a naturally-occurring condition in humans.",unknown,,
C0014804,Erythromelalgia,extremely rare,,incidence,0.35,weak,Drenth JP et al. (2007). Erythromelalgia: A review. Orphanet Journal of Rare Diseases. 2:20,https://pubmed.ncbi.nlm.nih.gov/17456235/,literature,False,,Rare paroxysmal condition characterized by burning erythema in extremities. Primary erythromelalgia estimated <0.1 per 100k incidence; secondary forms associated with myeloproliferative disorders more frequent but still rare.,unknown,,
C0741682,Premenopausal breast cancer,15.2,,incidence,0.78,moderate,"GLOBOCAN 2005, WHO (IARC)",https://gco.iarc.fr/,registry,True,Breast Cancer,"Premenopausal breast cancer incidence estimated at ~15 per 100k women (age <50), representing approximately 20-25% of total breast cancer cases. Based on global breast cancer incidence ~60-70 per 100k women from GLOBOCAN 2005. Age-stratified subset analysis.",high,,
C0742343,Acute Chest Syndrome,0.15,,incidence,0.55,moderate,Vichinsky EP et al. (2000). Acute chest syndrome in sickle cell disease: clinical presentation and course. Blood. 89(5):1787-1792,https://pubmed.ncbi.nlm.nih.gov/9057664/,literature,False,Sickle Cell Disease Complication,"ACS occurs in ~30% of sickle cell patients over lifetime. With global SCD prevalence ~1.5 per 100k and annual ACS rate of ~10% in SCD patients, estimated general population incidence ~0.15 per 100k. Confidence moderate due to geographic variation in SCD prevalence.",high,,
C0745091,Hypereosinophilia,2.5,,incidence,0.5,moderate,,,,False,,Hypereosinophilia (elevated eosinophil counts >1500/L) incidence estimated at ~2.5 per 100k based on hematology epidemiology. Can be primary (idiopathic hypereosinophilic syndrome) or secondary to parasitic/allergic/malignant causes. Moderate confidence due to variability in definitions and underlying etiologies.,high,,
C0746316,lymph node infected,150,,incidence,0.45,weak,,,,False,,"Acute lymphadenitis is common but poorly tracked in registries. Estimated ~150 per 100k based on primary care presentation rates, but lacks systematic epidemiological surveillance. Confidence limited by absence of verifiable source.",moderate,,
C0746402,manic symptom,,,,0.15,none,,,,False,,"Manic symptom is a psychiatric symptom or sign, not a disease entity itself. Manic episodes occur in bipolar disorder and other psychiatric conditions, but cannot be meaningfully isolated for independent incidence/prevalence estimation. Concept coherence is low - symptom manifestations vary across multiple underlying disease states.",unknown,,
C0748061,psychiatric hospitalization,,,,0.0,none,,,,False,,Not a disease entity but a healthcare service/event. Unmappable as it represents utilization of psychiatric inpatient services rather than a medical condition with epidemiological incidence.,unknown,,
C0014868,Esophagitis,5.0,,incidence,0.55,moderate,,,estimate,False,,"Esophagitis (all causes: reflux, infectious, eosinophilic) estimated at ~5 per 100k person-years for clinically diagnosed cases. True incidence likely higher due to underdiagnosis. Moderate confidence due to heterogeneous etiology and variable reporting.",moderate,,
C0749424,Thyroid Hurthle Cell Carcinoma,0.25,,incidence,0.68,strong,GLOBOCAN 2005 (IARC) with Hurthle cell proportion from SEER database,https://gco.iarc.fr/,registry,True,Thyroid Carcinoma,"Hurthle cell carcinoma comprises ~3-5% of thyroid cancers. Global thyroid cancer incidence ~5-7 per 100k (GLOBOCAN 2005), yielding Hurthle cell incidence ~0.25 per 100k. Based on SEER and cancer registry data.",low,,
C0750887,Adrenal Cancer,0.8,,incidence,0.65,moderate,,,,True,Endocrine Neoplasm,"Adrenal cancer (adrenocortical carcinoma) is a rare malignancy with estimated incidence ~0.7-0.9 per 100k globally based on cancer registry data. Approximately 4,200-4,700 new cases reported annually worldwide. Clinical presentation typically involves functional hormone excess (cortisol, aldosterone, androgens). Geographic variation relatively low compared to other rare cancers.",low,,
C0015300,Exophthalmos,16.0,,incidence,0.55,moderate,"Bartley GB et al. (1995). The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans Am Ophthalmol Soc. 93:477-588",https://pubmed.ncbi.nlm.nih.gov/8719692/,literature,False,,"Exophthalmos is a clinical sign, most commonly from thyroid eye disease. Using thyroid eye disease incidence (~16 per 100k) as proxy. Confidence reduced because exophthalmos is a sign with multiple etiologies, not a disease entity itself.",moderate,,
C0750951,Lenticulostriate Disorders,,,,0.0,none,,,,False,,"Lenticulostriate disorders is an anatomical descriptor referring to disorders affecting the lenticulostriate nuclei (part of the basal ganglia), rather than a specific disease entity. This umbrella term is too heterogeneous and poorly defined to estimate meaningfully. Would require specification of disorder type (e.g., Huntington's disease affecting lenticular nuclei, hypertensive putaminal hemorrhage, etc.).",unknown,,
C0750974,"Brain Tumor, Primary",15.0,,incidence,0.58,weak,Composite estimate from GLOBOCAN and national cancer registries,https://gco.iarc.fr/,registry,False,,"Broad umbrella term encompassing all primary brain tumors (benign and malignant). Aggregate estimate derived from summing major categories: meningioma (~6-7 per 100k), glioma (~3-4 per 100k), pituitary adenoma (~2-3 per 100k), and other primary CNS neoplasms (~2-3 per 100k) = ~13-17 per 100k globally. Confidence reduced due to significant heterogeneity and variability in epidemiological data between tumor types.",high,,
C0750977,Recurrent Brain Neoplasm,,,,0.2,none,,,,False,,Status descriptor indicating recurrence/relapse of a previously diagnosed brain tumor rather than a distinct disease entity. Incidence cannot be meaningfully estimated without specifying the primary tumor type. This represents a clinical state among existing brain cancer patients rather than a new disease diagnosis.,unknown,,
C0750979,Primary malignant neoplasm of brain,8.5,,incidence,0.72,moderate,"GLOBOCAN (IARC), WHO Global Burden of Disease reports",https://gco.iarc.fr/,registry,False,,"Aggregate estimate for primary malignant brain tumors including gliomas (glioblastoma, astrocytoma), medulloblastoma, and other malignant CNS neoplasms. Global incidence approximately 8-9 per 100k annually from GLOBOCAN and WHO data. Moderate confidence due to heterogeneity of included malignancies.",moderate,,
C0015302,External exostoses,2.0,,incidence,0.55,moderate,,,,True,Bone exostosis,"Benign bone outgrowths (osteochondromas). Estimated incidence ~2 per 100k based on orthopedic registry data, though many cases remain asymptomatic and undiagnosed.",moderate,,
C0751050,"Communication Disorders, Developmental",,8000,prevalence,0.3,weak,,,,False,,"Umbrella term covering multiple developmental communication disorders (language disorders, speech sound disorders, stuttering, social communication disorders). Aggregate prevalence estimate of 5-10% of children (5,000-10,000 per 100k), using 8,000 per 100k as midpoint. Low confidence due to heterogeneity, overlapping diagnoses, and variable diagnostic criteria across studies.",moderate,,
C0751071,Familial Dementia,2.5,,incidence,0.55,moderate,Estimated from dementia incidence data and familial proportion (5-10%) from genetic dementia literature,,estimate,True,Dementia,Familial dementia accounts for approximately 5-10% of all dementias. Estimated incidence of ~2.5 per 100k based on proportion of familial cases among all dementia incidence rates (~30-40 per 100k globally). Limited specific epidemiological data; confidence capped at 0.55 due to reliance on proportional estimates.,high,,
C0751081,"Trisomy 21, Mitotic Nondisjunction",extremely rare,0.5,prevalence,0.6,moderate,"Down Syndrome: Health Issues Across the Lifespan (2007), National Institutes of Health",,literature,True,Down Syndrome,"Mitotic nondisjunction accounts for 1-3% of Down syndrome cases, with prevalence <1 per 100k. Unlike meiotic nondisjunction (which occurs at meiosis during gametogenesis), mitotic nondisjunction occurs post-zygotically, making it extremely rare.",low,,
C0751117,Cryptogenic Tonic-Clonic Epilepsy,3.8,,incidence,0.52,moderate,"Annegers JF, Hauser WA, Lee JR, Rocca WA. (1995). Incidence of unprovoked seizures and nonfebrile seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 36(4):327-333",https://pubmed.ncbi.nlm.nih.gov/7750966/,literature,True,Tonic-Clonic Epilepsy,"Cryptogenic tonic-clonic epilepsy has no identifiable etiology despite investigation. Represents intermediate category between idiopathic and symptomatic forms. Estimated incidence 3-5 per 100k person-years, though exact prevalence varies by classification system used.",moderate,,
C0751118,"Epilepsy, Tonic-Clonic, Familial",2.5,,incidence,0.5,moderate,"Scheffer IE, Berkovic SF. (1997). Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain. 120(3):479-490",https://pubmed.ncbi.nlm.nih.gov/9126058/,literature,True,Tonic-Clonic Epilepsy,Familial (genetic) forms of tonic-clonic epilepsy account for 10-20% of all tonic-clonic epilepsy cases. Incidence estimated at 2-3 per 100k person-years. Heterogeneous genetic mechanisms with variable penetrance and expression.,low,,
C0751119,"Epilepsy, Tonic-Clonic, Symptomatic",4.2,,incidence,0.58,moderate,"Commission on Classification and Terminology, International League Against Epilepsy. (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 30(4):389-399",https://pubmed.ncbi.nlm.nih.gov/2502382/,literature,True,Tonic-Clonic Epilepsy,"Symptomatic (secondary) tonic-clonic epilepsy represents 30-40% of tonic-clonic epilepsy cases, incidence approximately 3-5 per 100k person-years. Caused by underlying brain lesion or neurological condition. Less common than idiopathic form.",moderate,,
C0015397,Disorder of eye,,,,0.0,none,,,,False,,Unmappable umbrella term encompassing all eye disorders from refractive errors to infections to degenerative diseases. Too broad and heterogeneous to estimate meaningfully - would require specification of particular eye condition.,unknown,,
C0751197,Fulminant Hepatic Failure with Cerebral Edema,0.05,,incidence,0.55,moderate,,,,True,Fulminant Hepatic Failure,"Fulminant hepatic failure is rare (~1-6 per million globally, 0.01-0.06 per 100k). Cerebral edema occurs in 80% of grade III-IV encephalopathy cases. Estimated 0.05 per 100k based on severe acute liver failure epidemiology with progression to cerebral complications.",high,,
C0751198,Hepatic Stupor,1.5,,incidence,0.48,weak,,,,True,Hepatic Encephalopathy,"Hepatic stupor is Grade 3 hepatic encephalopathy, intermediate severity. Estimated at ~1.5 per 100k based on clinical series. Overlaps with coma presentation.",high,,
C0751334,Progressive Proximal Myelopathic Muscular Atrophy,extremely rare,,,0.25,weak,,,,True,Motor Neuron Disease,Extremely rare variant of motor neuron disease with very limited case reports. Estimated <0.01 per 100k based on case frequency in literature.,unknown,,
C0751335,Scapuloperoneal Form of Spinal Muscular Atrophy,extremely rare,,,0.3,weak,,,,True,Spinal Muscular Atrophy,"Very rare scapuloperoneal variant of SMA. Extremely limited epidemiological data, estimated <0.1 per 100k based on case reports.",unknown,,
C0751356,Idiopathic Inflammatory Myopathies,3.5,,incidence,0.65,moderate,"Dalakas MC. (2006). Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 355:1858-1869",https://pubmed.ncbi.nlm.nih.gov/17079762/,literature,False,,"Incidence of autoimmune myopathies (polymyositis, dermatomyositis, inclusion body myositis) estimated at ~3-4 per 100k person-years from epidemiological studies. Moderate confidence due to heterogeneous category and limited large cohort studies.",moderate,,
C0751383,Juvenile Neuronal Ceroid Lipofuscinosis,extremely rare,,incidence,0.45,moderate,"Mole SE et al. (2005). Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics. 6(3):107-126",https://pubmed.ncbi.nlm.nih.gov/15965709/,literature,True,Neuronal Ceroid Lipofuscinosis,"Juvenile NCL (Batten disease) incidence ~1-9 per 1,000,000 births (<0.02 per 100k person-years). Rare lysosomal storage disorder with regional variation. Data from disease registries and genetic studies.",moderate,,
C0751414,"Parkinson Disease, Secondary Vascular",0.3,,incidence,0.65,moderate,"de Lau LM, Breteler MM. (2006). Epidemiology of Parkinson's disease. Lancet Neurol. 5(6):525-535",https://pubmed.ncbi.nlm.nih.gov/16713924/,literature,True,Parkinson Disease,Secondary vascular parkinsonism represents approximately 5-10% of parkinsonian syndromes. Estimated incidence of 0.3 per 100k derived from proportion of total Parkinson incidence (~3 per 100k).,low,,
C0751415,Atherosclerotic Parkinsonism,0.2,,incidence,0.4,weak,,,,True,Parkinson Disease,Atherosclerotic parkinsonism is a rare subtype of vascular parkinsonism. Limited systematic epidemiological data available; estimated at less than 0.5 per 100k based primarily on case series frequency.,unknown,,
C0751434,Classical phenylketonuria,6.0,,incidence,0.85,strong,van Spronsen FJ et al. (2017). Phenylketonuria. Nat Rev Dis Primers. 3:17088,https://pubmed.ncbi.nlm.nih.gov/29219151/,literature,True,Phenylketonuria,"Classical PKU (most severe form) incidence ~1 in 12,000-15,000 births based on newborn screening programs. Well-documented from global screening data at ~6 per 100k births.",high,,
C0751484,Sporadic Retinoblastoma,0.7,,incidence,0.72,moderate,Kivela T. (2009). The epidemiological challenge of the most frequent eye cancer. Br J Ophthalmol. 93(9):1129-1131,https://pubmed.ncbi.nlm.nih.gov/19704049/,literature,True,Retinoblastoma,"Retinoblastoma incidence approximately 0.7 per 100k person-years globally. Sporadic form represents ~60% of cases. Data from GLOBOCAN and pediatric oncology registries, though 2005-specific data limited.",moderate,,
C0751559,Pulsatile Tinnitus,0.1,,incidence,0.4,weak,,,,True,Tinnitus,"Pulsatile tinnitus is a rare subtype of tinnitus, representing <1% of tinnitus cases. Estimated at approximately 0.1 per 100k based on otolaryngology literature, though exact incidence is poorly characterized.",low,,
C0015469,Facial paralysis,25.0,,incidence,0.65,moderate,,,estimate,False,,"Umbrella term including Bell's palsy (~20 per 100k), traumatic facial nerve injury (~3 per 100k), tumor-related (~1 per 100k), and other causes. Estimated aggregate ~25 per 100k. Lower confidence due to heterogeneous etiologies.",moderate,,
C0751620,"Central Nervous System Neoplasms, Primary",7.2,,incidence,0.72,moderate,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,False,,"Umbrella term for primary CNS tumors including gliomas (glioblastoma, astrocytoma), meningiomas, pituitary adenomas, and medulloblastomas. Global incidence ~7 per 100k. Confidence reflects moderate heterogeneity within category.",moderate,,
C0751651,Mitochondrial Diseases,1.5,8.0,both,0.55,moderate,Wolf NI et al. (2009). Mitochondrial disorders: A practical approach for primary care physicians. J Clin Neurol. 5(4):198-211,https://pubmed.ncbi.nlm.nih.gov/20073763/,literature,False,,"Mitochondrial diseases are heterogeneous group of genetic disorders affecting mitochondrial function. Incidence ~1.5 per 100k (new diagnoses), prevalence ~8 per 100k. Aggregate BOTEC estimate from major subtypes: MELAS, MERRF, Leigh syndrome, and others.",moderate,,
C0751675,Cerebral Primitive Neuroectodermal Tumor,0.15,,incidence,0.65,moderate,Estimated from pediatric cancer registries and WHO reports on CNS neoplasms,,registry,True,Primitive Neuroectodermal Tumor (PNET),Rare pediatric CNS malignancy representing 2-3% of pediatric brain tumors. Incidence approximately 0.15 per 100k children/year globally. Limited epidemiological data; estimate based on pediatric cancer registry studies and WHO classifications.,low,,
C0751733,"Degenerative Diseases, Spinal Cord",4.5,,incidence,0.28,weak,,,estimate,False,,"Aggregate BOTEC estimate summing major spinal degenerative conditions: ALS (~2), Spinal Muscular Atrophy (~1.5), Hereditary Spastic Paraplegia (~0.5), Primary Lateral Sclerosis (~0.2), other spinal degenerative conditions (~0.3). Total ~4.5 per 100k. Low confidence due to umbrella nature and composite estimation.",moderate,,
C0751783,Lafora Disease,0.1,,incidence,0.45,weak,,,,True,Progressive Myoclonus Epilepsy,Lafora disease is a rare autosomal recessive progressive myoclonus epilepsy. Estimated incidence ~0.1-1 per 1 million globally. Converted to 0.1 per 100k. Limited epidemiological data; estimate based on case registries and genetic studies of progressive myoclonus epilepsies.,high,,
C0751964,"Multiple Sclerosis, Primary Progressive",0.25,,incidence,0.75,strong,"Miller DH, Leary SM. (2007). Primary-progressive multiple sclerosis. Lancet Neurol. 6(10):903-912",https://pubmed.ncbi.nlm.nih.gov/17884680/,literature,True,Multiple Sclerosis,"Primary progressive MS (PPMS) represents ~10-15% of all MS cases. Total MS incidence ~2.5 per 100k globally, so PPMS incidence ~0.25 per 100k based on epidemiological studies circa 2005.",moderate,,
C0752098,Autosomal Dominant Parkinsonism,0.3,1.5,both,0.55,moderate,Singleton AB et al. (2013). Genomewide association study for Parkinson disease. Arch Neurol. 70(7):857-863,https://pubmed.ncbi.nlm.nih.gov/23797316/,literature,True,Parkinson's Disease,"Autosomal dominant Parkinson's disease (primarily LRRK2 and other monogenic forms) represents 5-10% of all Parkinson's cases. With PD incidence ~15-20 per 100k, monogenic AD forms estimated at 0.3-0.5 per 100k. Prevalence estimated at 1-2 per 100k based on genetic screening studies.",moderate,,
C0752125,Spinocerebellar Ataxia Type 7,0.08,,incidence,0.55,weak,Klockgether T et al. (2019). Spinocerebellar ataxias. Nat Rev Dis Primers. 5(1):24,https://pubmed.ncbi.nlm.nih.gov/30760774/,literature,True,Spinocerebellar Ataxia,SCA7 is a rare autosomal dominant neurodegenerative disorder with incomplete penetrance and variable onset. Estimated incidence ~0.08 per 100k based on mutation frequency in SCA populations. Low confidence due to rarity and limited epidemiological studies.,unknown,,
C0752210,"Dyskinesias, Paroxysmal",0.2,,incidence,0.45,moderate,Bruno MK et al. (2004). Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia. Neurology. 63(12):2280-2284,https://pubmed.ncbi.nlm.nih.gov/15623687/,literature,True,Movement Disorders,"Paroxysmal dyskinesias are rare neurological disorders. Estimated incidence ~0.2 per 100k based on European registry data, but systematic epidemiological studies are limited.",unknown,,
C0752235,Lyme Neuroborreliosis,0.5,,incidence,0.55,moderate,Steere AC et al. Lyme borreliosis. Nat Rev Dis Primers. Based on CDC surveillance data,,literature,True,Lyme Disease,"Neurological manifestation of Lyme borreliosis occurring in ~10-15% of untreated Lyme disease cases. Global incidence estimated at 0.5 per 100k, with geographic variation based on Ixodes tick prevalence.",high,,
C0752308,"Hypoxia-Ischemia, Brain",3.5,,incidence,0.65,moderate,Kurinczuk JJ et al. (2010). Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev. 86(6):329-38,https://pubmed.ncbi.nlm.nih.gov/20554402/,literature,False,,"Reporting incidence of neonatal hypoxic-ischemic encephalopathy (HIE), the most common form. Global estimate ~2-3 per 1000 live births. With birth rate ~2000 per 100k population, incidence ~3.5 per 100k total population. Excludes adult hypoxic-ischemic brain injury from cardiac arrest/stroke.",high,,
C0795690,Congenital Omphalocele,1.2,,incidence,0.65,moderate,,,,False,,"Congenital abdominal wall defect affecting umbilical region. Incidence estimated ~1-2 per 10,000 births (0.01-0.02 per 100k live births annually, or ~1.2 per 100k person-years). Data from birth defect registries and hospital discharge data. Geographic variation exists with higher rates in some populations.",moderate,,
C0795878,Monosomy 22,extremely rare,,incidence,0.3,weak,,,,False,Chromosomal Abnormality,Complete monosomy 22 (loss of entire chromosome 22) is extremely rare and usually lethal in utero. Most reported cases are mosaic forms. Estimated <0.01 per 100k births based on case report frequency. Distinct from partial monosomy 22q (DiGeorge syndrome) which is more common.,unknown,,
C0015974,Periodic fever,1.2,,incidence,0.55,moderate,,,,False,,"Periodic fever covers multiple autoinflammatory syndromes (FMF, HIDS, TRAPS, others). Global incidence estimated at ~1.2 per 100k, but highly heterogeneous and underdiagnosed in many regions.",high,,
C0809983,Schizophrenia and related disorders,1.5,4000,both,0.75,strong,"Tandon R et al. (2009). Schizophrenia, ""just the facts"": what we know in 2008. Schizophr Res. 106(2-3):331-337",https://pubmed.ncbi.nlm.nih.gov/18938103/,literature,False,,"Schizophrenia spectrum disorders (schizophrenia, schizoaffective disorder, brief psychotic disorder) with incidence ~1-1.5 new cases per 100k annually. Prevalence ~0.4% (4,000 per 100k) accounting for chronicity. Reporting both metrics as literature provides both estimates.",low,,
C0810364,Cleft Lip with or without Cleft Palate,15.0,,incidence,0.82,strong,Mossey PA et al. (2009). Cleft lip and palate. Lancet. 374(9703):1773-1785,https://pubmed.ncbi.nlm.nih.gov/19747722/,literature,False,,"Common orofacial birth defect with global incidence of approximately 15 per 100k births (range 10-20). Strong epidemiological data from birth defect registries worldwide, though significant geographic and ethnic variation exists.",high,,
C0813142,Circadian Rhythm Disorders,,2800,prevalence,0.45,weak,,,,False,,"Umbrella term encompassing delayed sleep phase disorder, advanced sleep phase disorder, non-24-hour sleep-wake disorder, shift work sleep disorder, and irregular sleep-wake rhythm. Aggregate prevalence estimate ~2.8% of population (~2800 per 100k) from combined sleep medicine studies.",moderate,,
C0851887,Adenoviral infections,250,,incidence,0.45,moderate,,,,False,,"Adenoviruses cause respiratory and gastrointestinal infections with variable clinical severity. Estimated incidence ~250 per 100k based on symptomatic cases detected in surveillance systems, but actual incidence likely higher due to underreporting of mild cases and asymptomatic infection.",high,,
C0852336,Immune Hemolytic Anemia,3.0,13.5,both,0.82,strong,"Peffault de Latour R et al. (2024). Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 20162023. PLOS One. 19(3):e0323843",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0323843,literature,False,,"Autoimmune hemolytic anemia (warm antibody type most common) shows incidence of 1-3 per 100,000 person-years and prevalence of 6-21 per 100,000. Recent US multi-database analysis (2016-2023) reported incidence of 1.4-6.6 per 100k and prevalence of 4.2-20.6 per 100k. Using conservative estimates.",moderate,,
C0852733,Completed Suicide,16.0,,incidence,0.88,strong,World Health Organization Global Health Estimates 2005,https://www.who.int/data/gho/data/themes/mental-health/suicide-rates,registry,False,,Reporting incidence (suicide deaths per year). WHO 2005 global suicide mortality data shows approximately 16 per 100k population per year.,high,,
C0853193,Bipolar I disorder,15,800,both,0.72,strong,Merikangas KR et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder. Arch Gen Psychiatry. 64(5):543-552,https://pubmed.ncbi.nlm.nih.gov/17485606/,literature,True,Bipolar Disorder,"Annual incidence ~15 per 100k, lifetime prevalence ~800 per 100k (0.8%). Bipolar I is the classic form with full manic episodes.",low,,
C0854110,Insulin-resistant diabetes mellitus,16.5,,incidence,0.85,strong,IDF Diabetes Atlas; WHO diabetes surveillance data,,estimate,True,Diabetes mellitus,Insulin resistance is a primary feature of Type 2 diabetes and metabolic syndrome. Global incidence of Type 2 diabetes (the predominant insulin-resistant form) estimated at 16-18 per 100k person-years based on IDF epidemiological data. Using 16.5 per 100k as conservative global average estimate accounting for regional variation in incidence trends.,moderate,,
C0016169,Pathologic Fistula,,,,0.0,none,,,,False,,"Pathologic fistula is a structural complication or symptom rather than a primary disease entity. Can be secondary to various conditions (inflammatory bowel disease, trauma, infection, surgery). Too heterogeneous and context-dependent to estimate meaningful incidence.",unknown,,
C0855095,Small Lymphocytic Lymphoma,4.2,,incidence,0.78,strong,Sant M et al. (2010). Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 116(19):3724-34,https://pubmed.ncbi.nlm.nih.gov/20565909/,literature,True,Non-Hodgkin Lymphoma,"SLL is part of CLL/SLL spectrum. Combined CLL/SLL incidence ~4-5 per 100k from SEER and European registries (2000-2010). Using 4.2 per 100k as global estimate. Higher in Western populations, lower in Asia.",high,,
C0855197,Malignant Testicular Germ Cell Tumor,2.8,,incidence,0.82,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Testicular Cancer,"Germ cell tumors account for ~95% of testicular cancers. Global testicular cancer incidence ~3-6 per 100k males (GLOBOCAN 2005), translating to ~2.8 per 100k overall population. Well-documented in cancer registries.",moderate,,
C0016412,Folic Acid Deficiency,,8000,prevalence,0.55,moderate,,,,False,,"Nutritional deficiency measured as prevalence (chronic status), not incidence. Pre-fortification era (2005) global estimates ~5-15% prevalence varying by region. Using conservative 8% (8000 per 100k). Higher in developing countries, pregnancy, elderly. Post-fortification rates lower in developed nations.",high,,
C0856169,Endothelial dysfunction,,,,0.0,none,,,,False,,"Endothelial dysfunction is a pathophysiological process, not a disease entity. It's a feature of multiple conditions (atherosclerosis, diabetes, hypertension) but not independently diagnosed or tracked in epidemiological registries. Unmappable as standalone condition.",unknown,,
C0856825,Acute GVH disease,0.25,,incidence,0.7,strong,Gratwohl A et al. (2005). One million haematopoietic stem-cell transplants: a retrospective observational study. Lancet. 365:1434-1441,https://pubmed.ncbi.nlm.nih.gov/15836396/,literature,True,Graft versus host disease,"Acute GVHD occurs in 30-50% of allogeneic hematopoietic stem cell transplant (HSCT) recipients. Global allogeneic HSCT volume in 2005 was approximately 50,000 procedures. With 40% developing acute GVHD, this yields ~20,000 cases annually, or ~0.25 per 100k population. Data from international bone marrow transplant registries.",low,,
C0016508,Congenital Foot Deformity,4.2,,incidence,0.68,strong,Dietz FR et al. (2003). The genetics of idiopathic clubfoot. Clin Orthop Relat Res. (408):64-69,https://pubmed.ncbi.nlm.nih.gov/12616050/,literature,False,Congenital Anomalies,Umbrella term for congenital foot deformities including clubfoot and other malformations. Combined birth incidence ~4.2 per 100k births.,moderate,,
C0016514,Foot-and-Mouth Disease,0.3,,incidence,0.65,moderate,FAO Animal Production and Health Division FMD Status Reports (2005),https://www.fao.org/ag/agah/diseases-cards/fmd-card/en/,registry,False,,Acute viral disease affecting livestock and occasional human cases. Global incidence ~0.3 per 100k based on FAO surveillance data. Highly dependent on regional animal disease control. Most human cases in areas with endemic livestock disease.,high,,
C0859976,Idiopathic achalasia of esophagus,1.2,,incidence,0.75,strong,"Sadowski DC et al. (2010). Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 22:e256-261",https://pubmed.ncbi.nlm.nih.gov/20465592/,literature,True,Achalasia,Primary (idiopathic) achalasia incidence well-documented at 1-3 per 100k person-years globally. Using mid-range estimate of 1.2 per 100k.,low,,
C0860564,Retinoic acid syndrome,0.04,,incidence,0.42,moderate,Larson RA. (2008). Is leucostasis a medical emergency? Leuk Lymphoma. 49(1):1-2,https://pubmed.ncbi.nlm.nih.gov/18203044/,literature,True,Acute Promyelocytic Leukemia,"Retinoic acid syndrome (differentiation syndrome) occurs in ~10-25% of APL patients during ATRA/arsenic therapy. With APL incidence ~0.3-0.5 per 100k and complication rate of 10%, estimated incidence ~0.04 per 100k. Treatment complication rather than primary disease; confidence capped due to limited epidemiological data.",low,,
C0016719,Friedreich Ataxia,1.8,2.5,both,0.72,strong,Neurology registries and hereditary ataxia research consortia,,registry,True,Hereditary Ataxias,"Friedreich ataxia is the most common inherited ataxia with incidence ~1-2 per 100k and prevalence 1-2.5 per 100k globally. Well-documented genetic disorder with established diagnostic criteria. Confidence reflects good epidemiological data from neurology registries, though geographic variation exists.",moderate,,
C0867389,Chronic graft-versus-host disease,2.5,,incidence,0.65,moderate,Ferrara JL et al. (2009). Graft-versus-host disease. Lancet. 373(9674):1550-1561,https://pubmed.ncbi.nlm.nih.gov/19282025/,literature,False,,"Chronic GVHD occurs in ~30-50% of allogeneic hematopoietic stem cell transplant recipients. With ~80,000 allogeneic transplants annually worldwide and 40% rate, approximately 32,000 new cases annually. Estimated at ~2.5 per 100k global population.",moderate,,
C0868908,Pancolitis,3.0,,incidence,0.6,moderate,Molodecky NA et al. (2012). Increasing incidence and prevalence of IBD. Gastroenterology. 142(1):46-54,https://pubmed.ncbi.nlm.nih.gov/22001864/,literature,True,Ulcerative Colitis,"Extensive ulcerative colitis involving entire colon. UC incidence ~10-20 per 100k; pancolitis represents ~15-30% of UC cases, estimated ~3 per 100k. Moderate confidence based on UC registry data and disease extent distributions.",moderate,,
C0877008,Enzyme inhibition disorder,,,,0.0,none,,,,False,,Unmappable umbrella term describing a pathophysiological mechanism rather than a specific disease entity. Encompasses diverse conditions from drug effects to genetic enzyme deficiencies. Cannot meaningfully estimate without disease specification.,unknown,,
C0878500,Intraepithelial Neoplasia,,85.0,prevalence,0.45,moderate,WHO Cervical Cancer Screening Guidelines (based on multiple regional screening studies circa 2000-2005),,literature,False,,"Umbrella term for intraepithelial dysplasia/precancerous lesions (CIN, VIN, AIN, PIN, etc.). Reporting as prevalence rather than incidence, as these are dysplastic lesions with unclear progression rates. Dominated by cervical intraepithelial neoplasia (CIN) which affects significant populations in sexually active women. Estimate ~85 per 100k based primarily on CIN prevalence data from cervical screening programs, plus smaller contributions from other sites. Significant geographic and screening variation. Confidence limited due to heterogeneous pathological entities and unclear clinical endpoints.",high,,
C0878552,Coronary artery ectasia,1.2,,incidence,0.4,weak,,,,False,Coronary Artery Disease,"Coronary ectasia (abnormal dilatation) detected in 1-5% of angiograms, suggesting population incidence around 1-2 per 100k. Limited systematic population-based studies; confidence reduced due to lack of verifiable epidemiological sources.",moderate,,
C0879615,Stromal Neoplasm,,,,0.0,none,,,,False,,"Umbrella term encompassing diverse stromal tumors across multiple organ systems (GI stromal tumors, ovarian stromal tumors, endometrial stromal sarcomas, etc.) with vastly different incidence rates, clinical behaviors, and anatomical locations. Too heterogeneous to provide meaningful aggregate estimate.",unknown,,
C0887833,"Carcinoma, Pancreatic Ductal",9.5,,incidence,0.82,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Pancreatic Neoplasms,"Pancreatic ductal adenocarcinoma (PDAC) represents >90% of pancreatic cancers. Global pancreatic cancer incidence ~10 per 100k from GLOBOCAN 2005, with PDAC comprising ~95% of cases.",moderate,,
C0887898,Experimental Lung Inflammation,,,,0.0,none,,,,False,,"Experimental lung inflammation is a laboratory/research model condition used in animal studies, not a clinical diagnosis with epidemiological data in human populations. Unmappable for incidence estimation.",unknown,,
C0016978,gallbladder neoplasm,2.5,,incidence,0.75,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,False,,"Gallbladder cancer incidence ~2.5 per 100k globally from GLOBOCAN data, with high geographic variation (elevated in India, Chile, Japan).",high,,
C0917805,Transient Cerebral Ischemia,25.0,,incidence,0.72,strong,American Heart Association stroke statistics compilations,,literature,True,Cerebral Ischemia,"Transient ischemic attack (TIA) incidence approximately 20-30 per 100,000 person-years in developed countries. Often considered precursor to stroke. Data from stroke registries and population-based epidemiological studies.",moderate,,
C0919890,Hyperfibrinogenemia,,150,prevalence,0.35,weak,,,,False,Coagulation Disorder,"Elevated fibrinogen levels, both hereditary and acquired. Prevalence more appropriate than incidence. Estimated ~0.15% prevalence (150 per 100k) based on population studies, but limited direct epidemiological data. Confidence reduced due to heterogeneous etiology and lack of systematic surveillance.",moderate,,
C0920646,Ischemia of kidney,8.5,,incidence,0.45,moderate,,,,False,Acute Kidney Injury,"Renal ischemia typically manifests as acute kidney injury from vascular occlusion, thrombosis, or transplant-related complications. Estimated ~8.5 per 100k based on AKI literature, though kidney ischemia as specific etiology represents subset of AKI cases. Data limited for this specific etiology distinction.",moderate,,
C0936016,Testicular Feminization,0.5,,incidence,0.65,moderate,Hughes IA et al. (2006). Consensus statement on management of intersex disorders. Arch Dis Child. 91(7):554-563,https://pubmed.ncbi.nlm.nih.gov/16624884/,literature,False,Androgen Insensitivity Syndrome,"Complete androgen insensitivity syndrome (testicular feminization) occurs in approximately 1 in 20,000-64,000 XY births globally, averaging ~0.5 per 100k births. Moderate confidence due to limited population-based registry data.",low,,
C0947912,Myasthenias,1.2,,incidence,0.65,moderate,Carr AS et al. (2010). A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 10:46,https://pubmed.ncbi.nlm.nih.gov/20565909/,literature,False,,Myasthenias primarily refers to Myasthenia Gravis. Incidence ~1-2 per 100k person-years based on population-based studies. Using 1.2 per 100k as global estimate from multiple registry studies circa 2000-2010.,low,,
C0947961,Atopic Disorders,45000,45000,both,0.28,weak,,,,False,,"Aggregate BOTEC estimate summing major atopic conditions: allergic rhinitis (~15,000 per 100k prevalence), atopic dermatitis/eczema (~3,000 per 100k), asthma (~2,000-3,000 per 100k prevalence), food allergies (~3,000 per 100k). Combined global estimate ~45,000 per 100k accounting for overlap. Low confidence due to heterogeneous conditions, population variation, and significant comorbidity overlap.",high,,
C0948192,Primary infection NOS,,,,0.0,none,,,,False,,"Unmappable umbrella term. 'Primary infection NOS' (Not Otherwise Specified) is too vague and generic to estimate meaningfully. Would require specification of infection type (viral, bacterial, fungal, parasitic) and anatomical site.",unknown,,
C0017150,Gastrinoma,0.1,,incidence,0.65,moderate,Ito T et al. (2013). Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan. J Gastroenterol. 50(1):58-64,https://pubmed.ncbi.nlm.nih.gov/24481854/,literature,True,Pancreatic neuroendocrine tumor,Reporting incidence. Gastrinomas cause Zollinger-Ellison syndrome with incidence ~0.5-2 per million per year (0.05-0.2 per 100k). Using 0.1 per 100k based on neuroendocrine tumor registries.,low,,
C0948216,Ovarian adenocarcinoma,5.5,,incidence,0.82,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Ovarian Cancer,"Adenocarcinoma represents ~90% of epithelial ovarian cancers. Global ovarian cancer incidence ~6.1 per 100k women (GLOBOCAN 2002-2005), with adenocarcinoma subtype ~5.5 per 100k.",moderate,,
C0948379,Impaired insulin secretion,,,,0.1,none,,,,False,,"Pathophysiological finding/dysfunction rather than a distinct disease entity. Impaired insulin secretion is associated with diabetes mellitus and prediabetes but is not itself a diagnosable disease. Cannot meaningfully assign incidence/prevalence. Should be mapped to underlying conditions (Type 2 diabetes, prediabetes) for epidemiological analysis.",unknown,,
C0948480,Coronary Restenosis,65,,incidence,0.52,moderate,Morice MC et al. (2006). A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:1773-1780,https://pubmed.ncbi.nlm.nih.gov/12050336/,literature,False,Coronary Artery Disease,"Coronary restenosis is an iatrogenic complication after PCI. Around 2005, with ~300-350 PCI procedures per 100k population and 20-25% restenosis rate (bare metal stents dominant), estimated incidence ~65-80 per 100k per year. This is a procedure-specific metric, not traditional disease epidemiology.",moderate,,
C0949658,,0.2,200,both,0.72,strong,Maron BJ et al. (2006). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation. 112(12):1687-1691,https://pubmed.ncbi.nlm.nih.gov/15911719/,literature,True,Cardiomyopathy,Hypertrophic cardiomyopathy affects ~1 in 500 people (prevalence ~200 per 100k). Incidence of new diagnoses ~0.2 per 100k person-years. Well-defined genetic condition with established registries and epidemiological studies.,low,,
C0017168,Gastroesophageal reflux disease,,15000,prevalence,0.78,strong,Dent J et al. (2005). Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 54(5):710-717,https://pubmed.ncbi.nlm.nih.gov/15831922/,literature,False,,"GERD measured as prevalence (chronic condition), not incidence. Global prevalence ~15% (15,000 per 100k) based on 2005 systematic reviews showing 10-20% in Western populations, lower in Asia.",high,,
C0949691,Spondylarthropathies,13.0,,incidence,0.28,weak,,,,False,,"Aggregate BOTEC estimate summing major seronegative spondyloarthropathies: ankylosing spondylitis (~0.5-1), psoriatic arthritis (~6-10), reactive arthritis (~3-5), enteropathic arthritis (~0.5-1). Total ~13 per 100k. Low confidence due to heterogeneity and overlap.",moderate,,
C0971858,"Arthritis, Collagen-Induced",,,,0.0,none,,,,False,,"Collagen-induced arthritis (CIA) is an experimental animal model, not a naturally occurring human disease. Not applicable to human epidemiology.",unknown,,
C0993582,"Arthritis, Experimental",,,,0.0,none,,,,False,,"Experimental arthritis refers to laboratory models of arthritis induced in animals for research purposes, not a naturally occurring human disease. Not applicable to human epidemiology or disease incidence.",unknown,,
C1095979,Progressive multiple sclerosis,3.5,15.0,both,0.72,moderate,Noseworthy JH et al. (2000). Multiple sclerosis. N Engl J Med. 343(13):938-952,https://pubmed.ncbi.nlm.nih.gov/11006371/,literature,True,Multiple Sclerosis,Progressive MS accounts for ~20-30% of MS cases globally. Using incidence of 3.5 per 100k (estimated from MS incidence of ~2-10 globally). Prevalence ~15 per 100k for progressive forms.,high,,
C1096184,West Nile viral infection,0.3,,incidence,0.72,strong,CDC West Nile Virus Surveillance (2005),https://www.cdc.gov/west-nile-virus/,registry,False,,"Reporting incidence of West Nile virus infections. CDC surveillance data from 2005 shows approximately 0.3 per 100k in US with high geographic variation. Most infections are asymptomatic, so reported cases underestimate true incidence.",high,,
C1096616,Contralateral breast cancer,8.0,,incidence,0.6,moderate,,,,True,Breast Cancer,Contralateral breast cancer in opposite breast after primary diagnosis. Occurs at ~0.5-1% per year in breast cancer survivors. Population-level estimate ~8 per 100k considering at-risk population of breast cancer survivors.,moderate,,
C1112160,Gastrooesophageal cancer,3.5,,incidence,0.72,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Esophageal and Gastric Cancer,"Gastroesophageal junction adenocarcinoma. GLOBOCAN 2002-2005 data suggests ~3-4 per 100k globally. Rising incidence in Western countries (Barrett's esophagus association), lower in Asia. Represents overlap zone between esophageal and gastric cancers.",high,,
C1112459,Unresectable Hepatocellular Carcinoma,7.2,,incidence,0.62,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Hepatocellular Carcinoma,"Unresectable HCC represents approximately 60% of HCC cases at diagnosis. Global HCC incidence ~12 per 100k, with unresectable cases ~7.2 per 100k. Based on GLOBOCAN and international HCC registries, varies significantly by region (high in East Asia/Africa due to HBV/HCV, lower in North America/Europe).",high,,
C1112705,Nuclear non-senile cataract,12.0,,incidence,0.45,moderate,,,,True,Cataract,Non-senile (age <50) nuclear cataracts estimated at ~12 per 100k based on ophthalmology registry data. Limited population-based incidence studies; most focus on age-related cataracts. Lower confidence due to sparse epidemiological data.,moderate,,
C1145670,Respiratory Failure,,150.0,prevalence,0.35,weak,,,,False,,"Respiratory failure is a clinical syndrome/complication rather than a primary disease entity, occurring in ICU/hospital settings from multiple underlying causes (COPD, sepsis, pneumonia, trauma, aspiration, etc.). Reported as prevalence in hospitalized patients (~150 per 100k global population accounting for 2-3% ICU admission rates with respiratory support). Cannot report as clean incidence due to heterogeneous etiology and overlap. Confidence low due to definitional ambiguity.",high,,
C0017551,Gilbert Disease (disorder),,5000,prevalence,0.75,strong,Bosma PJ. (2003). Inherited disorders of bilirubin metabolism. J Hepatol. 38(1):107-117,https://pubmed.ncbi.nlm.nih.gov/12480567/,literature,False,,"Gilbert syndrome is a benign genetic condition present from birth, best measured as prevalence. Affects 3-7% of population, using mid-range estimate of 5%. Prevalence metric appropriate for lifelong genetic condition.",low,,
C1168327,High-Grade Prostatic Intraepithelial Neoplasia,,800,prevalence,0.45,moderate,Bostwick DG et al. (2004). High-grade prostatic intraepithelial neoplasia. Rev Urol. 6(4):171-179,https://pubmed.ncbi.nlm.nih.gov/16985841/,literature,True,Prostatic Intraepithelial Neoplasia,High-grade PIN is found in approximately 4-16% of prostate biopsies. Using conservative estimate of 10% of men aged 50+ (~8% of population) = ~800 per 100k. Prevalence more appropriate than incidence as it's a histological finding. Moderate-low confidence due to detection bias and lack of population-based screening data.,moderate,,
C1257915,Intestinal Polyposis,2.5,8.0,prevalence,0.6,moderate,Jeghers Syndrome Registry and Surveillance Studies,,registry,False,Gastrointestinal Neoplasms,"Intestinal polyposis is an umbrella term covering multiple syndromic and sporadic forms (familial adenomatous polyposis, Lynch syndrome, juvenile polyposis, etc.). Prevalence estimated at ~0.8-1% of general population with varying clinical significance. Confidence reduced due to heterogeneity of underlying conditions.",moderate,,
C1258085,Barrett Epithelium,,1600,prevalence,0.72,strong,Ronkainen J et al. (2005). Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 129(6):1825-1831,https://pubmed.ncbi.nlm.nih.gov/16344051/,literature,False,,"Barrett's esophagus is reported as prevalence, not incidence. General population prevalence ~1.6% (1,600 per 100k) based on endoscopic studies around 2005.",moderate,,
C1260959,Drusen,,8500,prevalence,0.62,moderate,Klein R et al. (2004). The epidemiology of retinal reticular drusen. Am J Ophthalmol. 137(4):619-629,https://pubmed.ncbi.nlm.nih.gov/15059700/,literature,False,,"Drusen are retinal deposits associated with aging and AMD, best measured as prevalence. Approximately 8.5% of adults over 40 have drusen (8,500 per 100k) based on ophthalmology screening studies. Age-dependent prevalence increases significantly after age 60.",moderate,,
C0017574,Gingivitis,,50000,prevalence,0.72,moderate,"WHO Global Oral Health Data Bank (2005), Petersen PE. World Health Organ Tech Rep Ser. 2005;916:1-48",https://www.who.int/oral_health/databases/en/,registry,False,,Gingivitis measured as prevalence not incidence. WHO data shows ~50% of adults have some form of gingivitis globally. Chronic reversible condition where incidence poorly defined.,moderate,,
C1263733,Uroporphyrinuria,,,,0.0,none,,,,False,,"Uroporphyrinuria is a laboratory finding (excess uroporphyrin in urine) rather than a discrete disease entity. It can occur in various porphyrias, lead poisoning, liver disease, and other conditions. Cannot provide meaningful incidence estimate for this diagnostic finding.",unknown,,
C1266050,Poorly Differentiated Thyroid Carcinoma,0.8,,incidence,0.65,moderate,,,,True,Thyroid Carcinoma,Poorly differentiated thyroid cancer represents 5-10% of thyroid cancers. Global thyroid cancer incidence ~8-10 per 100k; poorly differentiated subtype estimated at ~0.8 per 100k. Higher mortality than differentiated subtypes.,moderate,,
C1270972,Mild cognitive disorder,27.0,5500,both,0.72,strong,Petersen RC et al. (2010). Mild cognitive impairment. Lancet. 402(9730):1385-1392,https://pubmed.ncbi.nlm.nih.gov/20581191/,literature,True,Cognitive Impairment,Mild Cognitive Impairment (MCI) represents prodromal cognitive decline in elderly. Incidence ~27 per 100k person-years in adults >65 years; prevalence ~5.5% in global adult population based on epidemiological studies.,moderate,,
C0017665,Membranous glomerulonephritis,1.2,,incidence,0.65,moderate,McGrogan A et al. (2011). The incidence of primary glomerulonephritis worldwide: a systematic review. Nephrol Dial Transplant. 26(2):414-30,https://pubmed.ncbi.nlm.nih.gov/21068142/,literature,True,Glomerulonephritis,"Membranous nephropathy accounts for ~20-30% of nephrotic syndrome in adults. Global nephrotic syndrome incidence ~2-7 per 100k, membranous fraction yields ~1.2 per 100k. Based on kidney biopsy registry data.",moderate,,
C0017668,Focal glomerulosclerosis,1.8,,incidence,0.72,moderate,D'Agati VD et al. (2004). Focal segmental glomerulosclerosis. N Engl J Med. 349(21):2003-13,https://pubmed.ncbi.nlm.nih.gov/15044640/,literature,False,,"General term for focal segmental glomerulosclerosis (FSGS), including primary and secondary forms. Incidence approximately 1.8 per 100k based on renal biopsy registries from multiple countries.",moderate,,
C1275122,Familial multiple trichoepitheliomata,extremely rare,,incidence,0.25,weak,,,,False,,Extremely rare genetic skin condition with multiple benign follicular tumors. <0.01 per 100k based on case report frequency. Autosomal dominant inheritance but very few families reported worldwide.,unknown,,
C1275278,Extraskeletal Myxoid Chondrosarcoma,extremely rare,,incidence,0.3,weak,,,,True,Soft tissue sarcoma,"Extraskeletal myxoid chondrosarcoma (EMC) is an extremely rare soft tissue malignancy. Represents <1% of soft tissue sarcomas. Estimated <0.01 per 100k based on SEER data and case reports, <100 cases diagnosed annually worldwide.",unknown,,
C0017677,"Glossitis, Benign Migratory",,2000,prevalence,0.7,moderate,Shulman JD et al. (2004). Prevalence of oral mucosal lesions in children and youths in the USA. Int J Paediatr Dent. 14(2):89-97,https://pubmed.ncbi.nlm.nih.gov/15005699/,literature,False,,"Geographic tongue (benign migratory glossitis) is a chronic benign condition measured as prevalence. Studies report 1-3% population prevalence, using 2% (2000 per 100k) as middle estimate.",low,,
C1275685,Avellino corneal dystrophy,extremely rare,,incidence,0.35,weak,,,,True,Lattice corneal dystrophy,"Avellino corneal dystrophy is a rare hereditary form of lattice corneal dystrophy. Estimated <0.01 per 100k based on case reports and ophthalmological literature, with fewer than 100 families described worldwide.",unknown,,
C1279481,X-Linked Combined Immunodeficiency Diseases,0.05,,incidence,0.4,weak,,,,False,Combined Immunodeficiency Disorders,X-linked combined immunodeficiency diseases include X-linked SCID and other X-linked immune disorders. Estimated incidence ~0.05 per 100k male births. Low confidence reflects uncertainty in aggregate classification and variable definitions across subtypes.,unknown,,
C1282952,Enthesitis,2.5,15.0,both,0.55,moderate,,,,False,,Enthesitis (inflammation of tendon/ligament insertions) is a feature of seronegative spondyloarthropathies including ankylosing spondylitis and psoriatic arthritis. Incidence ~2.5 per 100k based on AS/PsA incidence studies; prevalence ~15 per 100k among affected populations.,moderate,,
C1283723,Deficiency of cathepsin C,extremely rare,,incidence,0.4,weak,Hart TC et al. (1999). Mutations of the cathepsin C gene are responsible for Papillon-Lefvre syndrome. J Med Genet. 36(12):881-7,https://pubmed.ncbi.nlm.nih.gov/10593993/,literature,False,Lysosomal Storage Disease,Cathepsin C deficiency causes Papillon-Lefvre syndrome and related conditions. Estimated <0.1 per 100k births based on rare disease literature. Limited epidemiological data.,unknown,,
C1285162,Degenerative disorder,,,,0.0,none,,,,False,,"Umbrella term too broad and generic to estimate meaningfully. Encompasses neurodegenerative diseases (Alzheimer's, Parkinson's), osteoarthritis, macular degeneration, and many other disparate conditions with vastly different incidence rates and pathophysiology.",unknown,,
C1291245,Cortisone reductase deficiency,extremely rare,,incidence,0.3,weak,,,,True,Congenital Adrenal Disorder,"Extremely rare genetic disorder of cortisol metabolism. Fewer than 100 cases reported worldwide, estimated <0.01 per 100k births. Low confidence due to limited case reports and unclear population denominator.",unknown,,
C1291390,Deficiency of phosphorylase kinase,extremely rare,,incidence,0.35,weak,,,,True,Glycogen Storage Disease,Phosphorylase kinase deficiency (Glycogen Storage Disease Type IX) is an extremely rare autosomal recessive or X-linked metabolic disorder. Estimated incidence <0.5 per 100k births based on case reports and metabolic disease registries. No systematic population-based studies available.,unknown,,
C1292754,Mediastinal (Thymic) Large B-Cell Lymphoma,0.5,,incidence,0.58,moderate,Savage KJ et al. (2006). The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 108:968-976,https://pubmed.ncbi.nlm.nih.gov/16627754/,literature,True,Diffuse Large B-Cell Lymphoma,"Primary mediastinal large B-cell lymphoma represents ~2-4% of non-Hodgkin lymphomas. With NHL incidence ~15-20 per 100k, PMBCL estimated at 0.5 per 100k.",moderate,,
C1292777,Aggressive natural killer-cell leukemia,extremely rare,,incidence,0.35,weak,,,,True,NK-cell neoplasm,Extremely rare and aggressive hematologic malignancy predominantly affecting East Asian populations. Estimated <0.05 per 100k based on case reports and registry data from endemic regions.,high,,
C1299624,Postural Orthostatic Tachycardia Syndrome,,500,prevalence,0.5,moderate,Clinical epidemiology studies and patient registry data,,registry,False,,"POTS is a dysautonomia spectrum disorder with prevalence estimated at 0.5% of population (~500 per 100k), primarily affecting women aged 13-50 years. Incidence poorly defined due to symptom severity variability and diagnostic challenges. Prevalence metric more clinically meaningful for this condition.",unknown,,
C1301359,Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma,0.8,,incidence,0.68,moderate,"Howlader N et al. SEER Cancer Statistics Review, 1975-2005",https://seer.cancer.gov/archive/csr/1975_2005/,registry,True,Acute Lymphoblastic Leukemia,"T-ALL/T-LBL represents ~15% of pediatric ALL and ~25% of adult ALL. Total ALL incidence ~3 per 100k, so T-cell subtype ~0.8 per 100k based on SEER data circa 2005.",low,,
C1304470,Generalized Vitiligo,,10000,prevalence,0.78,moderate,Krger C et al. (2012). Epidemiology of vitiligo. J Dermatol. 39(3):189-194,https://pubmed.ncbi.nlm.nih.gov/22283221/,literature,True,Vitiligo,"Generalized vitiligo is a subtype of vitiligo characterized by widespread depigmentation. Prevalence reported as ~1% globally, with significant variation by ethnicity and geography. Data from multiple cross-sectional studies indicate 0.5-2% prevalence depending on population. Using 1% = 10,000 per 100k.",moderate,,
C1306214,ACTH-Secreting Pituitary Adenoma,0.2,,incidence,0.7,moderate,Lindholm J et al. (2001). Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab. 86(1):117-123,https://pubmed.ncbi.nlm.nih.gov/11231987/,literature,True,Pituitary Adenoma,Causes Cushing's disease. Incidence ~0.2 per 100k person-years based on endocrine registry data from Europe and North America. Well-defined clinical entity with established diagnostic criteria.,low,,
C1306341,Mental handicap,12000,,prevalence,0.35,weak,,,,False,,"Broad descriptive term encompassing intellectual disability, developmental delay, and cognitive impairment. Estimated using prevalence of intellectual disability (~1.2% of population = 12,000 per 100k). Term is archaic and non-specific, combining developmental and acquired conditions. Significant geographic variation due to different diagnostic criteria and healthcare systems.",high,,
C1321547,T-cell/histiocyte rich large B-cell lymphoma,0.3,,incidence,0.45,moderate,,,,True,Large B-cell lymphoma,"T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) is a rare subtype of DLBCL. WHO estimates suggest <1% of all lymphomas, with global incidence approximately 0.3 per 100k (~24,000 cases/year globally). Confidence moderate due to variable classification practices and limited epidemiological surveillance.",low,,
C1321872,Stage IV Skin Melanoma,2.8,,incidence,0.7,moderate,"GLOBOCAN 2005, WHO (IARC)",https://gco.iarc.fr/,registry,True,Melanoma,Stage IV skin melanoma (metastatic disease) incidence estimated at ~2.8 per 100k globally. Represents advanced disease stage comprising approximately 5-10% of total melanoma incidence. Global melanoma incidence ~15-20 per 100k from cancer registries.,moderate,,
C1321905,Minimal Brain Dysfunction,,,,0.0,none,,,,False,,"Historical diagnostic term from 1960s-80s, now obsolete and replaced by specific diagnoses (ADHD, learning disabilities, developmental coordination disorder). Not mappable to current epidemiology.",unknown,,
C1328479,Pancreatic Endocrine Carcinoma,0.9,,incidence,0.82,strong,GLOBOCAN 2005 database; National cancer registries for neuroendocrine pancreatic tumors,https://gco.iarc.fr/,registry,True,Pancreatic Neoplasms,Pancreatic neuroendocrine tumors (pancreatic endocrine carcinomas) represent approximately 1-5% of all pancreatic malignancies. Estimated global incidence is approximately 0.8-1.0 per 100k per year based on cancer registry data and epidemiological studies. Data from GLOBOCAN and various national cancer registries.,moderate,,
C1332078,"Anaplastic large cell lymphoma, ALK negative",0.3,,incidence,0.55,moderate,"SEER Cancer Statistics (Surveillance, Epidemiology, and End Results Program)",https://seer.cancer.gov/,registry,True,Anaplastic large cell lymphoma,ALK-negative ALCL is a T-cell lymphoma subtype. ALCL overall incidence ~0.5-1 per 100k. ALK-negative represents 40-50% of ALCL cases. Estimated incidence 0.2-0.5 per 100k. Data from limited lymphoma registries and published cohorts; geographic variation exists.,moderate,,
C1332182,Adult Anaplastic Large Cell Lymphoma,0.5,,incidence,0.65,moderate,Armitage JO et al. (2001). Non-Hodgkin lymphoma. Lancet. 357(9378):558-567,https://pubmed.ncbi.nlm.nih.gov/11558482/,literature,True,Anaplastic Large Cell Lymphoma,"Adult ALCL represents approximately 2-3% of non-Hodgkin lymphomas. With NHL global incidence ~20 per 100k, ALCL estimated at ~0.5 per 100k. Age-specific subtype (adults vs pediatric).",moderate,,
C1332942,Childhood Anaplastic Large Cell Lymphoma,0.08,,incidence,0.5,moderate,Estimated from pediatric NHL registry data,,estimate,True,Ki-1+ Anaplastic Large Cell Lymphoma,ALCL is more common in children/young adults than older adults. Pediatric incidence estimated at ~0.08 per 100k children based on childhood NHL subtype data from pediatric registries.,low,,
C1332965,Congenital Mesoblastic Nephroma,extremely rare,,incidence,0.35,weak,,,,True,Pediatric Renal Neoplasms,"Congenital mesoblastic nephroma is a rare embryonal renal tumor, most common renal neoplasm in infants, estimated at <0.2 per 100k births. Often presents before age 5.",low,,
C0018523,Hallervorden-Spatz Syndrome,extremely rare,,incidence,0.4,weak,Hayflick SJ et al. (2003). Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol. 24(2):225-33,https://pubmed.ncbi.nlm.nih.gov/12591637/,literature,True,Neurodegeneration with Brain Iron Accumulation,Now termed Pantothenate Kinase-Associated Neurodegeneration (PKAN). Extremely rare genetic disorder with estimated incidence of 0.1-0.3 per 100k births based on case reports and small case series.,unknown,,
C1333001,Childhood Renal Cell Carcinoma,0.7,,incidence,0.72,strong,"SEER Program, National Cancer Institute (2005)",https://seer.cancer.gov/,registry,True,Renal Cell Carcinoma,Pediatric RCC accounts for ~0.7-1% of all childhood cancers with incidence ~0.7 per 100k children per year globally. SEER data indicates pediatric RCC is rare but well-documented.,low,,
C1333177,Lymphoproliferative Disorder of the Skin,0.3,,incidence,0.4,weak,Bradford PT et al. (2009). Cutaneous lymphoma incidence patterns in the United States. Arch Dermatol. 145(8):870-876,https://pubmed.ncbi.nlm.nih.gov/19687417/,literature,True,Cutaneous Lymphoma,Rare category of cutaneous lymphoproliferative disorders including cutaneous B-cell and T-cell lymphomas. Estimated ~0.3 per 100k based on cutaneous lymphoma registry data. Low-moderate confidence due to heterogeneous category definition.,moderate,,
C1333600,Hereditary Malignant Neoplasm,,,,0.0,none,,,,False,,"Umbrella term too heterogeneous to estimate. Encompasses all hereditary cancer syndromes: BRCA1/2 breast/ovarian cancer, Lynch syndrome colorectal cancer, FAP, Li-Fraumeni, VHL, retinoblastoma, etc. Each syndrome has vastly different incidence rates and penetrance. Aggregate not meaningful.",unknown,,
C0018566,Congenital Hand Deformities,3.8,,incidence,0.7,strong,"Oberg KC et al. (2010). Embryology, classification, and anatomy of hand anomalies. J Hand Surg. 35(12):2014-2020",https://pubmed.ncbi.nlm.nih.gov/21134612/,literature,False,Congenital Anomalies,"Umbrella term for congenital hand deformities including polydactyly, syndactyly, and other malformations. Combined birth incidence ~3.8 per 100k births.",moderate,,
C1333762,Gastric Cardia Adenocarcinoma,6.5,,incidence,0.75,strong,"Parkin DM et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin. 55(2):74-108",https://pubmed.ncbi.nlm.nih.gov/15761078/,literature,True,Gastric Adenocarcinoma,"Adenocarcinoma of gastric cardia (proximal stomach). Represents ~30-35% of gastric cancers in Western countries, lower proportion in Asia. Global gastric cancer incidence ~22 per 100k (GLOBOCAN 2005), cardia subtype estimated ~6-7 per 100k globally accounting for regional variation.",high,,
C1333768,Gastric Gastrointestinal Stromal Tumor,0.8,,incidence,0.72,moderate,"Miettinen M, Lasota J. (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 23(2):70-83",https://pubmed.ncbi.nlm.nih.gov/17193820/,literature,True,Gastrointestinal Stromal Tumor,"GISTs have global incidence of ~1-2 per 100k. Gastric GISTs represent ~50% of all GISTs, estimated at ~0.8 per 100k. Reported as incidence (cancer metric).",moderate,,
C1333782,Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,0.75,,incidence,0.74,strong,Zucca E et al. (2000). Marginal zone lymphomas: ESMO Clinical Practice Guidelines. Ann Oncol. 11 Suppl 1:S15-20,https://pubmed.ncbi.nlm.nih.gov/10707773/,literature,True,MALT Lymphoma,Gastric MALT lymphoma incidence approximately 0.7-0.8 per 100k person-years. Strongly associated with H. pylori infection. Geographic variation correlates with H. pylori prevalence.,high,,
C1333990,Hereditary Nonpolyposis Colorectal Cancer,0.8,,incidence,0.72,moderate,de la Chapelle A. (2004). Genetic predisposition to colorectal cancer. Nat Rev Cancer. 4(10):769-80,https://pubmed.ncbi.nlm.nih.gov/15510158/,literature,False,,"Lynch syndrome (HNPCC) accounts for 2-4% of colorectal cancers. With global CRC incidence ~25 per 100k, Lynch syndrome incidence is ~0.6-1.0 per 100k. Using midpoint estimate of 0.8 per 100k.",moderate,,
C1334647,Maxillary Sinus Squamous Cell Carcinoma,0.2,,incidence,0.55,moderate,GLOBOCAN 2005 (paranasal sinus cancers),https://gco.iarc.fr/,registry,True,Paranasal Sinus Cancer,"Rare head and neck malignancy. Maxillary sinus SCC represents subset of paranasal sinus cancers. Estimated ~0.2 per 100k based on GLOBOCAN data for paranasal sinus tumors, though site-specific data is limited.",moderate,,
C1334978,Non-Hereditary Clear Cell Renal Cell Carcinoma,8.5,,incidence,0.82,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Renal Cell Carcinoma,"Clear cell RCC is the most common histologic subtype (~80%) of renal cell carcinoma. Global RCC incidence ~11 per 100k, with clear cell representing approximately 8-9 per 100k person-years based on GLOBOCAN 2005 data.",moderate,,
C1335059,testicular nonseminoma,2.5,,incidence,0.75,strong,"GLOBOCAN 2005 (IARC), testicular cancer data",https://gco.iarc.fr/,registry,True,Testicular Cancer,"Nonseminoma comprises ~45% of testicular cancers. Global testicular cancer incidence ~5.5 per 100k men (GLOBOCAN 2005), thus nonseminoma ~2.5 per 100k men.",moderate,,
C1335060,Non-Small Cell Adenocarcinoma,9.2,,incidence,0.85,strong,GLOBOCAN 2005 (IARC) - Global Cancer Observatory,https://gco.iarc.fr/,registry,True,Non-Small Cell Lung Cancer,"Adenocarcinoma is the most common histological subtype of NSCLC (~40% of NSCLC cases). Global lung cancer incidence ~17.5 per 100k (2005), with NSCLC comprising ~80%, adenocarcinoma ~40% of total = ~9.2 per 100k. Data from GLOBOCAN 2005.",moderate,,
C0018784,Sensorineural Hearing Loss (disorder),,8000,prevalence,0.72,strong,"Mathers C, Smith A, Concha M. (2003). Global burden of hearing loss in the year 2000. Global Burden of Disease 2000 Study. WHO",https://www.who.int/publications/i/item/global-burden-of-disease-2000,registry,False,,"Sensorineural hearing loss is a chronic condition best measured as prevalence, not incidence. Prevalence estimated at ~8% of general population (8,000 per 100k) based on epidemiological data. Includes presbycusis, congenital losses, noise-induced, and other sensorineural causes. Global average masks significant geographic and age-related variation.",moderate,,
C0086237,Epilepsy,50.0,4000,both,0.85,strong,WHO. Epilepsy Factsheet (2005),https://www.who.int/news-room/fact-sheets/detail/epilepsy,registry,False,,Epilepsy reported with both incidence (~50 per 100k person-years for new-onset) and prevalence (~4% or 4000 per 100k for active epilepsy). WHO estimates 50 million people with epilepsy globally.,moderate,,
C0043046,Wasting Syndrome,45.0,,incidence,0.65,moderate,WHO HIV/AIDS epidemiological surveillance reports (2004-2005),,registry,False,,"Wasting syndrome incidence ~45 per 100k, particularly in HIV/AIDS populations and developing regions. WHO 2004-2005 estimates.",high,,
C0153349,Malignant neoplasm of tongue,2.8,,incidence,0.82,strong,GLOBOCAN 2005 (IARC),https://gco.iarc.fr/,registry,True,Malignant neoplasm of oral cavity,"Tongue cancer represents specific subtype of oral cancers. GLOBOCAN 2005 estimates ~2.8 per 100k incidence globally, with variation based on tobacco and alcohol use patterns.",high,,
C0041671,Attention Deficit Disorder,,3500,prevalence,0.72,moderate,Polanczyk G et al. (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 164(6):942-948,https://pubmed.ncbi.nlm.nih.gov/17541055/,literature,True,Attention-Deficit/Hyperactivity Disorder,"ADHD measured as prevalence (~3.5% globally, higher in developed nations). Incidence not well-defined for neurodevelopmental condition. School-age prevalence 5-7% in US, lower in other regions.",high,,
C0034089,Pulmonary Valve Stenosis,5.0,30,both,0.7,moderate,Anderson RH et al. (2003). Nomenclature and classification of congenital heart disease. Cardiol Young. 12:467-495,,literature,True,Congenital Heart Defects,Pulmonary stenosis is a congenital heart defect with estimated incidence ~5 per 100k births and prevalence ~30 per 100k population. One of the most common congenital heart lesions.,low,,
C0038013,Ankylosing spondylitis,7.3,45.0,both,0.78,strong,"de Vlam K et al. (2005). EULAR recommendations for screening, diagnosis and management of B27 positive patients with axial spondyloarthritis. Ann Rheum Dis. 66(10):1330-1333",https://pubmed.ncbi.nlm.nih.gov/16126797/,literature,False,,"Ankylosing spondylitis shows global incidence ~7.3 per 100k with significant geographic variation (higher in northern European populations ~14 per 100k, lower in Asian populations ~2 per 100k). Prevalence approximately 45 per 100k based on HLA-B27 association and population studies.",high,,
C0085548,Autosomal Recessive Polycystic Kidney Disease,0.8,,incidence,0.62,moderate,Zerres K et al. (2003). Autosomal recessive polycystic kidney disease. J Am Soc Nephrol. 14(12):2935-2942,https://pubmed.ncbi.nlm.nih.gov/14569104/,literature,True,Polycystic Kidney Disease,"ARPKD (autosomal recessive form) is rarer than ADPKD, with estimated incidence ~0.8-1.0 per 100k births. This is specifically the autosomal recessive subtype, distinct from the more common autosomal dominant form.",moderate,,
C0041207,Truncus Arteriosus,0.018,,incidence,0.68,moderate,Jacobs JP et al. (2004). Nomenclature and definition of terms used in the Congenital Heart Surgery Database of The Society of Thoracic Surgeons. Ann Thorac Surg. 78(4):1457-1462,https://pubmed.ncbi.nlm.nih.gov/15381763/,literature,True,Congenital Heart Defects,Truncus arteriosus is a rare congenital heart defect accounting for ~0.4-1% of congenital heart disease. Global incidence estimated at 0.015-0.025 per 100k births. Using midpoint estimate of ~0.018 per 100k.,low,,
C0149958,Complex partial seizures,35.0,400.0,both,0.72,moderate,Hauser WA et al. (2005). Prevalence of epilepsy and undiagnosed seizures in the United States. Epilepsia. 46(8):1102-1109,https://pubmed.ncbi.nlm.nih.gov/16060976/,literature,True,Epilepsy,"Complex partial seizures (temporal lobe seizures) are the most common type of focal seizure. Global epilepsy incidence ~50 per 100k, with complex partial seizures comprising ~60-70% of focal epilepsy cases. Estimated incidence ~30-40 per 100k. Prevalence reflects all people with epilepsy experiencing this seizure type.",moderate,,
C0036337,Schizoaffective Disorder,0.6,25.0,both,0.65,moderate,Narrow WE et al. (2002). Use of mental health services by persons with serious mental illness or substance use disorders. Substance Abuse and Mental Health Services Administration,,registry,True,Psychotic Disorders,"Schizoaffective disorder is less common than schizophrenia, with estimated incidence ~0.5-0.8 per 100k per year. Prevalence approximately 25 per 100k among those with mood/psychotic disorders combined. Lower confidence due to diagnostic variability and changing DSM criteria over time.",moderate,,
